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PREFACE 
The present Ph.D. study has been conducted at the National Food Institute (previously the National 
Institute for Aquatic Resources) at the Technical University of Denmark. The study lasted from January 2009 
to December 2011 under the supervision of Professor Lone Gram. The project included a 12 week research 
stay with Professor Debra Milton at the Department of Molecular Biology, Umeå University, Sweden. 
The Ph.D. project was carried out as part of the collaborative research project “Discovery of novel bioactive 
bacteria and natural products and their use to improve human health and safety” funded by the 
Programme Commission on Health, Food and Welfare under the Danish Council for Strategic Research. 
The work resulted in the preparation of four manuscripts which form the basis of this thesis. In addition, 
one genome announcement is in preparation for the Journal of Bacteriology, and collaborative efforts 
within the frame of the research project will likely result in a co-authorship (not included in this thesis). 
 
 
Nikolaj G. Vynne 
December 2011 
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SUMMARY 
The purpose of this Ph.D. project was to evaluate a global collection of marine Pseudoalteromonas bacteria 
as a source of novel bioactive compounds, and to investigate the distribution and production of such 
compounds among different species within the Pseudoalteromonas genus. The strain collection was 
obtained during the research cruise “Galathea 3”, which circumnavigated the Earth while screening marine 
bacteria for the ability to inhibit Vibrio anguillarum 90-11-287. Pseudoalteromonas strains were one of the 
most frequently isolated genera. 
The Pseudoalteromonas strains were evaluated for their ability to repeatedly inhibit the fish pathogen 
Vibrio anguillarum 90-11-287 or Staphylococcus aureus 8325. Based on previous work, a hypothesis that 
antagonistic Pseudoalteromonas strains primarily were pigmented and surface associated was investigated. 
This Ph.D. work confirmed that surface-associated strains were significantly more likely to possess stable 
antibacterial activity and be pigmented. Pseudoalteromonas strains are known as prolific producers of 
bioactive secondary metabolites; hence screening the global strain collection for production of novel 
antibiotics was initiated. Novel quinolone-related compounds were described, but were not antibacterial. 
Several antibacterial compounds known from other sources were identified, for instance indolmycin which 
was hitherto only known from terrestrial Streptomycetes. Genome sequencing of P. luteoviolacea S4054 
revealed up to 11 biosynthetic pathways with unknown products, confirming the potential for discovery of 
new secondary metabolites from Pseudoalteromonas strains. 
The elaborate secondary metabolite production led me to speculate whether it was possible to use 
secondary metabolites to assist in species identification within this genus. This would also provide 
information on the use of 16S rRNA gene sequences to dereplicate strain collections in biodiscovery efforts. 
A phylogenetic study of 16S rRNA gene sequences of the Pseudoalteromonas strains confirmed the division 
into two clades; one consisted of bioactive pigmented strains and one predominantly of inactive non-
pigmented strains. Correlating this to a dendrogram based on the secondary metabolites in each strain 
showed that some strains clustered together in a species-specific way, whereas other strains did not cluster 
near strains of the same species. Hence, secondary metabolite production was not unequivocally reflected 
in the secondary metabolite profile, possibly due to the limited resolving power of the 16S rRNA gene. The 
species P. luteoviolacea showed an interesting pattern indicative of phylotype specific antibiotic production 
strains. Detailed phylogenetic analysis of an expanded collection of P. luteoviolacea strains showed 
confirmed that production of antibiotics was related to phylogeny within this species, which indicates that 
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the underlying biosynthetic pathways are maintained under selective pressure and hence are important 
traits for the organism. 
One strain stood out during work with the strain collection, in part because of its production of an intense 
black pigment in contrast to its phylogenetic placement within the non-pigmented clade. This strain was 
subsequently shown to represent a new bacterial species named Pseudoalteromonas galatheae. 
Initial studies revealed the potential production of regulatory compounds involved in cell to cell signaling 
within some strains of the species P. luteoviolacea. Since such mechanisms are known to govern antibiotic 
production in some bacteria, this was investigated. A quorum sensing system controlling a putative novel 
biosynthetic pathway with high homology to the lux system of Vibrio fischeri was identified in P. 
luteoviolacea S4054. The signal molecule was potentially a new acylated homoserine lactone (AHL) like 
compound, and the AHL synthethase was phylogenetically distinct from related synthethases. This expands 
our knowledge of bacterial signaling and lux homologue system, and further work will resolve is this system 
has implications for antibiotic production. 
In summary, this Ph.D. work explored the phylogeny and chemical diversity of the genus 
Pseudoalteromonas. Novel compounds were discovered but they possessed no antibiotic activity. However, 
analysis of the genome sequence of P. luteoviolacea S4054 revealed genetic potential for discovery of 
secondary metabolites not known within this species. Secondary metabolites were not unequivocally 
representative of species assignments, but on an intra-species level the use of detailed phylogenetic 
analysis showed phylotype specific production of antibiotics within the species P. luteoviolacea. These 
findings validate the genus Pseudoalteromonas as a potential source of novel secondary metabolites and 
may be useful when designing future biodiscovery strategies. The novel species P. galatheae was described 
which contributed to resolving the taxonomy of the genus. This thesis also provides evidence of a quorum 
sensing system related to the lux system of Vibrio fischeri but relying on putatively novel signaling molecule 
encoded by a distinct synthethase, which might be involved in the regulation of antibiotics production. 
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RESUMÉ 
Formålet med dette Ph.D. studie var at udforske det bioaktive potentiale af indsamlede marine 
Pseudoalteormonas bakterier, samt at kortlægge hvorledes produktionen af bioaktive stoffer er fordelt 
imellem de enkelte Pseudoalteromonas arter. Stammesamlingen blev grundlagt under en jordomsejling 
med forskningsekspeditionen ”Galathea 3”, hvor marine bakterier blev screenet for hæmmende effekt mod 
Vibrio anguillarum 90-11-287. Pseudoalteromonas stammer udgjorde en af de primære slægter, der blev 
isoleret.  
Pseudoalteromonas stammerne blev testet for hæmmende effekt mod Vibrio anguillarum 90-11-287 og 
Staphylococcus aureus 8325. Baseret på tidligere arbejder udviklede jeg den hypotese at 
Pseudoalteromonas stammer der udviser en stabil hæmmende effekt oftere er pigmenterede eller isoleret 
fra et overfladeskrab. Det blev bekræftet via en statistisk analyse af de indsamlede bakterier. Det er kendt 
at Pseudoalteromonas stammer producerer bioaktive sekundære metabolitter, og på den baggrund 
igangsatte jeg en screening af de indsamlede Pseudoalteromonas stammer for at identificere nye stoffer 
med antibakteriel aktivitet. Denne screening resulterede i identifikation af ukendte quinolon-relatedere 
stoffer, men de var ikke antibakterielle. Derimod blev der isoleret allerede kendte antibiotika, f.eks. 
indolmycin som hidtil udelukkende var fundet i Streptomyces bakterie isoleret fra jord. Genomsekventering 
af P. luteoviolacea S4054 afslørede op til 11 biologiske pathways med ukendte slutprodukter der kunne 
være involverede i syntesen af sekundære metabolitter, hvilket bekræfter potentialet for opdagelse af nye 
stoffer fra Pseudoalteromonas bakterier. 
 Den omfattende produktion af sekundære metabolitter blandt Pseudoalteromonas stammerne førte til 
den ide at de sekundære metabolitter måske kunne bruges som et redskab til at adskille de forskellige arter 
inden for slægten. Dette ville også afklare om 16S rRNA gensekvenser kan bruges som et redskab til 
dereplikering af bakteriestammer i forbindelse med screening for sekundære metabolitter. En fylogeni 
baseret på 16S rRNA gensekvenser viste, som ventet baseret på tidligere studier, at stammerne opdeltes i 
to grupper. Den ene gruppe indeholdt hæmmende pigmenterede stammer, mens den anden gruppe 
primært indeholdt ikke-pigmenterede stammer uden hæmmende aktivitet. Ved sammenligning med et 
dendrogram basereret på produktion af sekundære metabolitter kunne det konstateres at nogle arter 
havde en ensartet sekundær metabolitprofil, mens andre arter producerede forskellige sekundære 
metabolitter alt efter hvilken stamme der blev undersøgt. Derfor kunne 16S rRNA gensekvenser ikke bruges 
som pålidelig metode til dereplikation af bioaktive Pseudoalteromonas stammer. Arten P. luteoviolacea 
udviste dog et interessant mønster der tydede på en overensstemmelse med fylogenetisk opdeling og 
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produktion af sekundære metabolitter. En detaljeret fylogenetisk analyse baseret på recombinase A og 
gyrase B generne afslørede at produktionen af to forskellige antibiotika var begrænset til hver sin 
fylogenetiske gruppering. Dette tyder på at generne der er involveret i biosyntesen af disse antibiotika 
bliver bevaret under et selektivt pres, som betyder at antibiotikaproduktionen er et vigtigt træk for 
organismen. 
Under arbejdet med stammesamlingen stod én stamme ud på grund af dens karakteristiske sorte pigment, 
som den producerede på trods af at fylogenetisk analyse placerede stammen i den ikke-pigmenterede 
gruppe. Denne stamme skulle vise sig at repræsentere en ny bakterieart som blev nanvgivet 
Pseudoalteromonas galatheae. 
Indledende studier viste, at visse P. luteoviolacea stammer producerede stoffer, der potentielt var 
involveret i kommunikation imellem cellerne. Sådanne mekanismer regulerer produktionen af antibiotika i 
visse andre bakterier, og blev derfor undersøgt nærmere i P. luteoviolacea S4054. Et quorum sensing 
system med stor lighed til lux systemet fra Vibrio fischeri blev identificeret. Selve signalmolekylet tegner til 
at være en ukendt acyleret homoserin lakton (AHL) analog, og i en fylogenetisk undersøgelse adskilte AHL 
syntasen PluI sig tidligt fra de nærmest beslægtede proteiner fra Vibrio bakterier, hvilket tyder på at det er 
en hidtil ukendt AHL syntase. Dette styrker vor viden om bakterielle signalsystemer, og videre arbejde vil 
klarlægge hvorvidt dette system har betydning for antibiotikaproduktionen i P. luteoviolacea S4054. 
For at opsummere har dette Ph.D. studie udforsket fylogeni og kemisk diversitet i slægten 
Pseudoalteromonas. Ingen nye antibiotika blev identificeret, men nye stoffer blev opdaget og det genetiske 
potentiale af P. luteoviolacea S4054 tyder Sekundære metabolitter var ikke universelt brugbare til 
artsidentifikation, men inden for arten P. luteoviolacea afspejledes produktionen af antibiotika i den 
fylogenetiske opdeling. Disse opdagelser tyder på at Pseudoalteromonas stammer er lovende mål for 
opdagelse af hidtil ukendte stoffer med biologisk aktivitet, og detaljeret fylogenetisk opklaring kan bruges 
som et værktøj i opdagelsen af sådanne nye stoffer. Den nye art P. galatheae blev beskrevet hvilket bidrog 
til en afklaring af taxonomien inden for slægten Pseudoalteromonas. Under dette Ph.D. arbejde blev det 
opdaget at P. luteoviolacea S4054 besad et quorum sensing system, der potentielt regulerer produktionen 
af antibiotika. Quorum sensing systemet havde ligheder med det lux system, der kendes fra V. fischeri, men 
de enkelte komponenter var ikke fuldt ud identiske og repræsenterer muligvis nye varianter af AHL syntase 
og AHL signal molekyler. 
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1.0 INTRODUCTION AND BACKGROUND OF THE PH.D. PROJECT 
The increase in hospital and community acquired infections caused by drug resistant bacteria is 
currently making an impact on societies worldwide. Developing new antibiotics is of the outmost 
importance, and searching for antibiotics that have a novel mechanism of action or are structurally 
distinct from those currently in use is one startegy to combat the spread of existing resistance 
mechanisms. Unfortunately, a combination of factors led to a decline in development of 
antibiotics, beginning in the late 1960’ies and lasting almost 40 years (Fischbach & Walsh, 2009). In 
this so called innovation gap, no new classes of antibiotics were introduced (figure 1). In fact, 73% 
of the approved antibiotics between 1981 and 2005 belonged to just three antibiotic classes: β-
lactams, macrolides and quinolones (Hughes & Fenical, 2010;Newman & Cragg, 2007). 
 
Figure 1: An illustration of the innovation gap from 1962 to 2000. No new classes of 
antibiotics were developed, leading to an almost empty drug pipeline when resistance 
against known antibiotic classes emerged. Adapted from Fischbach et al. (2009). 
Part of the reason for this lack of new antibiotic classes is the failure of combinatorial chemistry to 
deliver a significant number of lead compounds to the pharmaceutical development pipeline 
(Newman & Cragg, 2007)  and the low profitability of developing antibiotics compared to classic 
blockbuster drugs within e.g. cancer or metabolic conditions (Malik, 2008;Nathan & Goldberg, 
2005).  
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The marine environment is considered an underexplored source of novel bioactive natural 
products (Fenical, 1993;Gulder & Moore, 2009;Imhoff et al., 2011;Molinski et al., 2008) and the 
structural diversity of marine natural products (Newman & Cragg, 2007) make them a promising 
target for discovery of novel antibiotics. The potential for discovery of structurally diverse novel 
antibiotics is enormous considering oceans cover 70% of Earth and even the marine Polar Regions 
are teeming with life. Antagonistic compounds are widely believed to play important roles in 
microbial ecology, for instance through chemical warfare among bacteria or as weapons in prey-
predator interactions. The dual role of antibiotics in human therapeutics and microbial 
interactions is fascinating, and we are only just beginning to understand the context of this within 
research areas such as development of antibiotic resistance, microbial signaling, bacteria-
eukaryote interactions and microbial community dynamics. 
 
During the research expedition ‘Galathea 3’, the project ‘Stars of the ocean’ isolated antagonistic 
marine bacteria.  The majority of the isolated bacterial strains were identified as species of Vibrio, 
Pseudoalteromonas or the Roseobacter clade. (Gram et al., 2010). A subsequent grant from the 
Strategic Research Council for Food, Health and Welfare allowed the establishment of the project 
“Discovery of novel bioactive bacteria and natural products and their use to improve human 
health and safety” involving two research groups from the Technical University of Denmark (DTU) 
and three from University of Copenhagen (KU). The main research areas were divided, with work 
at the National Food Institute focused on cultivation and ecology of marine bacteria and screening 
for antagonistic compounds, DTU Systems Biology focused on purification and structure 
elucidation of bioactive compounds, KU-LIFE focused on virulence inhibition in Staphylococcus 
aureus by marine natural products and interactions of marine bacterial metabolites with the 
human immune system, and KU-Health focused on marine natural products in interference with 
quorum sensing. 
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1.0.1 SCOPE OF THE PH.D. PROJECT 
This Ph.D. work targeted the group of strains isolated during the ‘Galathea 3‘-expedition which 
belong to the marine Pseudoalteromonas genus. Pseudoalteromonads are known to frequently be 
bioactive (Bowman, 2007), and one of my primary aims was to screen the global collection of 
Pseudoalteromonas strains for antagonistic activity in order to isolate novel antibiotics. Bioactive 
Pseudoalteromonas strains are often found in association with higher eukaryotes or marine 
surfaces (Holmström & Kjelleberg, 1999), and we observed that production of antibacterial 
compounds often co-occurred with pigmentation. The nature of the strain collection allowed me 
to address the hypothesis that antagonistic Pseudoalteromonas are predominantly pigmented and 
surface associated (Vynne et al., 2011) using statistical tools. The bioactive potential of 
Pseudoalteromonads is well known (Bowman, 2007), hence screening a diverse global collection 
of Pseudoalteromonas strains for production of novel secondary metabolites might result in 
interesting compounds with e.g. antibiotic activity and provide an overview of the chemical 
diversity of the genus. Additionally, I hypothesized that secondary metabolites might be useful 
taxonomic markers to assist in species discrimination among Pseudoalteromonas strains since the 
majority of bioactive strains form a distinct clade when subjected to phylogentic analysis of 16S 
rRNA gene sequences (Gauthier et al., 1995). This might also facilitate biodiscovery strategies by 
providing an overview of the distribution of compounds among Pseudoalteromonas species. In 
working with the strain collection, one strain stood out in particular due to its production of an 
intense black pigment. This strain was identified as a new species; Pseudoalteromonas galatheae 
(Vynne et al., 2012a). During the screening for novel antibiotics I observed that four P. 
luteoviolacea strains based 16S rRNA phylogeny divided into two groups, each producing the 
common bioactive violacein and a specific antibiotic for the phylogenetic group in question. Based 
on these  observations and studies of species specific production of secondary metabolites in the 
Actinomycete genus Salinispora (Jensen et al., 2007), I developed a hypothesis that phylogenetic 
reconstruction of the evolutionary relationship among Pseudoalteromonas strain could be used to 
guide biodiscovery efforts at the sub-species level and avoid characterization of overlapping 
secondary metabolite profiles. This I showed within the species Pseudoalteromonas luteoviolacea 
(Vynne et al., 2012b). The strain P. luteoviolacea S4054 produced molecules capable of activating 
several quorum sensing monitor strains. The presence of a putative cell-density dependant 
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signaling system could suggest that one or more interesting phenotypes such as antibiotic 
production were controlled in this manner, which I investigated experimentally. The work on cell 
signaling is not yet concluded, however I have shown that a signaling system is present in P. 
luteoviolacea and that it might regulate a novel biosynthetic pathway (Vynne et al., 2012c). The 
signaling molecules are AHL-like and may also be novel. Finally, the potential for secondary 
metabolite production was assessed based on genome analysis, which indicated that strain S4054 
has the potential to produce several so far unknown compounds (Vynne & Gram, 2012). 
 
This Ph.D. thesis contains an overview of drug discovery strategies within marine bacteria and how 
efforts in microbial ecology and drug discovery may benefit from interacting (chapter 2). Chapter 3 
describes the ecology, industrial applications and biodiscovery potential of the marine bacterial 
genus Pseudoalteromonas, and chapter 4 presents an overview of quorum sensing and the 
relevance of quorum sensing in drug discovery. 
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2.0 BIOACTIVE SECONDARY METABOLITES FROM MARINE BACTERIA 
Bacterial secondary metabolites have historically played a central role in discovery of novel 
pharmaceutical lead compounds. In particular, terrestrial Actinobacteria have been a major source 
of biologically active secondary metabolites and most antibiotics in use today are either natural 
products or natural product derived (Newman & Cragg, 2007). Among the success stories are the 
discovery of streptomycin and tetracycline, with tetracycline and synthetic derivatives still being 
backbone drugs in treatment of bacterial infections when resistance is not present. Recent years 
have seen a dramatic increase in the discovery rate of marine natural products, many of which 
originate from marine microorganisms (figure 2). As we learn that marine eukaryotes may harbor 
distinct and species specific bacterial epibionts, it is becoming evident that some chemical 
compounds previously attributed to the macroorganism are in fact produced by epibiont bacteria. 
The discovery and origin of bryostatins, currently undergoing clinical trials as an anti-cancer agent, 
exemplifies this. Bryostatin 1, currently in phase I clinical trials against cancer, was originally 
isolated from samples of the marine bryozoan Bugula neritina and was immediately recognized for 
 
Figure 2: Number of new marine natural compounds discovered broken down by phylum.  
The compounds discovered from 1965 to 2005 were summed up and averaged. Adapted 
from Blunt et al. (2009) 
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its potent anticancer activity (Pettit et al., 1982). Initially thought to be a product of the bryozoan 
animal, it was later revealed that the biosynthetic genes were actually present in the bacterial 
symbiont “Candidatus Endobugula sertula” (Sudek et al., 2006) but not in the bryozoan. 
Production of bryostatins was also reduced after an antibiotic treatment and accompanying 
reduction in the number of bacterial symbionts (Sudek et al., 2006) offering strong evidence that 
the bryostatins are in fact of bacterial origin. The marked increase in discovery rates of microbially 
produced marine natural products likely in part due to an increased awareness of microbial 
epibionts as potential sources of bioactive metabolites (Mearns-Spragg et al., 1998;Penesyan et 
al., 2009;Sudek et al., 2006), but it is also an acknowledgement of the importance of marine 
microorganisms as a promising source of biologically active molecules. In 2010 the marine drugs 
pharmaceutical pipeline contained twelve drugs in phase I to III clinical trials (table 1) mainly 
targeting cancer, and four approved drugs (Mayer et al., 2010).  
Table 1: The status of the marine pharmaceutical pipeline, 2010. Modified from Mayer et al. (2010). 
Clinical 
status Compound name Chemical class 
Marine 
organism Disease area 
Approved Cytarabine, Ara-C Nucleoside Sponge Cancer 
 Viderabine, Ara-A Nucleoside Sponge Antiviral 
 Ziconotide Peptide Cone snail Pain 
 Trabectidin (ET-743) (EU registered only) Alkaloid Tunicate Cancer 
Phase III Eribulin Mesylate (E7389) Macrolide Sponge Cancer 
  Soblidotin (TZT 1027) Peptide Bacterium Cancer 
Phase II DMXBA (GTS-21) Alkaloid Worm Cognition, 
Schizophrenia 
 Plinabulin (NPI-2358) Diketopiperazine Fungus Cancer 
 Plitidepsin Depsipeptide Tunicate Cancer 
 Elisidepsin Depsipeptide Mollusc Cancer 
 PM1004 Alkaloid Nudibranch Cancer 
 Tasidotin, Synthadotin (ILX-651) Peptide Bacterium Cancer 
 Pseudopterosins Diterpene glycoside Soft coral Wound healing 
Phase I Bryostatin 1 Polyketide Bryozoa* Cancer 
  Hemiasterline (E7974) Tripeptide Sponge Cancer 
  Marizomib (Salinosporamide A; NPI-0052) β-lactone-γ-lactam Bacterium Cancer 
*: Evidence of bacterial origin, see text. 
   
Among the advantages of marine drug leads is a hypothesis that compounds of marine origin are 
very potent due to the inevitable dilution that occurs in this environment, and the structural 
diversity of the molecules is stunning (Grabowski et al., 2008). An additional distinct advantage of 
7 
 
pursuing bacterial metabolites as drug leads is that, presumably, biosynthetic pathways of 
bacterial origin are more amenable to heterologous recombinant expression in for instance E. coli, 
which has the potential to eliminate the very real problem of a stable, cost-efficient supply of 
compound for tests and clinical trials (Molinski et al., 2008). A recent success of biodiscovery 
within marine bacteria is the compound salinosporamide A. Salinosporamide A is a potent 20S 
proteasome inhibitor in clinical trials as anti-cancer agent (Feling et al., 2003). It was discovered 
from a novel streptomycete and the development process included several valuable proof-of-
concept milestones for marine drugs, for instance the implementation of a seawater based 
fermentation process in a cGMP setting (Fenical et al., 2009).  
 
2.0.1 THE MARINE ENVIRONMENT AS A SOURCE OF NOVEL MICROBIAL AND CHEMICAL DIVERSITY 
In the past, a common view was that the oceans were depleted in nutrients and presented harsh 
environmental parameters such as high salinity and a changing pH, which would not allow for 
microbial growth (MacLeod, 1965). This perception has changed, and today the marine 
environment is known to be teeming with microbial life considered a promising source of novel 
microbial and chemical diversity (Delong, 2007). A high diversity of marine bacteria are often 
found in marine surface associated microbial communities (Holmström et al., 2002;Webster et al., 
2001). Increasing evidence suggests that marine microbial communities can be highly specific to 
particular niches. A comparison of the surface communities of co-occurring marine eukaryotes 
revealed distinct bacterial communities when examined at the species level (Longford et al., 
2007), which is in agreement with later studies in which bacterial communities were found to be 
host-specific to several algae species (Lachnit et al., 2009). The bacterial community associated 
with marine sponges consists of specialist bacteria specific to a certain sponge species, sponge 
associated bacteria that are found on several sponge species but not in seawater and generalist 
marine bacteria found both on sponges and in seawater (Taylor et al., 2004). Even within one host 
individual, the composition of the epibiotic bacteria may be spatially distinct as reported for 
sponges (Meyer & Kuever, 2008;Thiel et al., 2007) and algae (Staufenberger et al., 2008). The 
niche specificity of bacterial communities is conceptually useful when trying to understand the 
vast diversity of marine bacteria and the implications on natural products discovery. Antagonistic 
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interactions among marine bacteria are frequently observed, and bacterially produced antibiotics 
are believed to be involved in microbial interactions and affect the structure of microbial 
communities (Long & Azam, 2001;Rypien et al., 2010;Slattery et al., 2001). In a recent study 
attempting to clarify interaction dynamics in soil microbial communities, a large number of 
pairwise interactions were observed among streptomycetes isolated from individual soil grains 
(Vetsigian et al., 2011). Based on these interactions, the authors suggest a model in which the 
original microbial community is highly likely to evolve and adapt rapidly through for instance 
acquisition or adaptation of antibiotic producing genetic pathways, subsequently countered by the 
emergence of antibiotic resistance (Vetsigian et al., 2011). It stands to reason that molecules 
involved in such interactions may evolve as microbial communities change, and thus microbial 
diversity and the assembly of diverse microbial communities may drive the evolution of chemical 
diversity. Hence, the understanding that many antibacterial compounds are involved in microbial 
interactions and shaping of microbial communities combined with the knowledge that microbial 
communities often are niche specific ties a link from microbial ecology to discovery of novel 
bioactive compounds (Imhoff et al., 2011). Understanding the implications of microbial diversity 
and the ecology of antibiotics may be of great assistance in maximizing the output of biodiscovery 
efforts. Developments in analytical techniques such as MALDI-TOF-MS (Esquenazi et al., 2008) 
have the potential to be of great assistance in research on the spatial location and identification of 
secondary metabolites within complex communities which has the potential to offer new and 
exciting insights at the interface of microbial ecology and natural products chemistry. 
 
2.0.2 BIOSYNTHESIS OF BACTERIAL SECONDARY METABOLITES 
Bioactive natural products of bacterial origin cover an enormous structural diversity and include 
multiple compound classes, such as terpenes, polyketides and nonribosomal peptides. These 
compounds are synthesized by cellular enzymes which are often encoded by genes organized on 
the same locus in so called biosynthetic pathways. Two of the classes with a well understood 
biosynthetic pathway are polyketides (PKs) and nonribosomal peptides (NRPs), which are often 
isolated from marine microorganisms (Hughes & Fenical, 2010). The synthesis machineries for 
these two classes of compounds are conceptually alike. The active domains are contained within 
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one large protein in a modular structure where the synthesized molecule is transferred from one 
domain to the next as the catalytic reactions proceed (Staunton & Weissman, 2001). The canonic 
type I PK biosynthetic machinery depicted in figure 3. In PK synthesis, each module mediates one 
extension step of the PK chain, including any modification such as reduction of a ketone to a 
hydroxyl. Examples of antibacterial polyketids of marine origin are shown in figure 4 below.  
 
 
 
Figure 3: Modular organization of erythromycin polyketide biosynthesis, a PKS type I pathway. 
Each module (except the loading and end modules) contains the essential ketosynthase, 
acyltransferase and acyl carrier protein domains required for elongation of the polyketide chain, 
whereas additional domains alter the substitutions on the chain. Adapted from Staunton and 
Weissman (2001). 
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A key difference among the two pathways is the use of different building blocks; polyketide 
synthetases (PKSs) rely on acetate (activated to form malonyl-CoA) and propionate (activated to 
form methyl-malonyl-CoA) (Cortes et al., 1990) whereas nonribsomal synthetases (NRPSs) utilize 
amino acids (Schwarzer et al., 2003). Variations of these archetypical PKS molecules exist, for 
instance a PKS gene cluster with no intrinsic AT domain (Piel, 2002). Instead, this pathway relies on 
discrete AT genes to synthesize the end product pederin. Antibacterial NRPS molecules are 
produced by marine bacteria (figure 5), and the generalized pathway shares the modular layout 
with PKS pathways, however the domains encode different functionalities. Marine NRPs include 
violacein and indolmycin, isolated from P. luteoviolacea strains in this Ph.D. work, which can be 
recognized as NRP compounds based on their tryptophan building blocks. Hybrid pathways 
including both PKS and NRPS domains are known (Shen et al., 2001). Such hybrid pathways further 
add to the potential structural diversity among natural products. 
 
Figure 4: Antibacterial polyketides of marine 
origin. BE-43472B (1) isolated from a marine 
Streptomycete; abyssomycin C (2) isolated 
from the marine actinomycete 
Verrucosispora sp; pestalone (3) isolated 
from a marine fungus; ariakemicin A (4) 
isolated from a marine gliding bacterium of 
the phylum Bacteroides. Modified from 
Huges & Fenical (2010). 
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Figure 5: Antibacterial nonribosomal peptide-derived molecules of marine origin. Bogorol A 
(1) isolated from the marine Bacillus laterosporus; emericellamide A (2) isolated from a 
marine fungus; thiocoraline (3) isolated from a marine actinomycete; YM-266183 (4) 
isolated from a marine Bacillus cereus. Modified from Hughes & Fenical (2010). 
 
The modular nature of these biosynthetic machineries has led to interest in so called 
combinatorial biosynthesis as reviwed by (Weissman & Leadlay, 2005), where the enzymes 
catalyzing the synthesis reactions are modified based on the desired outcome (Cortes et al., 1995). 
For instance, adding enoyl reductase domain to a module can eliminate a functional group and 
change the steric configuration of the molecule, thus potentially altering the biological activity. 
This metabolic engineering is gradually becoming ‘plug-and-play’ through the availability of 
distinct building blocks (Menzella et al., 2005). This approach opens for a virtually unlimited cache 
of structural scaffolds, and provides researches with the ability to directly modify sites which are 
identified as important for pharmacological activity. 
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2.1 STRATEGIES FOR DISCOVERY OF ANTIBACTERIAL COMPOUNDS FROM MARINE 
BACTERIA 
2.1.1 SCREENING PIPELINE FOR PSEUDOALTEROMONAS STRAINS IN THE GALATHEA 3 PROJECT  
In this Ph.D. work, a screening pipeline was used to facilitate efficient screening for antibacterial 
compounds among the bacteria isolated during the research expedition Galathea 3. Bacterial 
strains were isolated from a range of diverse marine samples during the global expedition (Gram 
et al., 2010) and pre-screened for antagonism towards Vibrio anguillarum 90-11-287 (Skov et al., 
1995), a potent fish pathogen. The bacterial strains were tentatively identified via BLAST queries of 
partial 16S rRNA gene sequences, and one of the dominant taxa was the genus 
Pseudoalteromonas which forms the topic of this thesis. The potentially antagonistic bacterial 
strains were screened for inhibitory activity following a principle similar to the outline in figure 6.  
 
Figure 6: An overview of the 
principles in a screening 
strategy such as the one used in 
this Ph.D. work. Adapted from 
Molinari (2009). 
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The chemical analysis pipeline includes HPLC coupled with a detector, for instance an UV/VIS 
diode-array-detector. The HPLC is used to separate compounds in a given mixture by size, polarity 
or charge, resulting in a series of fractions which can be tested in the bioassay. Once a pure 
compound has been isolated, LC-MS can be used to obtain the accurate mass of the compound. 
The accurate mass is used to calculate the elemental composition and in combination with the 
formation of distinct adducts during LC-MS analysis, the compounds can often be dereplicated and 
identified with help from database searches (Nielsen et al., 2011). However, to obtain the full 
structural information one must resort to nuclear magnetic resonance spectroscopy or x-ray 
crystallography. 
The main bioassay used was a simple well diffusion agar assay (Hjelm et al., 2004), where a target 
culture is cast into an agar substrate and test substances are added to wells cut in the agar (Figure 
7). 
 This bioassay provides a very direct assessment of the antibacterial potential of a given sample, 
and repeated cycles of chemical fractionation followed by bioassays to verify activity is a proven 
method of obtaining relatively pure active compounds. This approach is often referred to as 
 
Figure 7: Well diffusion agar 
assay of sterile filtered 
Pseudoalteromonas culture 
supernatants. The inhibition of 
Vibrio angullarum is seen as 
clearing zones of no bacterial 
growth, signifying the 
presence of an inhibitory 
compound in the tested 
supernatant. 
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bioassay guided fractionation. This principle can be used for the identification of practically any 
compound where a specific bioassay exists, however, as part of the work in this thesis shows 
(Vynne et al., 2012c), complications such as different detection limits among bioassays and 
chemical detectors or the inability to confine the active compound to one single fraction may 
occur. Also, as subsequent paragraphs reveal, the genome of P. luteoviolaceae potentially points 
to a range of bioactive compounds that are not expressed under standard laboratory growth 
conditions. 
 
2.1.2 CULTURABILITY AND THE INFLUENCE OF CULTURE CONDITIONS ON DISCOVERY OF SECONDARY 
METABOLITES FROM MARINE BACTERIA 
When determining if a bacterial strain produces for example antibiotics, growing the organism in 
pure cultures under controlled conditions is in most cases considered essential, and this approach 
has been greatly successful. It offers the immediate advantages of working with a pure culture 
growing under defined conditions for a high degree of reproducibility. Nevertheless, the fact that 
only a fraction of the cells in a given sample are culturable using standard laboratory approaches 
and growth substrates (an estimated 0.1 % for bacterioplankton (Gram et al., 2010)) suggests that 
a reliance on these classic techniques may also limit the potential for discovery of novel 
antibiotics. To compensate for this, several authors have taken alternative approaches to 
cultivation. A simple modification to growth conditions in liquid cultures was developed by (Yan et 
al., 2002) (figure 8). This presumably allows for increased biofilm formation and reduces oxygen 
limitations, and has the potential advantage of decreased exposure to autoinhibitory compounds. 
Culturing two marine Bacillus strains in this roller bottle setup induced production of two 
antimicrobial compounds which inhibited an MRSA test strain (Yan et al., 2002). Similarly, growth 
in biofilms may induce or enhance production of antibiotics as demonstrated for Phaeobacter 27-4 
(Bruhn et al., 2007). This illustrates how important the physical conditions can be to antibiotic 
production.  
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Figure 8: Agar coated roller 
bottle design. The bottle rotates 
at 1 rpm, and bacterial biofilms 
form on the agar coated interior 
walls. The thickened portion of 
the agar allows for aeration of 
the liquid substrate. Adapted 
from Yan et al. (2002). 
 
Laboratory growth substrates are often based on either a complex mix of carbohydrates and 
nitrogen designed to support fast bacterial growth, for instance yeast extract or peptone, or 
defined minimal substrates designed for selective enrichment of bacterial cultures or to support 
fastidious organisms. In the case of marine bacteria, neither substrate is likely to reflect the 
natural niche very and thus may not induce the production of key secondary metabolites. A recent 
study elegantly demonstrated how growth substrates may impact secondary metabolite 
production: A Vibrio corallilyticus strain shut down production of all secondary metabolites but the 
antibiotic andrimid when cultured on chitin or live chitinous Artemia instead of marine broth 2216 
(Wietz et al., 2011).This validates the use of growth substrates mimicking the natural nutrient 
regime, and is an excellent illustration of how microbial ecology and biodiscovery may go hand in 
hand. Preliminary results obtained during this Ph.D. work of P. luteoviolacea cultures grown on 
alga extracts suggests this strategy may indeed change the metabolic profile of the bacterium, and 
cultures grown in the complex growth substrate heart infusion broth supplemented with 2% 
sodium chloride caused a heavy production of extracellular polymers in the strain P. luteoviolacea 
S4054 (unpublished data). 
Elicitation of antibiotic production may be achieved by co-culturing the producer organism with 
other microorganisms in an effort to simulate environmental parameters from the natural 
environment, such as signaling and stress factors. One of the earliest studies involving marine 
bacteria demonstrated how marine bacteria exposed to cells of S. aureus or Pseudomonas 
aeruginosa responded with increased antibacterial activity compared to non-exposed controls 
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(Mearns-Spragg et al., 1998). Similar results were obtained for marine sponge-associated bacteria 
(Kanagasabhapathy & Nagata, 2008) and in a marine streptomycete (Slattery et al., 2001). Three 
of four tested tropical marine epibiotic bacteria showed antifungal activity when exposed to live 
cells of the fungus for 24 h, whereas pure cultures of the epibiotic bacteria were not antifungal 
(Dusane et al., 2011).  This is a logical extension of the hypothesis that antibiotics have ecological 
significance, and conceivably are produced as chemical weapons in response to being challenged 
by foreign competitor cells. However, in some cases the problem itself is accessing the secondary 
metabolism of a so called unculturable microorganism. The use of high-throughput microtiter 
plate techniques, dilution methods and a growth substrate containing natural levels of nutrients 
led to the culturing of 14% of the cells in a marine water sample (Connon & Giovannoni, 2002), 
compared to the ca. 0.1% normally achieved (Gram et al., 2010). Among the cultures were several 
novel Proteobacteria clades. One of these clades was related to the SAR11 lineage, which is 
considered ubiquitous in the ocean surface layer and may contribute up to 50% of the total 
bacterioplankton cell numbers (Morris et al., 2002). SAR11 does not grow at standard laboratory 
techniques, but the use of the high-throughput, low nutrient technique allowed the successful 
culturing of SAR11 bacterial strains (Rappe et al., 2002) and subsequent improvements to the 
technique have allowed the culturing of more diverse novel SAR11 strains (Stingl et al., 2007). 
Other approaches include the use of various growth factors (D'Onofrio et al., 2010;Nichols et al., 
2008), diffusion chambers (Bollmann et al., 2007) and membrane systems (Ferrari et al., 2008). 
Together, these innovative approaches to the fundamental microbiological task of culturing 
bacteria have opened new possibilities for culturing parts of the previously rarely isolated or 
unculturable majority of bacteria (Sogin et al., 2006), which allows access to practically unlimited 
diversity. 
 
2.1.3 GENOMICS AND METAGENOMICS AS TOOLS IN BIODISCOVERY: A MARINE PERSPECTIVE 
As the first bacterial genomes of prolific secondary metabolite producers were completed, it was 
observed that they contained gene clusters with homology to known biosynthetic pathways, but 
to which no known secondary metabolite could be associated. Although advanced culture 
techniques may activate some of these silent clusters one faces a daunting task if attempting to 
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elicit every biosynthetic pathway without further knowledge as for instance a genome sequence. 
With sequencing technologies rapidly advancing and sequencing costs dropping equally fast, 
genome and metagenome sequencing has become accessible to most labs in terms of both costs 
and the required expertise. Excellent software exists to aid in handling the large amounts of data 
generated by these approaches, and the modular nature of PKS and NRPS gene clusters makes in 
silico prediction of homologue loci an exciting opportunity. In fact, genome sequencing and 
analysis has already proven itself in discovery of previously non-described compounds from 
otherwise thoroughly studied bacteria. Prediction of novel secondary metabolites from such silent 
gene clusters are known from Streptomyces coelicolor (Challis & Ravel, 2000), where a silent NRPS 
pathway was shown to produce the novel iron chelator coelichelin under iron-limited growth 
conditions (Lautru et al., 2005). One of the first reports on secondary metabolites from 
thermophilic bacteria was based on genome analysis and identification of an orphan NRPS gene 
cluster in the thermophilic actinomycete Thermobifida fusca. The biosynthetic pathway showed 
unusual features including non-linear peptide assembly, and the end product was a siderophore 
molecule possessing a distinct novel iron chelation domain (Dimise et al., 2008). In the genome of 
the marine bacterium Pseudoalteromonas tunicata genome, a biosynthetic gene cluster was 
predicted based on the presence of an ATP-grasp domain (Blasiak & Clardy, 2009). The putative 
biosynthetic gene cluster, shown in figure 9, was then PCR amplified and cloned into a vector 
under control of an inducible promoter, and transformed into an E. coli host. Induction of the 
promoter resulted in the production and subsequent identification of two 3-formyl-tyrosine 
metabolites which were not previously identified in the otherwise well-studied P. tunicata strain 
D2 – possibly due to their lack of antibacterial activity.  
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Figure 9: Predicted biosynthetic gene 
cluster from the P. tunicata D2 
genome. 1; structure of 3-formyl-L-
tyrosine-L-threonine dipeptide, one of 
the discovered metabolites. Color 
codes indicate the proposed 
biosynthetic pathway. Adapted from 
Blasiak and Clardy (2010). 
In this Ph.D. work, the  genome sequence of P. luteoviolacea S4054 revealed between 7 (manually 
curated annotation of PKS and NRPS containing gene clusters in IMG/ER (Vynne & Gram, 2012)) 
and 14 (antiSMASH prediction (Medema et al., 2011)) potential biosynthetic pathways, one of 
which was the violacein pathway. The violacein pathway is known (Antônio & Creczynski-Pasa, 
2004;August et al., 2000;Hoshino, 2011) and can be identified through homology searches, but 
none of the remaining potential biosynthetic pathways were homologue to pathways encoding 
known secondary metabolites. The antibiotics indolmycin and pentabromopseudilin were 
identified in P. luteoviolacea S4054 during this Ph.D. work, and their biosynthetic pathways are 
likely among the predicted gene clusters. However, since the genes involved in the biosynthesis 
are unknown, no pathway could be directly assigned to these compounds. The presence of up to 
14 novel biosynthetic pathways opens the possibility that P. luteoviolacea S4054 may produce up 
to 11 as yet unknown secondary metabolites, highlighting the power of genomic analysis and the 
potential for genome assisted biodiscovery in marine Pseudoalteromonas. 
Metagenomics have shown a potential as a biodiscovery related technique, as evidenced by the 
Global Ocean Sampling expedition, which based on the DNA sequence data obtained predicted a 
multitude of unknown proteins and protein families (Yooseph et al., 2007). However, a general 
limitation of homology based studies is the reduced chance of finding something very different 
from what is already known, as genetic homology does imply a structural or conceptual similarity 
among the end products. Hence, in silico genomic and metagenomic studies offer a fantastic 
supplement to classical culture-based approaches but cannot be relied upon as the sole means of 
assessing the secondary metabolite diversity of a single strain or microbial community. A more 
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direct approach is using metagenomic DNA directly to create libraries of clones containing large 
inserts of metagenomic DNA and perform functional screens for expression of e.g. antibacterial 
activity. In a pioneering study on functional screening of uncultured marine symbionts, a 
functional screen of shotgun cloned ‘metagenomic’ DNA (mainly Prochloron sp.)  led to the cloning 
and characterization of the biosynthetic pathway of the cytotoxic compound patellamide D 
DOI: 10.1002/cbic.200500210. A fosmid library was used to screen metagenomic DNA from microbial 
communities associated with a sponge (Cymbastela concentrica) and an alga (Ulva australis) for 
novel antibacterials, which resulted in the identification of three novel antibacterial proteins (Yung 
et al., 2011).   
 
2.2 BACTERIAL TAXONOMY IN BIODISCOVERY 
Proper identification and taxonomical assignment is crucial to scientific communication, also 
within natural product discovery (Jensen, 2010). The production of secondary metabolites is often 
considered to be strain specific (Waksman & Schatz, 1943), in part due to the involvement of 
biosynthetic gene clusters in lateral gene transfer (LGT) (Egan et al., 2001b). This would seem to 
exclude bacterial taxonomy as a useful tool for dereplicating bacterial strains in a biodiscovery 
setting, however screening of a taxonomically dereplicated collection of actinomycetes led to a 
high number of discovered compounds compared to the strain througput (Goodfellow & Fiedler, 
2010). Studies of the secondary metabolites produced by Salinispora species showed that a core 
set of metabolites are restricted to specific species (Jensen et al., 2007;Penn et al., 2009) and 
among species of the Roseobacter clade, production of a brown pigment and the antibacterial 
compound tropodithietic acid was shown to be related to growth conditions in a species-specific 
manner (Porsby et al., 2008). Hence, species specific chemoprofiles can exist. This is valid for some 
filamentous fungi as well, and has been used for guided discovery of secondary metabolites 
(Frisvad et al., 2008). Since the available resources often limit the amount of strains that can be 
included, not screening strains with identical or overlapping secondary metabolite profiles would 
be beneficial in biodiscovery efforts. In this Ph.D. work, a comparison between a statistical 
clustering based on secondary metabolites and 16S rRNA gene sequence phylogeny was made to 
reveal the extent, if any, of species specific secondary metabolite production in the 
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Pseudoalteromonas genus (Vynne et al., 2011). Some strains, such as P. ruthenica or the P. 
aurantia – P. citrea complex were found to cluster together as expected based on 16S rRNA 
sequence identity. However, some species, e.g. P. luteoviolacea, were split in distinct clusters by 
chemoprofiling and strains of P. rubra were very diverse from a secondary metabolite point of 
view. This study showed that 16S rRNA gene sequences are insufficient for reliable dereplication of 
secondary metabolite profiles in Pseudoalteromonas strains. However, in a follow up study it was 
demonstrated that a more detailed phylogenetic analysis of GyrB and RecA sequences were 
capable of resolving phylogenetic groups matching the observed distribution of bioactive 
secondary metabolites (figure 10) (Vynne et al., 2012b). In addition, the strains that produced the 
antibiotic indolmycin were exclusively isolated from algae, suggesting an ecology aspect is 
involved in production of this compound. The fixation of secondary metabolites within 
phylogenetic clusters is a strong indication that the biosynthetic gene clusters are under selective 
pressure and thus play an important functional role (Jain et al., 1999), which further supports the 
importance of antagonistic compounds in microbial ecology. Furthermore, the detailed phylogeny 
could be used as a tool for dereplication of bacterial strains in biodiscovery. 
 
 
Figure 10: Phylotype specific 
production of bioactive 
compounds within P. 
luteoviolacea. The phylogentic 
tree was based on 
concatanated GyrB and RecA 
sequences. Closed boxes: 
pentabromopseudilin producer, 
open circles: indolmycin 
producer. All strains produced 
violacein. Adapted from Vynne 
et al. (2011). 
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2.3 CONCLUSIONS FROM CHAPTER 2 
Marine bacteria are a proverbial ‘treasure trove’ of bioactive natural compounds, many of which 
are likely to possess interesting pharmacological activities. Advances in microbial ecology may be 
of great use within biodiscovery programs, as these bioactive compounds are highly likely to be 
involved in microbial ecology. For instance, sampling strategies could benefit from targeting 
specific niches if a certain biological activity was desired, or could simply aim at obtaining samples 
from as diverse microbial communities as possible. Once the biological material is collected, a 
dereplication of the bacterial strains may be carried out based on phylogeny and knowledge of 
microbial ecology to reduce the inclusion of overlapping secondary metabolomes. The 
biosynthetic potential of a Pseudoalteromonas luteoviolacea strain was assessed using 
bioinformatic approaches, and was found to contain up to 14 pathways involved in secondary 
metabolism. Accessing the biosynthetic potential via both culture dependent and culture 
independent techniques is likely to produce the best results, and modulation of growth conditions 
play an important role in this process.  
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3.0 THE GENUS PSEUDOALTEROMONAS – ECOLOGY AND BIOACTIVITY  
The genus Pseudoalteromonas consists of obligate marine bacteria found ubiquitously in the 
marine environment. They are Gram-negative non-sporeforming straight or curved rods belonging 
to the γ-Proteobacteria. The cells are motile by one or more polar flagella (Romanenko et al., 
2003) with some species reported to have lateral flagella in addition to polar. They are oxidase 
positive, vary in catalase reaction and are non-fermenting with a genomic DNA GC content of 37-
50 mol% and several species are intensely pigmented (figure 11) (Gauthier et al., 1995). Many 
Pseudoalteromonas show bioactivity such as antagonism towards other bacteria, hydrolytic 
enzymatic activities or anti-fouling activity. Pseudoalteromonads are considered obligate marine, 
but will grow on a range of nutrient regimes if marine salts are present. Some species, such as P. 
ruthenica can grow on NaCl as the sole salt source (Vynne, unpublished). All species grow at 20ºC, 
with growth ranges within 4ºC to 40ºC. The bacteria are readily cultured on e.g. Marine Agar 2216 
(Difco, USA) using routine culture techniques.  
 
Figure 11: Pseudoalteromonas strains 
streaked on Marine Agar 2216.  
 
Non-pigmented: P. agarivorans, 
yellow: P. flavipulchra,  
dark purple: P. luteoviolacea  
red: P. rubra 
 
The first descriptions of Pseudoalteromonas species were published in the 1940s and 1950s when 
the isolates were assigned to the Flavobacterium, Pseudomonas or Vibrio genera (Bein, 
1954;Berland et al., 1969;ZoBell & Upham, 1944). In 1972, the genus Alteromonas was created to 
harbor marine aerobic bacteria with GC-mol% of 42.8 to 48 and a polar flagellum (Baumann et al., 
1972), however with the advent of 16S rRNA gene sequence analysis it was clear that the genus 
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type strain Alteromonas macleodii formed a monophyletic cluster away from the remaining 
species in the genus (Gauthier et al., 1995). To account for this discovery, the genus 
Pseudoalteromonas was created with Pseudoalteromonas haloplanktis as genus type strain and 
containing a total of 12 species. The genus now encompasses 36 species (Euzéby, 1997) including 
several that were recently described (Oh & Park, 2011;Xu et al., 2010).  
 
3.1 PSEUDOALTEROMONAS PHYLOGENY AND TAXONOMY 
Understanding and navigating the taxonomy of Pseudoalteromonas species requires some 
attention to detail, as many species share a very high (>99%) 16S rRNA gene sequence identity. 
This can complicate the designation of species names to novel isolates, in particular since 
phenotypic traits will also often be similar and it is not practical to do DNA-DNA hybridization for 
each interesting novel strain. Thus, the reader is encouraged to study the phylogenetic relations 
among the Pseudoalteromonas type strains presented in figure 12, and keep in mind that there is 
likely a degree of overlap in what different authors identify as e.g. P. aurantia or P. citrea. The 
importance of proper species designation should not be understated. Accurate identification of a 
novel isolate is key in order to communicate science and allow other scientists to perform 
satisfactory literature searches as stressed in a recent review on marine natural products (Blunt et 
al., 2009). The use of 16S rRNA gene sequences to resolve bacterial taxonomy to the species level 
is widely accepted, cheap and fast to use. A 97% sequence identity is the accepted threshold for 
species delineation (Stackebrandt et al., 2002), however above 97% sequence identity does not 
confirm two strains as one species (Stackebrandt & Goebel, 1994). The gold standard remains 
DNA-DNA hybridization among species type strains where less than 70% DNA similarity is required 
to separate two strains into distinct species (Wayne et al., 1987), although the use of whole-
genome sequence data may replace this method (Konstantinidis & Tiedje, 2005). The use of DNA-
DNA hybridization, biochemical data and phylogenetic analysis of 16S rRNA genes is termed the 
polyphasic approach (Vandamme et al., 1996). 
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Figure 12: Phylogenetic analysis of 16S rRNA sequences of Pseudoalteromonas type strains. 
Sequences were retrieved from GenBank, aligned in MEGA5 (Tamura et al., 2011) and a 
phylogenetic tree inferred by maximum likelyhood analysis. Scale bar:  0.005 nucleotide 
substitutions per site. 
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In the course of this Ph.D. study, strain S3431 was identified as a potentially novel 
Pseudoalteromonas species. The strain was originally isolated from a polychate near Canal 
Conception in Chile and immediately caught our attention due to its deeply black pigment when 
cultured on marine agar 2216. Initial results of the S3431 16S rRNA gene sequence analysis 
showed that it had below 97% similarity to any described Pseudoalteromonas type strain. Further 
analyses of phenotypic traits and chemotaxonomic markers were conducted, and DNA-DNA 
hybridization was initiated. A later revision of the 16S rRNA sequence revealed sequencing errors 
and, after careful re-sequencing, the strain was found to have a 16S rRNA sequence identity of 
99% to a number of non-pigmented Pseudoalteromonas type strains. However, it was decided that 
the preliminary results combined with the interesting pigmented phenotype was sufficient to 
warrant further investigations. DNA-DNA hybridizations (table 2), physiological data and 
biochemical tests revealed that S3431 represents a novel species given the name 
Pseudoalteromonas galatheae (Vynne et al., 2012a).  
Table 2: Per cent DNA-DNA similarity in 2X SSC at 66ºC (Vynne et al., 2012a). All related 
type strains have less than 70% DNA-DNA similarity to S3431, which is the accepted 
threshold for species delineation (Wayne et al., 1987).  
 
Pseudoalteromonas species Per cent DNA:DNA similarity to strain 
S3431 
P. agarivorans DSM 14585T 28.2 
P. aliena LMG 22059T 44.5 
P. atlantica NCOMB 301T  26.9  
P. carrageenovora DSM 6820T 14.8  
P. distincta CIP 105340T 44.5  
P. elyakovii LMG 14908T 44.2  
P. espejiana DSM 9414T 48.0  
P. issachenkonii LMG19697T 33.6  
P. nigrifaciens LMG 2227T 15.4  
P. paragorgicola LMG 19696T 58.4  
P. tetraodonis DSM 9166T 11.3  
P.undina LMG 2880T 13.8  
 
Unfortunately, the antibacterial effect that the strain was originally isolated for turned out to not 
be reproducible upon frozen storage and repeated culture in the lab. This is not uncommon, and 
may be due to several factors such as a need for specific nutrients or a lack of interaction with for 
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instance co-cultured microorganisms. As described above, using culture conditions closer to the 
natural environment (C-source, associate microbiota) may re-evoke the production of antibacterial 
activity. 
Figure 12 above reveals a characteristic feature of the genus, namely the phylogenetic division 
into two groups when 16S rRNA gene sequences of the type strains are analysed (Gauthier et al., 
1995;Ivanova et al., 2004). One group predominantly consists of non-pigmented bacteria with 
little antibacterial activity while the majority of the other group is pigmented bacteria typically 
isolated from marine biotic surfaces. This latter group often produce compounds involved in 
microbial antagonism (Mikhailov et al., 2002) and correlation between pigmentation and anti-
fouling activity was reported for P. tunicata and Pseudoalteromonas sf57 (Huang et al., 2011) 
where anti-fouling activity was lost in non-pigmented mutants. It is important to note that 
bioactivity is not exclusively linked to pigmentation as recently shown by Bernbom et al. (2011).  A 
more comprehensive review is presented in the paragraph on bioactivity in Pseudoalteromonas. 
 
Figure 13: Isolation sites of 101 Pseudoalteromonas strains with each color code 
representing one of the 8 clusters indicated in Table 1 in Vynne et al. (2011) 
 
The present work investigated 101 novel environmental Pseudoalteromonas isolated globally from 
a range of marine sources (figure 13), and whilst all isolates in initial screenings displayed some 
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degree of antibacterial activity, reproducible inhibition of Vibrio anguillarum occurred significantly 
more frequent among pigmented strains (table 3). Analysis of 16S rRNA gene sequences 
supported the phylogenetic grouping of pigmented and non-pigmented strains respectively 
(Vynne et al., 2011). 
Table 3: Identity, antibacterial activity and pigmentation of Pseudoalteromonas strains from 
a global collection. Modified from Vynne et al. (2011) 
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I 1 37 P.agarivorans 16 22 0 0 0 
II 5 0 P.aurantia 2 3 5 0 0 
III 0 9 P.prydzensis 8 1 0 0 0 
IV 3 3 P.phenolica 3 3 3 2 0 
V 4 0 P.luteoviolacea 4 0 4 0 4 
VI 9 0 P.rubra 9 0 9 0 0 
VII 13 0 P.flavipulchra 13 0 13 0 0 
VIII 15 0 P.ruthenica 14 1 15 0 15 
S1712 0 1 P.mariniglutinosa 0 1 0 0 0 
S3655 1 0 P.spongiae 1 0 0 0 0 
Total 51 50  70 31 49 2 19 
 
 
3.2 ECOLOGY OF PSEUDOALTEROMONAS 
Pseudoalteromonas bacterial cells constitute 0.5-6% of the oceanic bacterioplancton (Wietz et al., 
2010) and 0.01%-2.1% of surface associated bacteria on a selection of marine surfaces (Skovhus et 
al., 2004;Skovhus et al., 2007). The strains included in this Ph.D. study originated from the open 
water column, from algae and seaweeds, fish skin or copepods as well as rocks and sediment, 
illustrating the wide range of environments to which Pseudoalteromonas species have adapted 
and successfully colonized. 
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The antagonistic Pseudoalteromonas species are frequently associated with marine microbial 
surface communities on biotic or abiotic surfaces (Gram et al., 2010;Holmström & Kjelleberg, 
1999). From an ecology point of view this makes sense, since a bacterium adapted to planktonic 
life will rarely want to find itself in a situation where production of antagonistic compounds would 
provide a competitive advantage. Intuitively one can imagine polar antagonistic compounds 
diffusing freely away resulting in concentrations much too low to exert their antagonistic effects, 
thus incurring a fitness (production) cost without any gains. Environmental biofilms consists of 
mixed microbial species and competition for nutrients and space is high (Egan et al., 2008). Several 
strategies to overcome these challenges exist, e.g. production of antagonist compounds, 
production of EPS and modulation of bacterial and/or host signaling (Hibbing et al., 2009). The 
high density of microbial cells in surface biofilms may also facilitate an increased rate of exchange 
of genetic material, allowing for exchange of e.g. biosynthetic pathways. Additionally the biofilm 
complex may physically limit the rate of diffusion (Stewart, 2003), making it easier for antagonistic 
species to maintain the local concentration of the bioactive compound.  
 
Many Pseudoalteromonas species produce enzymes which degrade complex polysaccharides such 
as xylan, chitin or cellulose. In planktonic Pseudoalteromonas strains these enzymes likely allow 
rapid breakdown of particulate organic matter (POM) to support bacterial growth and survival, 
while surface associated Pseudoalteromonas could rely on such enzymes to break down host cell 
wall polysaccharides for nutrition. Cellulose induces assembly of type IV-like pili in P. tunicata 
which in turn promotes attachment to the algae Ulva lactuca, a known host of P. tunicata (Dalisay 
et al., 2006) and thus could play a central role in initiating biofilm formation. It also suggests that 
P. tunicata may selectively colonize and feed on surfaces with specific available polysaccharides, 
providing a model for niche colonization within marine bacteria. It is hypothesized that some 
Pseudoalteromonas species may also colonize and interact with higher eukaryotes to the benefit 
of the host organism. In this scenario, the Pseudoalteromonas produce antagonistic compounds to 
e.g. protect the host from excessive fouling (Boyd et al., 1999;Dobretsov & Qian, 2002;Holmström 
et al., 2002) and may in turn acquire nutrients either by scavenging directly from the host via 
enzymatic degradation or from the increased concentration of organic matter found on any 
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marine surface (Wahl, 1989). These are examples of how Pseudoalteromonas species have 
adapted to life on marine surfaces. In the present study, the strains with antagonistic effects 
towards Vibrio anguillarum and Staphylococcus aureus were significantly more likely to originate 
from a surface (Vynne et al., 2011). This is consistent with bacterial antagonism as a selective 
advantage in the competitive environment of marine surfaces. However it was previously reported 
that the overall abundance of Pseudoalteromonads was lower in surface associated communities 
than in bacterioplankton (Skovhus et al., 2007). This is likely a reflection of the multiple strategies 
that exist for microbial competition in surface communities. 
 
3.2.1 PSEUDOALTEROMONAS SPECIES INTERACT WITH HIGHER EUKARYOTES 
It is known that some marine host-microbe interactions are highly specific, to the point of a 
symbiosis. Pseudoalteromonas species are known to be associated with higher eukaryotes 
(Holmström & Kjelleberg, 1999), and the suite of bioactive compounds produced by some species 
may relate to such interactions. The macroalga M. oxyspermum will not develop its normal 
morphology unless it is colonized by certain marine bacteria (Tatewaki et al., 1983). Similarly, 
larvae of many bivalve species are more likely to settle where bacteria that secrete a chemical cue 
have already established (Hadfield & Paul, 2001). Indeed, biofilms of some Pseudoalteromonas 
species induce settlement of eukaryote larvae to actively promote macrofouling (Huggett et al., 
2006;Tebben et al., 2011), while other species deter settlement (Holmström et al., 1992). Crustose 
corraline algae (CCA) are important in marine ecology as several organisms including sea urchin 
feed on these calcifying algae, and studies of CCA epiphytic bacteria provide excellent insight into 
the complexity of Pseudoalteromonas - eukaryote interactions. Hugget et al. (2006) reported that 
Pseudoalteromonas strains were among the bioactive bacteria isolated from a crustose corraline 
alga, and that some greatly induced settlement of larvae from the sea urchin Heliocidaris 
erythrogramma while other Pseudoalteromonads were poor inducers of larval settlement. Upon 
closer inspection, a BLAST search reveals that strains related to P. luteoviolacea were found in 
both the highly and poorly inducing group. It is tempting to speculate that some of these bacteria 
produce compounds with cytotoxic activity towards sea urchin to protect the CCA host although 
no direct evidence of this exists. Furthermore, it would be of interest to perform a detailed 
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phylogenetic study on these P. luteoviolacea strains, as this Ph.D. study has revealed a correlation 
between phylogeny and production of bioactive compounds (Vynne et al., 2012b) and extending 
this approach could reveal any phylogenetic patterns in larval interactions which may be related to 
production of small-molecule compounds (Tebben et al., 2011). Furthermore, a bachelor student 
in our group recently demonstrated that some strains of P. luteoviolacea are highly toxic to live 
Artemia nauplii whilst others have no adverse effect. This division reflected the antibiotic profile of 
the strains, since two strains producing pentabromopseudilin killed Artemia whereas two strains 
producing indolmycin had no effect (Anna Neu, unpublished data).  
 
The Pseudoalteromonas eukaryote interactions could represent a strategy to attract potential host 
organisms and repel undesired settlement of macroscopic species, providing an indication of a 
microbe-host relationship with some symbiotic characteristics. 
 
3.3 PSEUDOALTEROMONADS AS PROBIOTICS IN AQUACULTURE 
The increase in fish rearing for human consumption has been dramatic and comes at a cost to the 
environment in part due to the accompanying use of antibiotics(Cabello, 2006). Probiotics have 
been defined by FAO/WHO as "live microorganisms which when administered in adequate 
amounts, confer a health benefit on the host."(FAO and WHO, 2001) Adding live antagonistic 
marine bacteria to an aquaculture system has reduced mortality in certain models and could 
reduce the need for antibiotics (Gatesoupe, 1997;Moriarty, 1998;Planas et al., 2006;Rengpipat et 
al., 1998). This provides a basic ‘proof-of-concept’ that antagonistic bacteria can act as probiotics. 
Based on their bacterial antagonist properties, Pseudoalteromonas strains are candidates for 
application as probiotics. Longeon et al. describes the probiotic effect of Pseudoalteromonas sp. 
X153 which produces an antibacterial protein of 87 kDa(Longeon et al., 2004). Rearing of scallop in 
co-culture with Pseudoalteromonas sp. X153 significantly reduced scallop mortality but also, due 
to reasons unknown, slightly reduced the scallop growth rate. Interestingly, 16S rRNA gene 
sequence analysis showed a 99.9% identity to P. piscicida, a known fish pathogen. A co-culture of 
three commensal strains, one of them identified via 16S rRNA gene sequence similarity as P. 
elyakovii, of larvae of Atlantic halibut was shown to improve survival of the larvae when grazing on 
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bacteria inoculated prey (Bjornsdottir et al., 2010). Probiotic functions are not restricted to 
promoting animal life, as illustrated by the ability of a marine bacterium to enhance the growth 
rate of a range of plant species due to production of an enzyme with catalase activity (Dimitrieva 
et al., 2006). The bacterium was assigned to the Pseudoalteromonads based on biochemical and 
physiological tests, and identified by the authors as Pseudoalteromonas porphyrae based on 16S 
rRNA gene sequence similarity. However, the bacterium should likely be referred to as a strain of 
P. atlantica or P. elyakovii (both >97% 16S rRNA gene sequence similarity) as P. porphyrae is 
currently not an accepted species designation (Euzéby, 1997). These studies illustrate the potential 
of Pseudoalteromonads to function as probiotics within diverse aquaculture applications, and 
provide a glimpse into the possible roles played by assorted Pseudoalteromonas strains in the 
marine environment. In this thesis work, the fish pathogenic bacterium Vibrio anguillarum 90-11-
287(Skov et al., 1995) was frequently used as test organism in agar based assays to evaluate 
production and activity of antagonistic compounds by Pseudoalteromonas strains. The ability of 51 
strains to consistently inhibit V. anguillarum in a live cell assay (Vynne et al., 2011) suggests that 
these antagonistic Pseudoalteromonas strains might present interesting opportunities for research 
and industrial applications within aquaculture probiotics. In spite of the pathogenic traits of some 
Pseudoalteromonads, they are not considered a problem within aquaculture where e.g. Vibrio 
species will typically pose a greater problem (Toranzo et al., 2005). This opens the possibility for 
evaluating Pseudoalteromonas as fish probiotics on a case-by-case basis. Ideally non-pathogenic 
strains would be pursued. However, pathogenic traits may be specific towards certain species of 
fish or mollusks which may allow for selective use of for instance an algal pathogen in turbot 
aquaculture. 
  
3.4 PATHOGENICITY OF PSEUDOALTEROMONADS 
Whether discussing biotechnological applications or the ecology of Pseudoalteromonas strains, it 
is prudent to consider their potential for pathogenic interactions. The majority of 
Pseudoalteromonas strains are unlikely to be human pathogens as they do not grow well at 37ºC, 
and there are no literature reports of infectious disease in humans caused by Pseudoalteromonas 
bacteria. While not strictly a result of pathogenicity, the poisoning that can occur when eating 
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certain fish of the order Tetradontiformes is attributed to an accumulation of diverse marine 
bacteria that produce the neurotoxin tetrodotoxin (Chau et al., 2011;Noguchi et al., 2006). Among 
these, Pseudoalteromonas tetraodonis was isolated from the skin slime of a pufferfish and 
produces tetrodotoxin (Simidu et al., 1990), hence it is likely involved in human poisoning 
following consumption of pufferfish. Pseudoalteromonas species also colonize and grow on ice-
stored fish (Broekaert et al., 2011) but are unlikely to be a cause of infectious disease since they 
do not grow at human body temperature (37C). Going beyond the human perspective and into the 
natural marine environment of Pseudoalteromonas bacteria, a number of Pseudoalteromonas 
species are associated with infectious disease in fish, molluscs or seaweed and alga. As the name 
suggests, P. piscicida is a fish pathogen. Rapid killing was observed in challenge tests involving live 
bacterial culture (Bein, 1954). No attempts were made to identify the cause of killing, but no fish 
death was observed when using a different unidentified marine bacterium in the same 
experimental setup. A different strain of P. piscicida infects damselfish eggs causing significantly 
higher mortality than untreated controls or common fish pathogen Vibrio anguillarum (Nelson & 
Ghiorse, 1999). P. piscicida is known to produce several bioactive substances and one might 
speculate that the cytotoxic compound norharman could be involved in pathogenicity (Zheng et 
al., 2006). Pseudoalteromonas sp. LT-13 may be an opportunistic pathogen, taking advantage of 
the weakening that occurs upon infection in scallop larvae (Sandaa et al., 2008). An earlier study 
suggested Pseudoalteromonas sp. LT-13 acted as a true pathogen (Torkildsen et al., 2005), 
however this may have been due to a general weakening of the scallop larvae due to the high 
bacterial load encountered in the experimental setup. A follow-up study using lower bacterial 
concentrations indicated that LT-13 is not a primary pathogen, but may be involved in infections as 
an opportunistic secondary pathogen (Sandaa et al., 2008). Pseudoalteromonas species have been 
isolated in numerical abundance from diseased pacific oysters (Garnier et al., 2007), but no direct 
evidence of infection was obtained through re-inoculation of a healthy population with a pure 
bacterial culture. P. elyakovii was isolated from diseased spots on Laminaria japonica (Sawabe et 
al., 2000) and was suggested to cause the disease.  
The limited number of literature reports on pathogenic Pseudoalteromonas species suggests that 
these bacteria do not represent a danger to human health, and only rarely are involved in 
eukaryote disease.  
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3.5 BIOACTIVE COMPOUNDS PRODUCED BY PSEUDOALTEROMONAS 
The wide occurrence of Pseudoalteromonas shows that members of this genus are successful in 
colonizing and persisting in a broad range of habitats. Bioactive substances such as enzymes, 
antimicrobials and antifouling cues are likely part of the reason for this success, enabling the 
producer strains access to nutrients or advantages through inhibition of competing microbes and 
modulation of the behavior of macroscopic animals. The bioactive molecules can be roughly 
divided into two groups: Small-molecule (molecular weight of less than ca. 3 kDa) non-
proteinaceous compounds that are products of secondary metabolism and proteinacious 
compounds including both large enzyme complexes and small peptides. The chemical diversity of 
the compounds is staggering when considering compounds with antibacterial or cytotoxic action, 
making Pseudoalteromonas strains interesting targets for discovery efforts focused on bioactive 
compounds with both pharmaceutical and industrial applications. Here, an overview of the known 
bioactive compounds produced by Pseudoalteromonas strains is presented (table 4, see page 36). 
Enzyme activity and modulation of eukaryote behavior are covered in separate paragraphs. P. 
luteoviolacea will have a dedicated bioactivity paragraph, as this species has been a focal point of 
this Ph.D. work. 
 
3.5.1 NON-LUTEOVIOLACEA PSEUDOALTEROMONAS  
Antibacterial activity is observed in multiple species of Pseudoalteromonads. The inhibitory 
spectrum varies however, as some species inhibit Gram-negative or Gram-positive bacteria 
exclusively while others have very broad or very narrow ranges of inhibition. An example of this is 
P. phenolica O-BC30 which produces novel structurally related anti-MRSA compounds. The 
compound MC21-A was bacteriocidal against MRSA Staphylococci and exhibited broad-spectrum 
antibacterial activity (Isnansetyo & Kamei, 2003) while MC21-B inhibited Gram-positive strains but 
not Gram-negative bacteria or fungi (Isnansetyo & Kamei, 2009). Similarly Pseudoalteromonas sp. 
F-420 produces the antibiotic korormicin, which is active against Gram-negative marine bacteria 
(Yoshikawa et al., 1997). The compound targets a unique NADH:quinone reductase (Yoshikawa et 
al., 1999) found in many marine bacteria which enables the bacteria to maintain a sodium-motive 
force under the conditions present in the marine environment (Unemoto & Hayashi, 1993). This 
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makes korormicin a highly specialized substance which targets marine bacteria, and more 
knowledge of its in situ role in ecology would be of great interest. Another interesting case are the 
structurally distinct class of small molecule antibiotic compounds called thiomarinols, produced by 
Pseudoalteromonas sp. SANK 73390 (Shiozawa et al., 1993;Shiozawa et al., 1995;Shiozawa et al., 
1997). Thiomarinols are active against both Gram-negative and Gram-positive bacteria, and are 
synthesized from the products of two biosynthetic pathways located on a plasmid (Fukuda et al., 
2011). Synthetic analogues have been engineered by mutagenesis of the producer bacterium 
(Murphy et al., 2011). Pseudoalteromonas sp. CMMED 290 produces pentabromopseudilin (PBP), 
bromophene and two novel anti MRSA compounds structurally related to PBP and bromophene 
respectively (Fehér et al., 2010). This is a good example of how biosynthetic intermediates may be 
isolated as interesting bioactive lead compounds based on bioassays which likely do not reflect the 
ecological role of the active compound. Prodigiosin and related compounds feature prominently in 
several bacteria, notably Serratia marcescens. Among the Pseudoalteromonads, P. denitrificanas 
(Kawauchi et al., 1997;Kim et al., 1999) and P. rubra (Fehér et al., 2008;Gerber, 1971;Vynne et al., 
2011) produce the red pigments prodigiosin and cycloprodigiosin HCl (figure 14).  
 
Figure 14: Fractionated ethyl acetate extracts of P. rubra strains (Maria Månsson) 
 
This class of compounds has been investigated for several pharmacological effects as reviewed by 
(Bennett & Bentley, 2000), for example cycloprodigiosin has potential applications as an 
antimalarial (Kawauchi et al., 1997) and immunosuppressive agent (Kim et al., 1999). Recent 
research has shown that prodigiosin is a potential insecticide with activity against mosquito larvae 
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(Patil et al., 2011), while others have provided evidence that prodigiosin functions as a UV-
protective pigment which may be the actual reason for its wide-spread occurrence in marine 
bacteria (Boric et al., 2011). 
Some Pseudoalteromonas species produce antifungal compounds which are speculated to have a 
role in surface colonization. P. issachenkonii produces the antifungal compound isatin 
(Kalinovskaya et al., 2004), which was suggested to confer a competitive advantage in colonizing 
algal thalli which is the natural niche of the producer species. Isatin-producing Alteromonas 
bacteria have also been isolated from shrimp embryos and it was shown that the Alteromonas 
bacteria protected the embryos from infection by a pathogenic fungus (Gil-Turnes et al., 1989).  P. 
tunicata produces an antifungal tambjamine compound structurally related to prodigiosin (Burke 
et al., 2007). This is likely the compound that was responsible for the antifungal activity observed 
in co-culture biofilms of P. tunicata and a marine fungus, where P. tunicata was able to exclude 
the fungus from the biofilm (Franks et al., 2006).  
P. maricaloris KMM 636 produces the chromopeptides bromoalterochromide A and A’ which are 
cytotoxic towards sea urchin eggs (Speitling et al., 2007). We identified bromoalterochromide A in 
12 strains of P. flavipulchra which are closely related to P. maricaloris and P. pisicida, and in one P. 
phenolica strain and one P. rubra strain. From these strains we also identified what is likely two 
novel bromoalterochromides, that were also produced in 2 strains of P. aurantia / P. citrea (Vynne 
et al., 2011). Synthesis of bromoalterochromides is shared among several Pseudoalteromonas 
species, and the cytotoxic effect of bromoalterochromides A and A’ provides evidence for the 
involvement of bromoalterochromides in bacterial-eukaryote interactions. Unfortunately, 
bromoalterochromides degrade rapidly upon exposure to UV light which makes them hard to 
purify and detect. 
The antibacterial compound 2-n-pentyl-4-quinolinol was identified from a Pseudoalteromonas 
strain related to P. citrea and P. aurantia (Long et al., 2003), and from P. piscicida A1-J11 (del 
Castillo et al., 2008). During my Ph.D. work, the compound was identified in 5 of 5 strains related 
to P. citrea and P. aurantia, and in 1 of 13 strains related to P. flavipulchra and P. piscicida (Vynne 
et al., 2011). An additional 3 quinolinone compounds were also identified in some of these strains, 
with no apparent species-specific pattern. 2-n-pentyl-4-quinolinol strongly inhibited Vibrio harveyi 
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and Vibrio fischeri but not other Vibrio sp. or Pseudomonas sp. (Long et al., 2003). Interestingly, it 
was previously described as a primary antibiotic in a marine Pseudomonad (Wratten et al., 1977) 
and as seen in figure 15 resembles the structure of the quinolone molecules utilized for signalling 
by Pseudomonas aeruginosa (Pesci et al., 1999) which opens for discussion of the role of small-
molecule antibiotics in the environment.  
 
1 2
 
 
Figure 15: Chemical structure of 2-n-
pentyl-4-quinolinol 1 and the 
Pseudomonas quinolone signal 2-
heptyl-3-hydroxy-4-quinolone 2. 
 
Recent publications have raised questions regarding the role of antimicrobial compounds in situ. 
Many antibiotics have profound influence on gene expression levels in microorganisms exposed to 
sub-lethal concentrations of the antibiotics (Davies et al., 2006), for instance subinhibitory 
concentrations of β-lactam or aminoglycoside antibiotics induce biofilm formation in 
Pseudomonas aeruginosa (Bagge et al., 2004;Hoffman et al., 2005). Biofilm formation is known to 
increase bacterial resistance towards antibiotics (Mah & O'Toole, 2001), and thus may be 
considered a defense mechanism. Indeed, laboratory studies indicate that antibiotic production 
may be of particular benefit in a structured environment (Chao & Levin, 1981) which may also be 
applicable for marine surface colonizers. Little is known of the effect of an antibiotic on the 
producer organism itself and the microbial community as a whole in a marine natural 
environment, and exploration of the in situ activities of naturally occurring antibiotics has the 
potential to shed a new light on marine microbial ecology. 
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Table 4: Bioactive compounds produced by Pseudoalteromonas species. Modified from Bowman (2007) 
Species Source Pigment Bioactive compounds Bioactivity 
P. aliena Seawater + (melanin) Unknown compounds Anti-tumorogenic 
P. agarivorans Seawater, ascidians - Unknown Degrades algal 
polysaccharides 
P. antarctica Seawater, sea-ice, 
muddy soils 
- - Cold-active enzymes 
P. arctica Seawater - - - 
P. atlantica Seawater, marine 
alga 
- - Degrades algal 
polysaccharides 
P. aurantia Seawater, alga Yellow 2-pentyl-4-quinolinol Antibacterial 
   Macromolecule Antibacterial 
   Unknown Antidiatom 
P. byunsanensis Tidal flat sediment - - - 
P. carrageenovora Seawater, marine 
alga 
- - Degrades algal 
polysaccharides 
P. citrea Seawater, mussels, 
ascidians, sponges 
Yellow, 
melanin 
2-pentyl-4-quinolinol Antibacterial 
  Unknown Antidiatom 
P. denitrificans Seawater Red Cycloprodigiosin HCl Antimalarial, 
immunosuppressant,           
anti-tumerogenic 
   Unknown substance Induces settlement 
of sea urchin 
Heliocidaris 
erythrogramma 
P. distincta Sponge (melanin) - - 
P. donghaensis Seawater - - - 
P. elyakovii Mussels, alga - - - 
P. espejiana Seawater - - - 
P. flavipulchra Seawater, copepod Orange/yellow 2-pentyl-4-quinolinol Antibacterial 
P. haloplanktis Seawater, scallop - Isovaleric acid Antibacterial 
   Unknown Antidiatom 
    Cold-active enzymes 
P. issachenkonii Alga - Isatin Antifungal, 
hemolytic 
P. lipolytica Estuarine water - - - 
P. luteoviolacea Seaweed, algae, 
rocks, seawater 
Purple Violacein Antibacterial, 
cytotoxic 
    Pentabromopseudilin Antibacterial, 
inhibits myosin 
motor activity 
      Indolmycin Antibacterial 
      L-amino acid oxidase Antibacterial 
      2,4-Dibromo-6-chlorophenol  Antibacterial, 
antifungal 
P. maricaloris Sponges Yellow Bromoalterochromides A and 
B 
Antibacterial, 
cytotoxic towards 
sea urchins 
P. marina Tidal flat sediment - - - 
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P. mariniglutinosa Diatoms - - - 
P. nigrifaciens Seawater, raw fish, 
salted foods, mussels 
(melanin) - - 
        
P. paragorgicola Sponge - - - 
P. peptidolytica Seawater Yellow Unknown compounds Antimicrobial, 
hemolytic 
P. phenolica Seawater Brown 2,2',3-tribromobiphenyl-4-4'- 
dicarboxylic acid 
Antibacterial against 
Gram-positive 
bacteria 
   3,3',5,5'-tetrabromo-2,2'-
biphenyldiol 
Antibacterial 
P. piscicida Estuarine water, fish 
samples, copepods 
Yellow Protein Antibacterial 
    2-n-pentyl-4-quinolinol Antibacterial 
      Unknown Antidiatom 
P. prydzensis Seawater - - - 
P. rubra Seawater Red Prodigiosin, cycloprodigiosin,                                   
2-(p-
hydroxybenzyl)prodigiosin 
Antimalarial, 
immunosuppressant, 
insecticide, UV-
protection 
      Rubrenoic acids Bronchodilatory 
      Unknown Antidiatom 
P. ruthenica Shellfish, seawater Pale orange Unknown compounds Antimicrobial 
P. spongiae Sponge Pale orange Unknown compounds Strong induction of 
Hydroides elegans 
settlement 
P. tetraodonis Puffer fish - Tetrodotoxin Neurotoxic 
P. translucida Seawater - - - 
P. tunicata Tunicate Dark green Tambjamine Kills C. elegans 
   Violacein Antibacterial, 
cytotoxic 
   AlpP L-amino acid oxidase Antibacterial, 
autoinhibitory 
   Unknown Antidiatom 
   Unknown protein Rapidly kills C. 
elegans 
P. ulvae Marine alga Purple Unknown Inhibits settlement 
of invertebrate 
larvae and algal 
spores 
      Unknown Antidiatom 
P. undina Seawater, fish - Unknown Antidiatom, 
hemolytic 
     
Pseudoalteromonas sp. :    
SANK 73390   Thiomarinols A, B, C, D, E, F, G Antibacterial 
F-420 Alga White / yellow Korormicin Antibacterial against 
Gram-negative 
bacteria 
SWAT5 Marine particle Unknown 2-n-pentyl-4-quinolinol Antibacterial 
S2V2 Seawater White / yellow Non-proteinaceous Antibacterial 
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Unknown (a) Seaweed Unknown Halophenol Antibacterial, 
antifungal 
CMMED 290 Nudibranch Unknown 2,3,5,7-tetrabromobenzofuro-       
[3,2-b]pyrrole 
Anti MRSA 
      4,4',6-tribromo-2,2'-biphenol Anti MRSA 
      Pentabromopseudilin Antibacterial, 
inhibits myosin 
motor activity 
      Bromophene Antibacterial 
J010 Corraline algae Unknown Tetrabromopyrrole Induces settlement 
and metamorphosis 
of coral larvae 
(a) Jiang et al. 2006    
 
 
3.5.2 PSEUDOALTEROMONAS LUTEOVIOLACEA 
One of the first antibacterial compounds that were described from marine bacteria was 
pentabromopseudilin (PBP), identified as a novel compound produced by a bacterium later 
assigned to the Pseudoalteromonas (Burkholder et al., 1966;Fenical, 1993). This compound was 
identified in a subset of P. luteoviolacea strains in this Ph.D. work (figure 16), and although it was 
claimed to also be produced by a Chromobacterium sp. (Andersen et al., 1974) the bacterial strain 
in question shows biochemical characteristics resembling P. luteoviolacea over Chromobacterium, 
in particular a negative catalase reaction, survival for 3-4 days in plate cultures and optimum 
growth around room temperature (Gauthier, 1982;Gauthier & Flatau, 1976).  
 
Figure 16: Small-molecule bioactive compounds produced by P. luteoviolacea. Violacein 1, 
pentabromopseudilin 2 and indolmycin 3.  
 
PBP shows excellent in vitro activity against Gram-positive bacteria but is not active against Gram-
negative bacteria or Candida albicans (Burkholder et al., 1966). PBP is a potent inhibitor of myosin 
motor activity with clinical potential in treatment of malaria, cancer and heart disease (Fedorov et 
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al., 2009). In addition to PBP, P. luteoviolacea produces the purple pigment violacein. Violacein 
was reported to have antibacterial activity (Lichstein & Vandesand, 1945), though this was not 
observed in this Ph.D. work in tests against P. luteoviolacea strains, Vibrio anguillarum and 
Staphylococcus aureus. Violacein has potent cytotoxic activity (da Silva Melo et al., 2000), and is 
likely used as a chemical defense molecule by the producing organisms (Matz et al., 2004;Matz et 
al., 2008). Violacein production is also described in P. tunicata (Matz et al., 2008), P. denitrificans 
(Yada et al., 2008) and in several other genera (Agematu et al., 2011;Becker et al., 2009;Hakvåg et 
al., 2009;Lichstein & Vandesand, 1945;Wang et al., 2009). Phylogenetic analysis of amino acid 
sequences of biosynthetic proteins involved in violacein synthesis indicate that the violacein 
biosynthesis in Pseudoalteromonads diverged at an early point (Hakvåg et al., 2009). This may be 
the result of a genetic transfer event involving ancestral bacteria which since differentiated into 
Pseudoalteromonas species and violacein producing β-Proteobacteria, respectively, or it could 
indicate that violacein biosynthesis is an ancient pathway which originated in a common ancestor. 
 
 A third small-molecule antibiotic substance produced by P. luteoviolacea is indolmycin (Månsson 
et al., 2010;Vynne et al., 2011), as described in this Ph.D. work. Hitherto known only from 
Streptomyces species (Kanamaru et al., 2001;von Wittenau & Els, 1961) indolmycin is a potent 
antibacterial agent with selective antibacterial activity against both Gram-negative and Gram-
positive bacteria and particularly effective against S. aureus with a reported minimum inhibitory 
concentration of 0.25 µg/ml (Hurdle et al., 2004) and Helicobacter pylori (Kanamaru et al., 2001). 
The tryptophan-derived indolmycin inhibits the bacterial tryptophanyl-tRNA synthetase (Werner 
et al., 1976) by competitive binding, and mutations leading to changes of specific amino acids in 
the tryptophanyl-tRNA synthetase or changes in the promotor sequence of the tryptophanyl-tRNA 
synthetase gene leads to high levels of indolmycin resistance in Streptomyces coelicolor and E. coli 
(Kitabatake et al., 2002;Vecchione & Sello, 2009). A P. luteoviolacea with no strain name given was 
reported to produce the antibacterial and antifungal compound 2,4-Dibromo-6-chlorophenol 
(Jiang et al., 2000).  
 
In the course of this Ph.D. study a link between phylogeny based on housekeeping genes and 
production of the bioactive compounds indolmycin and PBP was discovered (Vynne et al., 2012b). 
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Indolmycin or PBP were produced by distinct phylogenetic groups, providing evidence for the 
importance of these compounds in the producer organisms as the biosynthetic pathways are 
maintained over evolutionary time. 
In addition to the small-molecule compounds mentioned above, P. luteoviolacea is capable of 
synthesizing a macromolecular antibacterial substance. An L-amino acid oxidase (LAO) was 
characterized from two P. luteoviolacea strains by (Gomez et al., 2008) and is likely synonymous 
with the macromolecule previously described in the type strain (Gauthier, 1976). Other LAOs are 
known from marine bacteria (Lucas-Elio et al., 2005) and includes the AlpP autolysis protein 
produced by P. tunicata (Mai-Prochnow et al., 2008) and an anti-MRSA agent produced by P. 
flavipulchra (Chen et al., 2010). It is tempting to speculate that autolysis in P. luteoviolacea is due 
to LAO activity (Gauthier & Flatau, 1976), as suggested for P. tunicata (Mai-Prochnow et al., 2004). 
The physiological role of LAOs in marine bacteria is unknown, though the antimicrobial effect of 
LAOs is due to the release of hydrogen peroxide when the LAO substrate is oxidized (Gomez et al., 
2008;Mai-Prochnow et al., 2008). In addition to possible in situ antimicrobial effects they may 
increase available nitrogen by oxidizing amino acids in the local milieu as suggested for fungal 
LAOs (Davis et al., 2005). 
 
3.6 ENZYMATIC ACTIVITIES OF PSEUDOALTEROMONADS 
Microbial life is dependent on enzyme activities. Extracellular enzymes play crucial roles in 
providing accessible nutrient sources and are often highly specialized for the niches of the 
producer organism. This ecology-driven specialization has gone on for the entirety of microbial 
evolution, and thus offers a wealth of highly specialized enzymes which may have uses within 
industries as diverse as dairy production and biofuels. The ubiquitous nature of the 
Pseudoalteromonads is an indication that they thrive in a wide range of environments, and arctic 
strains in particular have been investigated for enzymatic activities in the expectation that novel 
enzymes active at low temperature would be discovered. An overview of some of the currently 
described enzymatic activities is presented in table 5.  
Many of the characterized enzymes from Pseudoalteromonas strains are from psychrophilic strains 
and exhibit cold-adapted properties. This opens for different applications such as treatment of 
dairy products to remove lactose at low temperature (Hoyoux et al., 2001), however the cold 
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adapted enzymes are often also less stabile and will denature or undergo conformational changes 
at a lower temperature than mesophilic enzymes (Georlette et al., 2004). 
 
 
Representative strains from the collection used in the present work were screened for production 
of industrially relevant enzymes in an agar based assay (figure 17 below) containing azurine cross-
linked polysaccharides (Megazyme, Ireland). Six of 12 strains tested amylase positive and 5 of 12 
tested curdlanase positive, with four strains testing positive in both assays (Vynne, unpublished).  
 
Table 5: Enzyme activity from Pseudoalteromonas strains 
Strain Product Reference 
P. haloplanktis Cold-adapted β-galactosidase Hoyoux et al. 2001 
Pseudoalteromonas sp.  Cold-adapted β-galactosidase Fernandes et al. 2002 
P. haloplanktis TAC125 Lipase PhTAC125 Lip1 de Pascale et al. 2008 
Pseudoalteromonas sp. DY3 Cold-active cellulase Zeng et al. 2006 
Pseudoalteromonas sp. NJ276 Cold-active protease Wang et al. 2008 
Pseudoalteromonas sp. SM9913 Cold-adapted subtilase Yan et al. 2009 
P. haloplanktis TAB23 Cold-adapted α-amylase Tutino et al. 2002 
P. haloplanktis ANT/505 Pectate lyase Van Truong et al. 2001 
P. haloplanktis Xylanase Van Petegem et al. 2002 
Pseudoalteromonas sp. MB-1 Endoglucanase You et al. 2005 
Pseudoalteromonas sp. 005NJ α-l-rhamnosidase Gaston Orrillo et al. 2007 
Pseudoalteromonas arctica Cold-adapted esterase Al Khudary et al. 2010 
P. haloplanktis Cold-adapted cellulase Violot et al. 2005 
P. haloplanktis DNA ligase Georlette et al. 2000 
P. carrageenovora Carrageenase Michel et al. 1999 
Pseudoalteromonas sp. S9 Chitinase Techkarnjanaruk et al. 1997 
P. arctica GS230 Cold-adapted α-amylase Lu et al. 2010 
P. antarctica N-1 Agarase Vera et al. 1998 
Pseudoalteromonas sp. CKT1 Agarase Xavier Chiura et al. 2000 
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Figure 17: Amylase assay on 
Pseudoalteromonas strains. The AZCL-
substrate is seen as blue particles in the 
agar and dark blue halos indicate enzyme 
activity. 
 
The positive strains were both pigmented and non-pigmented. A reason for the low number of 
observed enzymatic activities within the Pseudoalteromonas strains from this Ph.D. study could be 
that pigmented strains were overrepresented in the selection for screening, since the pigmented 
bacteria were the primary research interest due to their antagonist activities while the majority of 
the producer organisms listed in table 5 are of the non-pigmented clade. Also, since the screening 
took place at 25ºC, some strains may have cold-adapted enzyme activities which were not 
detected due to the incubation temperature. 
 
3.7 ANTI-FOULING POTENTIAL OF PSEUDOALTEROMONAS SPECIES 
While some Pseudoalteromonas promote settlement of eukaryotes as previously described 
(Huggett et al., 2006), many species have been investigated for their anti-fouling and anti-biofilm 
activities (Bernbom et al., 2011;Boyd et al., 1999;Dobretsov & Qian, 2002;Egan et al., 
2001a;Holmström et al., 2002). Fouling is a build-up of biological material on a surface, which in 
the marine environment develops rapidly unless preventive measures are taken. Briefly, 
submerging a clean surface into the marine environment will cover the surface in a thin film of 
organic substances within minutes. Bacteria and diatoms will follow within hours, forming the 
basis for increased colonization by larvae of macrofouling organisms(Abarzua & Jakubowski, 
1995;Colwell, 1983;Wahl, 1989). Fouling is a problem in the marine industries, particularly within 
shipping as a dense layer of fouling rapidly develops on a submerged hull reducing speed and fuel 
efficiency unless preventive measures are taken (Champ, 2000).  
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Pseudoalteromonas tunicata D2 produces anti-fouling compounds (Holmström et al., 1998) shown 
to correlate with pigment production (Egan et al., 2002). Other Pseudoalteromonas strains inhibit 
larvae and diatom settlement in direct cell interaction assays (Lee & Qian, 2003) and in tests of 
aqueous bacterial cell extracts (Dobretsov & Qian, 2002). Some antifouling effects may be due to 
bacterial antagonism towards other microorganisms which promote larval settlement, but there is 
no consistent link between antifouling and antibacterial compounds (Bernbom et al., 2011). 
 
 
 
 
3.8 CONCLUSION FROM CHAPTER 3 
The genus Pseudoalteromonas has a complex and intricate taxonomy and underlying phylogeny. 
Care should be taken if 16S rRNA gene sequences are used as the only means of species 
identification when a novel Pseudoalteromonas isolate is being described, as this Ph.D. thesis 
demonstrate that even at 99% 16S rRNA sequence identity, it remains possible to describe new 
species. Correct taxonomical assignments are important for scientific communication and 
understanding evolutionary dynamics with a bacterial genus. Many Pseudoalteromonas species 
produce bioactive compounds and the present study expanded on the knowledge of bioactive 
small-molecule compounds and their distribution within the Pseudoalteromonas species. The 
potent antibacterial compound indolmycin was discovered for the first time in marine bacteria, 
and several other known bioactives were identified. It was discovered that, within a single species, 
three antibiotics were produced by distinct phylogenetic groups. The selective maintenance of the 
biosynthetic pathways suggests the antibiotics play an important role for the producer organism, 
likely in community interactions and protection given the antagonist nature of the compounds. 
The role of antibiotics in the natural environment is increasingly up for debate, as sublethal 
concentrations of antibiotics may in fact have dramatic effects on bacterial populations and hence 
what we perceive as antibiotics may in some cases serve a different purpose under natural 
conditions. As novel Pseudoalteromonas species and strains with interesting bioactivities are 
continuously described, it stands to reason that there is a rich untapped potential for biodiscovery 
of novel bioactive substances within the Pseudoalteromonads. 
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4.0 QUORUM SENSING IN REGULATION OF BACTERIAL PRODUCTION OF  
ANTIMICROBIAL COMPOUNDS 
Traditionally, bacteria were thought of as individual cells with no means to actively coordinate a 
change in the population of gene regulation and phenotype. As our understanding of bacterial 
behavior in both pure cultures and mixed communities has increased, it has become clear that 
intra- and inter-species cell-cell communication play a key role in coordinating gene expression 
and subsequently phenotype in both pure cultures and mixed communities. There are many types 
of bacterial communication (Blango & Mulvey, 2009;Dubey & Ben-Yehuda, 2011), however, one of 
the currently most studied is often referred to as quorum sensing (QS). The name quorum sensing 
reflects its reliance on cell numbers, and it is now known to regulate advanced phenotypes such as 
bioluminescence (Nealson & Hastings, 1979), virulence (Latifi et al., 1995),  motility (Huber et al., 
2001;Kohler et al., 2000), biofilm formation (Labbate et al., 2004) and antibiotic production 
(Berger et al., 2011;Duerkop et al., 2009;Hothersall et al., 2011). QS is mediated by small-molecule 
chemical compounds called auto-inducers, which diffuse freely into the extracellular environment 
and act as signal carriers. As part of the work with antibiotic producing Pseudoalteromonas, we 
discovered compounds that possibly could be autoinducers and hypothesized that these were 
involved in regulation/production of a particular antibiotic.  This chapter outlines the general 
principles of QS and focuses on examples in which bacterial antibiotic production is QS regulated. 
 
4.1 THE VIBRIO FISCHERI LUXI/LUXR QUORUM SENSING MODEL 
The process of QS has been described in many bacterial species and regulates diverse physiological 
and chemical processes (see e.g. (Dobretsov et al., 2009;Van Houdt et al., 2007). Quorum sensing 
was first described in the marine bacteria Vibrio fischeri where it regulates bioluminescence 
(Nealson & Hastings, 1979). This cell density dependent QS system is studied in depth and forms 
the canonic Lux-based QS system (figure 18). Similar LuxIR-like QS systems have been widely 
described in Gram-negative bacteria (Whitehead et al., 2001) and are characterized by containing 
homologues to the LuxI and LuxR proteins. Four main components are involved in LuxIR QS: the 
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LuxI AHL synthetase, the acylated homoserine-lactone (AHL) signaling molecules, the LuxR 
transcriptional regulator and the genes encoding the QS regulated phenotype (Miller & Bassler, 
2001). The LuxI protein is responsible for synthesis of the AHL molecules and even at low cell 
densities individual cells produce a small amount of the cognate AHL (Engebrecht & Silverman, 
1984). As cell density increases, the local concentration of AHL rises and eventually reach a 
threshold concentration which activates the LuxIR regulatory system. The system is activated by 
LuxR proteins binding the cognate AHL, which induces a conformational change that allows the 
DNA binding domain of the LuxR protein to recognize and bind to a specific DNA sequence called a 
lux-box (Choi & Greenberg, 1992;Welch et al., 2000;Zhu & Winans, 2001). Upon LuxR binding, 
transcription of the genes downstream of the lux-box is activated. The luxI gene may also be 
situated downstream of the LuxR binding site, which upon LuxR binding leads to an increased 
production of LuxI and subsequently increased AHL concentration creating a positive feedback 
loop. Several variations on this central concept exist, for instance LuxR can focus as a repressor 
protein (Fuqua et al., 1996). 
 
Figure 18: The canonical LuxI/LuxR QS system in V. fischeri.  IM, inner membrane; OM, outer 
membrane. Adapted from Waters & Bassler (2005). 
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4.1.1 ACYLATED HOMOSERINE-LACTONES: STRUCTURE AND ANALYSIS 
The AHL molecules are the active signal carrying molecules in LuxIR quorum sensing. Most diffuse 
freely in and out of the individual bacterial cells, enabling the AHL-producing bacteria – and 
possible “eavesdroppers” – to probe the concentration of signal molecules and monitor the 
microbial environment to respond in a coordinated, social way. Figure 19 shows the typical AHL 
compositions consisting of a homoserine lactone ring with a C4 – C18 N-acyl side chain (Fuqua et 
al., 2001).  
 
 
Figure 19: Acylated homoserine lactones 
produced by different bacterial species and 
recognized by corresponding LuxR 
homologues. The R side chain may also 
contain a number of double bonds. Adapted 
from Ng & Bassler (2009). 
 
 
 
The lactone ring will open at alkaline pH, eliminating the signaling properties of the AHL. 
Susceptibility to this lactonolysis decrease as the N-acyl chain increases in length (Yates et al., 
2002). AHLs commonly have 3-oxo or 3-hydroxy substitutions, which influences signal specificity, 
and may have a number of unsaturated double bonds in the side chain. The biosynthesis of AHLs 
rely on cellular pools of acylated acyl carrier protein and S-adenosyl-L-methionine which are the 
substrates used by the LuxI AHL synthetase (Parsek et al., 1999;Watson et al., 2002). A very 
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interesting recent study identified a new class of homoserine lactone QS signal molecules which 
are based on p-coumaric acid rather than cytoplasmic fatty acids and function in a LuxIR analogue 
QS system (Schaefer et al., 2008).  
AHLs are commonly identified via bioassays that rely on well characterized QS systems that detect 
AHL signals with varying sensitivity and specificity (Cha et al., 1998;McClean et al., 1997;Ravn et 
al., 2001;Winson et al., 1998). Often, these systems are engineered to function as biosensors, e.g. 
through a lacZ or luminescence reporter fusion (figure 20).  Since the assays are based on naturally 
occurring pathways, a given biosensor will in most cases produce a stronger response when its 
cognate AHL is added, and the range of AHLs recognized varies among biosensors (Fekete et al., 
2007). The biosensors are also used in conjunction with methods from analytical chemistry in 
order to purify and identify the AHL compounds following bioassay guided fractionation strategies 
as described in chapter 1 but using AHL biosensors as indicator strains (Fekete et al., 2007;Wang et 
al., 2011).  
 
 
 
Figure 20: Bioassay for 
detection of AHLs. The monitor 
strain is Agrobacterium 
tumefaciens pZLR4. pZLR4 
contains the Lux homologue 
Tra-system with a lacZ fusion. 
The blue zones indicate that the 
Tra-system was activated and 
lacZ transcribed, leading to 
production of a blue pigment 
due to specific cleavage of 5-
bromo-4-chloro-indolyl-β-D-
galactopyranoside (Cha et al., 
1998). The samples tested were 
C-18 fractions of an ethyl 
acetate extract of P. 
luteoviolacea S4054. 
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4.2 THE ROLE OF QUORUM SENSING IN REGULATING BACTERIAL PRODUCTION OF 
ANTIBIOTICS 
One of the many phenotypes regulated by QS is, in some bacteria, the production of antibiotic 
compounds. The ability to regulate and coordinate production of an antibiotic compound is an 
obvious advantage to the producer organisms, e.g. in surface colonization where QS could restrict 
production of antibiotics to situations where a microbial community is established, cell density is 
high and action against competitors is needed.  
 The genus Burkholderia contains several species that utilize signaling via QS mechanisms.  Among 
these, production of antibiotic compounds by Burkholderia cepacia and Burkholderia thailandensis 
is under QS regulation. The antibiotic bactobolin which is effective against both Gram-positive and 
Gram-negative bacteria was recently identified in B. thailandensis E264 (Seyedsayamdost et al., 
2010). A biosynthetic pathway was proposed (figure 21) (Seyedsayamdost et al., 2010) and shown 
to be under LuxIR-homologue QS control with AHL production being essential for expression of 
antibacterial activity (Duerkop et al., 2009). Bactobolin inhibited Bacillus subtilis which, like B. 
thailandensis, is a soil bacterium and the authors speculate that the QS regulated production may 
allow B. thailandensis to chemically defend itself during growth as microcolonies in the soil 
environment. Other LuxIR-homologue QS systems with high homology to QS systems in the closely 
related Burkholderia mallei and Burkholderia pseudomallei exist in B. thailandensis and are 
speculated to regulate virulence factors  (Duerkop et al., 2007;Duerkop et al., 2008).  
 
Figure 21: The QS regulated bactobolin pathway. I2 and R2 are LuxI and LuxR homologues, 
respectively. The red arrows are annotated as NRPS genes, green arrows indicate PKS genes, pink 
arrows are potential accessory antibiotic synthesis genes, orange arrows are putative transport 
genes, the brown arrow is a metallopeptidase, and gray indicates genes of unknown function. The 
numbers indicate genes targeted for molecular analyses. Modified from Duerkop et al. (2009) 
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The polyketide antibiotic mupirocin used in topical treatment of Staphylococci is produced by 
Pseudomonas fluorescens NCIMB 10586 and is under QS control (Thomas et al., 2010). The genes 
mupI and mupR are regulatory genes with their products showing high amino acid homology to 
LuxI and LuxR, respectively (El-Sayed et al., 2001). These genes are essential for biosynthesis of 
mupirocin and the MupI product was recently identified as 3-oxo-C10-HSL (Hothersall et al., 2011). 
Interestingly, production of mupirocin was not increased by addition of exogenous 3-oxo-C10-HSL 
or in trans expression of mupI, suggesting that an additional control mechanism possibly related to 
the amidase homologue MupX influences production of mupirocin (Hothersall et al., 2011). The 
involvement of the putative AHL-degrading enzyme MupX adds an extra level of complexity to this 
QS network and provides a glimpse of how tight regulatory control is employed by bacteria to 
ensure correctly timed production of, in this case, secondary metabolites with bioactivity.  
The Gram-negative γ-Proteobacteria Erwinia carotovora and Serratia sp. ATTC 39006 produce the 
broad-spectrum β-lactam antibiotic carbapenem (Parker et al., 1982). The production of 
carbapenem is under QS control in both bacteria (Bainton et al., 1992;Thomson et al., 2000) 
although interestingly the QS mechanisms are different with respect to the AHL binding molecules 
(figure 22 below). In Erwinia, the LuxR homologue CarR binds the AHL directly and subsequently 
activates transcription of the car biosynthetic pathway, in similar fashion as the canonical LuxIR 
system. In Serratia sp. ATTC 39006, two LuxR homologues exist: the AHL binding transcriptional 
repressor SmaR and the AHL independent transcriptional activator CarR (Cox et al., 1998;Thomson 
et al., 2000).  C4-HSL or C6-HSL binds to the repressor SmaR which is then released and 
transcription is activated by CarR. The different approaches to regulation of the car biosynthetic 
pathway illustrate how LuxR homologues can act in different ways, possibly as a result of 
adaptation to different environments and variation in the role within regulatory cascades. In 
Serratia spp., QS is also involved in regulating production of the bioactive pigment prodigiosin 
(Thomson et al., 2000) and several other interesting phenotypes such as swarming and biofilm 
formation (reviewed by Van Houdt et al. (2007)). 
Members of the marine bacterial Roseobacter clade are widely isolated from the marine 
environment, often in association with marine alga (Buchan et al., 2005). Some species of the 
Roseobacter clade are antibacterial (Gram et al., 2010;Hjelm et al., 2004;Martens et al., 2007) and 
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this is frequently associated to production of the antibacterial compound tropodithietic acid (TDA) 
(Brinkhoff et al., 2004;Bruhn et al., 2007;Geng et al., 2008;Porsby et al., 2008). AHL production is 
widespread among Roseobacter strains (Bruhn et al., 2007;Gram et al., 2002;Wagner-Döbler et al., 
2005) and production of QS signals has been hypothesized to play an important role in 
Roseobacter ecology (Bruhn et al., 2005;Slightom & Buchan, 2009). 
 
Figure 22: QS systems regulating the carbapenem biosynthesis pathway in Erwinia and Serratia sp. 
ATCC 39006. In Erwinia carbapenem synthesis is induced at high cell density due to the AHL signal 
binding the LuxR homologue CarR and subsequent induction of the car biosynthetic pathway. In 
contrast, carbapenem biosynthesis in Serratia is activated by AHL binding to and inactivating the 
SmaR repressor, allowing the AHL independent Serratia CarR to induce the car pathway. Modified 
from Barnard et al. (2007). 
 
The synthesis of TDA is cell-density dependent in some strains (Bruhn et al., 2007), and recent 
work concluded that production of TDA is under QS control by a 3-OH-C10-HSL induced LuxIR 
homologue system in Phaeobacter gallaciensis DSM 17395 (Berger et al., 2011). The tdaA gene 
regulates expression of the TDA biosynthetic pathway and is induced by the LuxR-homologue 
PgaR. As expected PgaR induces tdaA expression when stimulated with the PgaI AHL-product, but 
curiously TDA can also activate PgaR and induce tdaA. Although there is no distinct structural 
similarity between TDA and the cognate AHL (figure 23), TDA effectively functions as an 
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autoinducer acting on parts of a LuxIR homologue system, although much higher concentrations of 
TDA are needed to induce similar expression levels (Berger et al., 2011).  
 
Figure 23: Chemical structures 
of 3-OH-C10-HSL 1, TDA 2. 
 
 
4.3 QUORUM SENSING IN PSEUDOALTEROMONAS 
Only few studies are published on QS in Pseudoalteromonas. Two strains have been investigated 
for QS aspects in their physiology (Guo et al., 2011;Wang et al., 2008), and Pseudoalteromonas 
spp. have been identified as AHL producers in subtidal biofilms (Huang et al., 2008a;Huang et al., 
2008b). Pseudoalteromonas are also likely included in more general studies of marine microbiota, 
for instance a survey of coral-associated bacteria revealed Pseudoalteromonas strains that 
activated the biosensors Agrobacterium tumefaciens KYC55 or Escherichia coli K802NR-pSB1075 
(Golberg et al., 2011). Pseudoalteromonas sp. 520P1 produces two AHLs, with one inducing 
production of violacein in the wild type strain (Wang et al., 2008). Recombinant expression of the 
violacein gene cluster under control of the WT promotor in E. coli did, however, not result in 
violacein production, whereas placing the gene cluster under control of a T7 promoter did (Zhang 
& Enomoto, 2011). This indicates that a regulatory system native to the WT strain may be essential 
for expression of the violacein gene cluster from Pseudoalteromonas 520P1. However despite 
attempts to identify lux related elements, neither luxI, luxR or a lux-box were identified, thus no 
conclusive evidence was presented.  
AHL synthesis and quorum sensing regulated antibiotic production was reported for 
Pseudoalteromonas sp. NJ6-3-1, related to P. denitrificans (BLAST search of reported 16S rRNA 
nucleotide sequence) (Guo et al., 2011). However, the authors claim that diketopiperazines are 
the inducer compounds. It is known that diketopiperazines can induce Lux homologue systems, 
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but it would be nice to see compelling evidence that the native AHLs do not induce a QS response, 
for instance AHL negative knockouts. 
During this Ph.D. work it was discovered that the bioactive strain P. luteoviolacea S4054 produces 
one or more molecules that induce the biosensor strains Agrobacterium tumefaciens pZLR4 (Cha 
et al., 1998) and Chromobacterium violaceum CV026 (McClean et al., 1997) (Vynne et al., 2012c). 
The luxI gene homologue pluI was identified through shotgun cloning and expression in E. coli 
JM109-pSB401 (Winson et al., 1998) followed by sequencing by ‘primer walking’. Later, whole 
genome sequencing revealed a putatively QS regulated operon structure downstream of the pluI 
gene, followed by a luxR homologue pluR (Vynne & Gram, 2012). The genomic organization is 
shown in figure 24. 
 
Figure 24: Genomic organization of QS related elements in P. luteoviolacea S4054 and a 
putatively QS regulated operon. Predicted functions: Dark blue: pluI, red: aminotransferase, 
yellow: dehydrogenase, green: methyltransferase, grey: hypothetical protein, purple: coenzyme 
F390 synthethase, pink: methylase, brown: lyase, olive: tryptophanyl t-RNA synthethase, light 
blue: pluR. Upstream of pluI a palindromic sequence reminiscent of lux-boxes was identified (not 
shown). 
 
The function of the genes downstream of luxI is currently unknown, but several of the genes are 
annotated as enzymes that are known to be active in formation of the antibiotic indolmycin 
(Hornemann et al., 1971), which correspondingly was identified in strain S4054.  In spite of 
focused efforts it has not been possible to identify the chemical structure of the compound 
causing activation of the monitor strains. Fractionation using standard approaches in analysis of 
AHLs (Fekete et al., 2007;Wang et al., 2011) did not result in clear separation of the active 
compounds into distinct fractions. Raw extracts of the molecules lost the ability to induce a QS 
response in the biosensors after alkaline treatment but was stable upon acid treatment, as 
expected for AHLs (Vynne et al., 2012c).  
In my studies of a collection of P. luteoviolacea strains for phylogenetic and biodiscovery purposes, 
I discovered that only the indolmycin producing strains synthesized these molecules now denoted 
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AHL-like (Vynne et al., 2012c). However, all strains produced the purple bioactive pigment 
violacein which is under QS control in C. violaceum (McClean et al., 1997) and possibly in 
Pseudoalteromonas sp. 520P1 (Wang et al., 2008). In Serratia, horizontal transfer of QS related 
elements have revealed interesting aspects of the impact of QS on microbial physiology. Transfer 
of a complete prodigiosin biosynthetic cluster to a nonpigmented Serratia strain placed 
prodigiosin biosynthesis under control of the native QS system, and correspondingly, transfer of 
the luxIR homologues smaIR to a QS negative prodigiosin producing strain placed the native 
prodigiosin biosynthesis under QS control (Coulthurst et al., 2006). These fascinating experiments 
show how some biosynthetic elements can be inherently disposed to QS regulation, and may offer 
an explanation to the variability in QS regulation of violacein synthesis. 
 
4.4 CONCLUSION FROM CHAPTER 4 
Quorum sensing plays an important role in microbial ecology as it enables bacteria to act as 
coordinated units rather than individual cells. This confers benefits such as biofilm formation, 
production of defensive antibiotics and expression of virulence factors (Miller & Bassler, 
2001;Milton, 2006). Some Pseudoalteromonas strains, like many proteobacteria, produce AHLs 
and possess LuxIR homologue QS machineries which may be involved in regulating production of 
bioactive compounds. Clearly, the production of antibiotics is quorum sensing regulated in some 
bacteria and thus QS has a role in microbial interactions both as a direct signal and indirectly 
through regulating biosynthesis of antagonistic molecules that can affect the microbial 
community. It is well known that some bacteria have orphan LuxR genes in their genome 
(Patankar & González, 2009). These may be remnants from previous evolutionary events, but 
perhaps more interestingly, they may also allow non-AHL producing bacterial cells to “eavesdrop” 
on conversations among other AHL-producing bacteria. This could allow preemptive production of 
e.g. antibiotic resistance mechanisms to counter QS-induced antibiotic production or activation of 
otherwise silenced biosynthetic pathways. Consequently, understanding the role of QS in 
microbial ecology has the potential to benefit biodiscovery efforts focused on novel antibiotics. 
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5.0 CONCLUSION  
5.0.1 BIOACTIVE SECONDARY METABOLITES FROM MARINE BACTERIA 
This part of the thesis addressed marine bacteria as a source of bioactive secondary metabolites 
and strategies for biodiscovery efforts. In this study it was confirmed that Pseudoalteromonas 
strains exhibiting stable antibacterial activity are significantly more likely to be isolated from 
marine surfaces. The potential of marine bacteria to deliver novel bioactive compounds was 
confirmed. Although no strictly novel antibiotics were discovered, several antibiotics were 
identified and non-antibiotic novel compounds were discovered. The marine environment has 
great diversity and, as shown for P. luteoviolacea, application of high resolution phylogenetic 
reconstruction may provide a guiding tool to determine which bacterial strains should be included 
in further screening efforts. Genome sequencing of the bioactive strain P. luteoviolacea S4054 
revealed a large unharnessed genetic potential with as many as 11 predicted biosynthetic 
pathways without a known product. As genome sequencing becomes ever more accessible, whole 
genome sequencing may become the preferred technique for direct comparison and dereplication 
of the biosynthetic potential of a collection of marine bacteria. Knowledge of the ecology of the 
wild type organism is very useful in such a case, as culturing the organism under specific 
environmentally relevant nutrient levels or physical conditions may result in the production of 
otherwise absent secondary metabolites, which may not be easily expressed in heterologous 
hosts.    
 
5.0.2 THE GENUS PSEUDOALTEROMONAS – ECOLOGY AND BIOACTIVITY  
The genus Pseudoalteromonas has broad biotechnological applications. This thesis addressed the 
phylogeny of the genus and its production of antibacterial compounds. The use of secondary 
metabolites in species identifications was not wholly successful as phylogenetic analysis revealed 
varying levels of species specificity in secondary metabolite production, with P. ruthenica as an 
example of a narrow species specific secondary metabolite profile and P. rubra as an example of a 
species with a very diverse secondary metabolite profile. The potent antibiotic indolmycin was 
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discovered in marine bacteria for the first time, which may be evidence of genetic exchange 
among the terrestrial and marine ecosystems. During the course of the study, a new species was 
described and given the name Pseudoalteromonas galatheae after the expedition on which it was 
first isolated. Within Pseudoalteromonas luteoviolacea, three antibiotics were produced in a 
phylotype specific manner. This provided evidence that these antibiotics are maintained under 
selective pressure and thus likely are important in microbial ecology.   
 
5.0.3 QUORUM SENSING IN REGULATION OF BACTERIAL PRODUCTION OF 
ANTIMICROBIAL COMPOUNDS 
Quorum sensing regulates a range of potential phenotypes. In the context of this thesis, the 
interest has primarily been regulation of antibiotic production. A potentially novel AHL-like 
molecule was described from P. luteoviolacea S4054, and this may take part in regulation of a 
novel biosynthetic pathway. However, such molecules may also be involved in countless other 
interactions when released into a microbial community. Understanding novel quorum sensing 
systems and their influence on microbial interactions could help us not only discover novel natural 
products, but also to better understand the regulatory events in complex microbial communities 
both in nature and in medicine. 
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5.1 OUTLOOK 
Discovery of novel antibiotics and other strategies to combat the spread of resistant human 
pathogenic bacteria will remain a priority. Efficient screening strategies combined with sampling of 
novel microbial diversity will likely remain one of the most promising avenues to achieve this, 
although revisiting known antibiotic producing strains with modern techniques may be necessary.  
In the near future, whole genome sequencing and metagenome approaches appear poised to 
dominate within natural product discovery. This will offer nearly unlimited access to genetic and 
chemical diversity, and allow dereplication of biosynthetic gene clusters as one of the first steps in 
a biodiscovery program. As a result, the discovery of molecules with coveted pharmaceutical 
properties will accelerate. In addition, selective targeting of specific microbial communities for 
sequencing, e.g. sponge symbiotic bacteria or bacteria from dense biofilms, may lead to a higher 
rate of discovery than other wise obtained.  The use of heterologous expression systems will 
provide access to some of these compounds, yet some gene clusters may not be properly 
expressed, or the end product may be toxic to the producer cell. Alternatively, combining genomic 
approaches with knowledge of the ecology and physiology of a bioactive bacterium may lead to 
production of novel compounds by the wild type strain. Genome sequencing would reveal the 
presence of any known signaling systems, which could then be activated to potentially induce 
novel biosynthetic pathways, or growth conditions may be adjusted based on in silico 
reconstructions of the metabolic network of the organism in order to induce expression of 
biosynthetic clusters, for instance by culturing under simulated natural conditions.  
Knowledge of in situ microbial interactions and the role antibiotics play in the microbial 
community will naturally be of interest to microbial ecologists, but it may also help us understand 
why important phenomena such as resistance to antibiotics evolve, adapt and persist in the 
environment, and potentially make us better equipped to counter the emergence of antibiotic 
resistance in pathogenic bacteria. 
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Abstract One hundred one antibacterial Pseudoalteromonas
strains that inhibited growth of a Vibrio anguillarum test
strain were collected on a global research cruise (Galathea 3),
and 51 of the strains repeatedly demonstrated antibacterial
activity. Here, we profile secondary metabolites of these
strains to determine if particular compounds serve as strain
or species markers and to determine if the secondary
metabolite profile of one strain represents the bioactivity of
the entire species. 16S rRNA gene similarity divided the
strains into two primary groups: One group (51 strains)
consisted of bacteria which retained antibacterial activity, 48
of which were pigmented, and another group (50 strains) of
bacteria which lost antibacterial activity upon sub-culturing,
two of which were pigmented. The group that retained
antibacterial activity consisted of six clusters in which strains
were identified as Pseudoalteromonas luteoviolacea, Pseu-
doalteromonas aurantia, Pseudoalteromonas phenolica,
Pseudoalteromonas ruthenica, Pseudoalteromonas rubra,
and Pseudoalteromonas piscicida. HPLC-UV/VIS analyses
identified key peaks, such as violacein in P. luteoviolacea.
Some compounds, such as a novel bromoalterochromide,
were detected in several species. HPLC-UV/VIS detected
systematic intra-species differences for some groups, and
testing several strains of a species was required to determine
these differences. The majority of non-antibacterial, non-
pigmented strains were identified as Pseudoalteromonas
agarivorans, and HPLC-UV/VIS did not further differentiate
this group. Pseudoalteromonas retaining antibacterial were
more likely to originate from biotic or abiotic surfaces in
contrast to planktonic strains. Hence, the pigmented, antibacte-
rial Pseudoalteromonas have a niche specificity, and sampling
from marine biofilm environments is a strategy for isolating
novel marine bacteria that produce antibacterial compounds.
Keywords Pseudoalteromonas . Antibacterial activity .
Secondary metabolites . Bioprospecting . Galathea 3
Introduction
Compounds of relevance for the pharmaceutical and
biotechnology industries are produced by marine micro-
organisms (Burgess et al. 1999), and it has been suggested
that some compounds of pharmacological interest previously
attributed to macroorganisms may in fact be of microbial
origin (Bewley and Faulkner 1998; Simmons et al. 2008;
Sudek et al. 2006). The emergence of multiresistant
pathogenic bacterial strains and the failure of combinatorial
and diversity-oriented chemistry to adequately supply the
drug discovery pipeline (Newman 2008) have re-invigorated
natural product chemistry as a path for discovery and
development of new antibiotics. With this in mind, we
isolated marine bacteria with antibacterial activity during the
Danish Galathea 3 marine research expedition (Gram et al.
2010). The antibacterial strains were tentatively identified
using 16S rRNA similarity, and one of the major groups of
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isolated bacteria was identified as Pseudoalteromonas (Gram
et al. 2010).
The genus Pseudoalteromonas consists of Gram-
negative marine bacteria belonging to the γ-proteobacteria
and is present globally in marine waters where they
constitute 0.5% to 6% of the total bacterioplankton (Wietz
et al. 2010). They are heterotrophic aerobes and non-
fermentative, and the cells are motile by one or more polar
flagella. The genus divides into two groups: pigmented and
non-pigmented species. The pigmented species are often
producers of bioactive secondary metabolites (Bowman 2007)
displaying cytotoxic (Zheng et al. 2006), antibacterial
(Gauthier 1976b; Gauthier and Flatau 1976; Isnansetyo and
Kamei 2003; Jiang et al. 2000; McCarthy et al. 1994),
antifungal (Franks et al. 2006; Kalinovskaya et al. 2004), or
antifouling (Egan et al. 2001; Holmström et al. 2002) effects.
It has been hypothesized that bioactive Pseudoalteromonas
are primarily associated with higher organisms (Holmström
and Kjelleberg 1999), suggesting an ecological role in which
some bioactive species might play an active part in host
defense against pathogens and fouling organisms (Holmström
et al. 1996; Armstrong et al. 2001; Egan et al. 2008). A link
between surface colonization and antibacterial activity has not
been experimentally verified, although several studies have
successfully isolated epiphytic bacteria with antibacterial
activity from algae and other marine organisms (Armstrong
et al. 2001; Boyd et al. 1999; James et al. 1996; Penesyan et
al. 2009). The group of non-pigmented species has highly
similar 16S rRNA gene sequences (Ivanova et al. 2004) and
is rarely inhibitory against other microorganisms, although,
Pseudoalteromonas haloplanktis strain INH produces iso-
valeric acid and 2-methylbutyric acid showing a broad
spectrum of bacterial inhibition (Hayashida-Soiza et al.
2008).
Phylogeny and differentiation of bacterial species rely
heavily on 16S rRNA gene similarity (Stackebrandt et al.
2002); however, 16S rRNA gene similarity does not
provide sufficient differentiation below species level (Fox et
al. 1992). Comparison of secondary metabolite production
has supported species delineation within the actinomycete
genus Salinispora, where strains with high 16S rRNA
similarity were shown to belong to distinct species each
with different specific metabolite profiles (Jensen et al.
2007). In mycology, comparison of chemical profiles (e.g.,
TLC, direct-infusion mass spectrometry, and HPLC with
various detectors such as UV/VIS and/or mass spectrometry)
of secondary metabolites has been widely used to identify
and differentiate filamentous fungi (chemotaxonomy) also at
sub-species level (Frisvad et al. 2008), and the chemo-
phylogeny correlates well with phylogenetic analysis of
sequences of specific housekeeping genes (e.g., chitin
synthase, β-tubulin, and calmodulin; Geiser et al. 2007).
Since several Pseudoalteromonas species produce a range of
secondary metabolites, we hypothesized that chemical
profiling and specific marker compounds could be indicative
of bioactive potential and at the same time be useful in
species identification or differentiation (Jensen et al. 2007).
The aim of the present study was to profile the
secondary metabolites of these strains to determine if
particular compounds serve as markers of strains or species
with antibacterial activity and to determine if several strains
of each species must be tested to assess the full bioactivity
potential. As part of this, we provide accurate identification
and phylogeny of these organisms by detailed 16S rRNA
gene sequence comparative analysis. Since the bacteria
were isolated from different sample types, our collection
also allows us to address aspects of Pseudoalteromonas
ecology such as the possible link between surface or
planktonic lifestyle and antibacterial activity.
Materials and Methods
Strain Isolation Approximately 500 marine bacterial strains
with antagonist activity against Vibrio anguillarum strain
90-11-287 (Skov et al. 1995) were isolated during the
Danish Galathea 3 research expedition (Gram et al. 2010).
One hundred one of these strains tentatively identified as
Pseudoalteromonas species were included in the present
study. V. anguillarum 90-11-287 was used as target strain
since the expedition ship was not equipped to handle, e.g.,
potential human pathogens, and this Vibrio strain is in our
experience very sensitive to antibacterial compounds from
other marine bacteria (Hjelm et al. 2004).
Growth Media and Culture Conditions Pseudoalteromonas
strains were grown in marine broth (MB) 2216 (Difco,
Detroit, MI, USA) and on marine agar (MA) 2216 (Difco,
Detroit, MI, USA) prepared in accordance with the
manufacturer’s instructions. Broth cultures were incubated
under stagnant conditions at 25°C. Pigment production was
determined by visual inspection of 48-h-old culture broths
(MB) and colonies grown on MA for 24 to 48 h.
Antibacterial Activity Instant Ocean (IO) bioassay agar
plates were prepared as described by Hjelm et al. (2004).
Ten grams per liter agar, 3.3 g/l casamino acids (Difco
223050, Detroit, MI, USA), and 30 g/l Instant Ocean
aquatic salts (Instant Ocean® Aquarium systems Inc.,
Sarrebourg, France) were added to distilled water and
autoclaved. Glucose (0.4%) and 10 μl/ml of V. anguillarum
overnight culture were added to the cooled (44°C) IO and
plates poured. The plates were allowed to dry for 15 min,
and if used for well diffusion agar assays (WDAA), wells
(diameter 6 mm) were punched. The inhibitory activity of
live Pseudoalteromonas bacterial cells was tested by
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spotting 48-h-old MA grown colonies on freshly prepared
IO agar plates containing V. anguillarum. Plates were
incubated at 25°C and inspected for clearing zones in the
growth of V. anguillarum after 24 h.
Cell-free supernatants were prepared to test for the
presence of water-soluble antibacterial compounds secreted
to the broth, and ethyl acetate extracts were prepared to test
for production of non-polar antibacterial compounds. Each
strain was grown in 20 ml of MB for 48 h. A 1.5-ml sample
was withdrawn for 0.2 μm filtering, and subsequently the
remainder of the culture was extracted with an equal
volume of ethyl acetate. The ethyl acetate fraction was
transferred to a new vessel, evaporated to dryness, and
redissolved in 2×0.5 ml ethyl acetate. The 1.5-ml cell-free
sterile-filtered supernatant and the ethyl acetate extracts
were stored at −20°C until tested in the WDAA (50 μl
sample per well) based on IO agar plates containing V.
anguillarum. Controls (sterile MB and pure ethyl acetate)
did not cause any inhibition zones.
The number of antibacterial Pseudoalteromonas strains
in surface samples (e.g., algae, driftwood, fish, and
sediment samples) was compared to their numbers in water
samples by the Fisher’s exact test (Fisher 1958). A 2×2
contingency table was used to test the hypothesis that
presumed antibacterial strains with stable antibacterial
activity were equally likely to be isolated from water
samples and surface samples.
16S rRNA Gene Sequence Analyses A detailed phylogenetic
analysis was performed on 16S rRNA sequences obtained in a
previous study (Gram et al. 2010). For the analysis in this
study, we conducted a BLAST (http://blast.ncbi.nlm.nih.gov)
search against a compilation of Pseudoalteromonas type
strain sequences retrieved from GenBank (list of type strains
obtained from http://www.bacterio.cict.fr), and sequences of
the type strains with a BLAST match in our strain collection
were included in 16S rRNA sequence analysis to obtain a
robust phylogenetic tree. Sequences from two additional
Pseudoalteromonas strains were included: The genus type
strain P. haloplanktis and the bioactive Pseudoalteromonas
tunicata. Salinispora arenicola CNS-205 was used as
outgroup. The sequences were aligned by the MAFFT online
software (http://www.ebi.ac.uk/Tools/mafft/; Katoh et al.
2002) and curated with the Gblocks software on its least
stringent settings (Castresana 2000; Talavera and Castresana
2007). The resulting alignment was processed using the
MEGA4 software (Tamura et al. 2007) to create neighbor-
joining and minimum evolution trees. PhyML 3.0 was used
to generate a maximum likelihood tree (Guindon and
Gascuel 2003). Phylogenetic trees were generated under
default parameters with 1,000 bootstrap replications for
neighbor-joining and minimum evolution trees and 100
bootstrap replications for the maximum likelihood tree.
GenBank accession numbers for the Pseudoalteromonas
strains used in this study are included in Supplementary
Table 1.
HPLC-UV/VIS Analysis of Secondary Metabolites The
strains were grown in static cultures in 10 ml MB for
3 days at 25°C, and for each species, one strain was
cultured in triplicate to establish extraction and growth
variation. Cultures were extracted with equal volumes of
ethyl acetate, centrifuged, and the ethyl acetate was
evaporated under N2 to dryness. Samples were redissolved
in 300 μl acetonitrile–water (1:1v/v) and filtered through a
13-mm ID PFTE syringe filter. A subsample of 2 μl was
then analyzed by reversed phase HPLC on an Agilent 1100
System equipped with a UV/VIS photo diode array detector
(scanning 200–600 nm). Separation was done on a
100 mm×2 mm i.d., 3 μm Gemini C6-phenyl column
(Phenomenex, Torrance, CA, USA), running at 40°C using
a binary linear solvent system of water (A) and acetonitrile
(B; both buffered with 50 μl/l trifluoroacetic acid) at a flow
of 300 μl/min. The gradient profile was t=0 min, 5% B;
t=22 min, 70% B; t=24.5, 100% B; t=27 min, 100% B; and
t=29 min, B=5%, holding this for 8 min prior to the next
injection. The chromatographic profiles were compared,
subtracting peaks present in media blank extracts. Samples
were analyzed in random order, and six of the first extracts
were analyzed several times during the sequence to determine
any retention time shifts. Cluster analysis was done on a
matrix of detected / non-detected peaks (1/0) using NTSYSpc
2.20q (Exeter Software, Setauket, NY, USA). SAHN clustering
was used by unweighted pair-group method (UPGMA) and
simple distance measurement. Representative extracts were
also analyzed by HPLC-UV/VIS-TOFMS in both positive and
negative electrospray (Nielsen and Smedsgaard 2003). Peaks
were tentatively identified by UV spectra and accurate mass
data by matching in Antibase 2009 (35 930 microbial
secondary metabolites; Wiley & Sons, Hoboken, NJ, USA;
Nielsen et al. 2006).
Results
Pigmentation and Antibacterial Activity The one hundred
one Pseudoalteromonas strains were originally isolated for
their ability to inhibit V. anguillarum (Gram et al. 2010).
However, on re-cultivation and re-testing for the ability to
inhibit V. anguillarum after storage at −80°C for several
months, only 51 strains retained inhibitory activity (Table 1).
These 51 strains were all inhibitory when tested as live
cultures in the “spot test” assay. Twenty of the strains
produced water-soluble, diffusible, antibacterial substances
as indicated by the ability of cell-free sterile-filtered
supernatant to inhibit growth of V. anguillarum in the
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WDAA. These 20 strains were identified as Pseudoalteromo-
nas phenolica (one strain), Pseudoalteromonas luteoviolacea
(five strains), Pseudoalteromonas rubra (nine strains), Pseu-
doalteromonas citrea (one strain), and Pseudoalteromonas
aurantia (four strains). Ethyl acetate extraction of culture
broths resulted in 19 crude extracts which inhibited growth of
V. anguillarum in the WDAA. Four of these were identified
as P. luteoviolacea and were the only strains where both cell-
free supernatant and crude ethyl acetate extracts inhibited
Vibrio growth. The remaining 15 inhibitory crude extracts all
originated from strains identified as Pseudoalteromonas
ruthenica. The crude ethyl acetate extracts of 26 strains were
intensely colored; however, only some of these extracts
inhibited growth of Vibrio indicating that the pigments were
not universally antibacterial. Cell-free culture supernatants
and ethyl acetate crude extracts of strains with no growth
inhibition of V. anguillarum in the “spot test” assay were also
tested but showed no growth inhibition.
Forty-eight of the 51 antibacterial strains were pig-
mented, while two (S3431 and S3655) of the 50 non-active
strains were pigmented (Table 1). Antibacterial activity was
significantly more likely to be produced by pigmented
strains as determined by Fisher’s exact test (two-tailed p
value of 0.0000). In total, 70 strains were isolated from
surface swabs and 31 from water samples. Of the surface-
associated strains, 45 remained active in the spot-assay in
comparison to six of the water sample strains. The Fisher’s
exact test demonstrated a significant relation between surface
association and stable antibacterial activity (two-tailed p value
of 0.0000).
Pseudoalteromonas strains were isolated on all parts of
the global cruise in both tropical and temperate waters
(Fig. 1). Our strain collection is not large enough to allow
for complete biogeographic analysis, but pigmented strains
appeared to be more frequent in coastal areas whereas the
non-pigmented strains appeared associated with open
waters (Fig. 1).
16S rRNA Gene Sequence Analyses We initially performed
a BLAST search querying the 16S rRNA gene sequence of
each strain against the GenBank database. The results of
this analysis were ambiguous, as some sequences returned
more than 40 hits all with identical scores in the BLAST
results (data not shown), frequently including the sequences
of several different Pseudoalteromonas species. Therefore,
a BLAST analysis was carried out querying the sequences
against a complete set of Pseudoalteromonas type strains,
and hence, each strain is matched with the best type strain
BLAST match (Suppl Table 1).
The 16S rRNA gene sequences were used to cluster the
strains by constructing a neighbor-joining tree, and branch
support was verified by comparison to minimum evolution
and maximum likelihood trees (Fig. 2). Nodes supported by
an 80% bootstrap cutoff were collapsed when three or more
strains were included in the cluster (Fig. 2). An exception
was made for clusters VI and VII, which are shown as
separate clusters due to obvious differences in phenotype
(pigment, bioactivity, secondary metabolite profile).
Ninety-nine of the strains fell into one of eight primary
clusters.
Clusters I and III consisted of non-pigmented non-inhibitory
strains (Table 1). Cluster I included 38 strains and the type
strains of P. haloplanktis, Pseudoalteromonas agarivorans,
Pseudoalteromonas tetraodonis, Pseudoalteromonas para-
gorgicola, Pseudoalteromonas distincta, Pseudoalteromonas
arctica, Pseudoalteromonas nigrifaciens, Pseudoalteromonas
Table 1 Identity, antibacterial activity, and pigmentation of Pseudoalteromonas strains from a global collection
16S rRNA cluster No. of strains Related type
straina
No. of strains from No. of strains
inhibiting Vibrio
Inhibition
of Vibrio
by EtAc
extractsPigmented Non-pigmented Surface samples Water samples Pigmented Non-pigmented
I 1 37 P. agarivorans 16 22 0 0 0
II 5 0 P. aurantia 2 3 5 0 0
III 0 9 P. prydzensis 8 1 0 0 0
IV 3 3 P. phenolica 3 3 3 2 0
V 4 0 P. luteoviolacea 4 0 4 0 4
VI 9 0 P. rubra 9 0 9 0 0
VII 13 0 P. flavipulchra 13 0 13 0 0
VIII 15 0 P. ruthenica 14 1 15 0 15
S1727 0 1 P. mariniglutinosa 0 1 0 0 0
S3655 1 0 P. spongiae 1 0 0 0 0
Total 51 50 70 31 49 2 19
a The type strain which the majority of the strains in the cluster were most closely related to
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elyakovii, Pseudoalteromonas carrageenovora, Pseudoalter-
omonas marina, and Pseudoalteromonas aliena. Strain
S3431—a black-pigmented strain in cluster I—did not show
more than 97% similarity even when compared to the full
GenBank database which suggests that S3431 could represent
a novel Pseudoalteromonas species. Despite the low BLAST
similarity score, phylogenetic analysis and tree construction
placed strain S3431 in the diverse cluster I (the non-collapsed
cluster I is shown in Supplementary Figure 1). Cluster III
contained no type strains which supported the BLAST
analysis where the strains in cluster III were 98% similar to
the best type strain match (Supplementary Table 1).
The remaining six of the eight clusters contained
pigmented strains. Pale yellow strains clustered with the
Fig. 1 Isolation sites of 101
Pseudoalteromonas strains with
each color code representing
one of the eight clusters as
indicated in Table 1. Each
circle represents the isolation
of one or more strains
belonging to the given cluster.
White=cluster I, yellow=cluster
II, gray=cluster III, green=
cluster IV, violet=cluster V,
red=cluster VI, orange=cluster
VII, pink=cluster VII, and
blue=non-clustered strain
 Cluster I
P mariniglutinosa AJ507251
 P prydzensis U85855
 S1727
 Cluster II
 Cluster III
 P tunicata Z25522
 P spongiae AY769918
 S3655
 Cluster IV
Cluster V
 Cluster VI
 Cluster VII
Cluster VIII
 S arenicola CNS-205
100
89
98
100
87
88
95
96
84
88
0.02
Fig. 2 Phylogenetic tree based
on 16S rRNA gene sequences of
the Galathea 3 Pseudoalteromo-
nas strains. Sequences were
aligned by MAFFT (default
options), and the resulting
alignment was used to generate
a neighbor-joining tree in the
MEGA4 software package
(default settings, 1,000
bootstraps). S. arenicola
CNS-205, GenBank accession
number CP000850, GeneID:
5705939 was used as outgroup.
Clusters containing two or more
non-type strain sequences were
collapsed. The scale bar
represents 0.02 amino acid
substitutions per nucleotide
position. Circle nodes also oc-
curred in minimum
evolution and maximum
likelihood trees
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type strains of P. citrea and P. aurantia (cluster II) and four
intensely purple strains grouped in cluster V with the type
strain of P. luteoviolacea. Cluster VI contained nine red-
pigmented strains and the type strain of P. rubra, and cluster
VII consisted of 12 intensely yellow strains, one pale yellow
strain, and the Pseudoalteromonas flavipulchra, Pseudoal-
teromonas maricaloris, and Pseudoalteromonas piscicida
type strains. Fifteen strains and their nearest BLAST match,
P. ruthenica, formed cluster VII. These strains all produced a
pale brown pigment. Cluster IV contained six strains and the
type strain of P. phenolica. Four of the strains in this cluster
had P. phenolica as their best type strain BLAST match;
however, strain S1093 had P. luteoviolacea as its best match
at 98% identity, while P. rubra and P. luteoviolacea type
strains scored identically (97%) as the best matches for
S2724. The strains in cluster IV were heterogeneous with
respect to pigmentation, some were non-pigmented and
others appeared brown.
Profiling of Secondary Metabolites The 101 strains and
select type strains were separable in discrete groups by
HPLC-UV/VIS (Fig. 3), and the triplicate profiles from an
isolate of each species were very reproducible and could be
superimposed on each other (data not shown). All of the 38
strains of the 16S rRNA cluster I fell into group A, in
which no UV/VIS peaks were unique compared to the
media blanks indicating that no secondary metabolites were
produced. This large group also included all nine strains
from 16S rRNA cluster III and strains of P. phenolica and P.
ruthenica less proficient in secondary metabolite production.
A summary of the detected compounds is shown in Table 2,
and the producer organisms are shown by 16S rRNA cluster
in Table 3.
Based on their production of specific metabolites, the
majority of pigmented bacteria formed six main groups not
including four P. rubra strains (Fig. 3). In the pigmented
bacteria, a total of 26 distinct peaks were detected and
included in the cluster analysis. We identified indolmycin,
violacein, and prodigiosin among the significant peaks
based on reference standards. Furthermore, nine peaks could
be tentatively identified based on HPLC-UV/VIS-TOFMS
results and data in Antibase2009. These nine included two
likely novel bromoalterochromides and a brominated indole
(Table 2).
Comparing the 16S rRNA gene sequence clusters with
the chemical profiling revealed several patterns. Some
compounds were exclusively produced by strains belonging
to the same cluster whereas other compounds were
produced across several strains from different clusters. All
strains in cluster II (P. aurantia/P. citrea) shared production
of compound B (retention time, RT 12.31 min) whereas the
production of four other compounds F, Q, T, and U (RT
15.47, 16.60, 17.96, and 18.28 min) were scattered in the
group. This included a novel bromoalterochromide (com-
pound Q, RT 16.60 min) that was also found in cluster VII
(P. flavipulchra/P. piscicida). Three of the other compounds
were identified as quinolines based on distinct UV spectra
and accurate mass.
P. luteoviolacea strains (cluster V) shared production of
compound D (violacein, RT 14.29) in all four strains and
the type strain but were sub-divided by compound A
(indolmycin, RT 11.21) produced by two strains and
compound Z (pentabromopseudilin, RT 22.65) produced
by the two other strains and the type strain. This division is
visible in Fig. 4, which shows chromatograms of the four
strains in cluster V. Interestingly, also two P. phenolica
strains produced compound Z.
Cluster VII (P. flavipulchra and P. piscicida) was
chemically very homogeneous. All strains except one
produced three bromoalterochromides P, Q, and R (RT
16.49, 16.60, and 17.10) of which Q and R were novel
compounds. In contrast to cluster V and compound D, the
production of P, Q, and R was not a unique marker for
strains of this cluster as P, Q, and R were also detected in
one strain from cluster II and one strain from cluster VI.
Thirteen of the 15 strains in cluster VIII, identified as P.
ruthenica, shared a unique chemical profile and produced
the compounds H, K, and O (RT 15.78, 15.98, 16.30) with
characteristic UV spectra. None of these matched com-
pounds in Antibase2009 and potentially constitute novel
antibacterials. These compounds were not detected among
strains from other clusters, yet they were not suitable as a
distinct chemical marker for cluster VIII since no secondary
metabolites were detected in the remaining two strains in
this cluster or the type strain.
The strains in cluster VI were identified as P. rubra and
were chemically very heterogeneous. Five of nine strains
produced the red pigment prodigiosin (compound M, RT
16.00) which was not detected in strains of other clusters.
Additionally, a multitude of known and non-identified
compounds were detected in one or more strains in the
cluster. In total, 16 compounds were detected within the
cluster, and 12 of these were unique for this cluster. Only
two strains shared an identical production of secondary
metabolites, further stressing the chemical diversity among
the strains in this cluster.
Discussion
We demonstrate in this study, in agreement with earlier
findings (Bowman 2007), that species within the
Pseudoalteromonas genus produce a range of secondary
metabolites, some with antibacterial activity. Several
species of the genus are intensely pigmented, and it is
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hypothesized that pigmentation co-occur with antibacterial
activity (Egan et al. 2002). In our global collection of
Pseudoalteromonas strains that demonstrated antibacterial
activity on initial isolation, strains that were pigmented
were significantly more likely to retain antibacterial
activity on re-growth than non-pigmented strains. Several
intensely colored organic extracts were not inhibitory
against V. anguillarum, and hence, we do not believe that
the pigments, in general, are the cause of the antibacterial
activity although, e.g., the purple pigment violacein is a
known antibiotic compound (Lichstein and Vandesand
1945).
Coefficient 
0.72 0.79 0.86 0.93 1.00 
 S4047 P. luteoviolacea  
 S4054 P. luteoviolacea  
 S2756 P. ruthenica 
 S4388 P. ruthenica 
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 S4382 P. ruthenica 
 S3137 P. ruthenica 
 S3258 P. ruthenica 
 S2899 P. ruthenica 
 S2898 P. ruthenica 
 S2897 P. ruthenica 
 S3138 P. ruthenica 
 S3244 P. ruthenica 
 S3136 P. ruthenica 
 S2233 P. citrea  
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P. flavipulchra LMG20361 (T) 
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 S2724 P. rubra / P. luteoviolacea 
 S2050 P. piscicida 
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 S1947 P. flavipulchra 
 S2040 P. flavipulchra 
 S1946 P. rubra  
 S2599 P. rubra  
 S2472 P. rubra  
 S2471 P. rubra  
 S4048 P. phenolica 
P. luteoviolacea ATCC33492 (T)  
 S2607 P. luteoviolacea  
 S4060 P. luteoviolacea  
 S3663 P. phenolica  
S1093 P. luteoviolacea
S1189 P. phenolica 
P. phenolica JSM21460 (T) 
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S1609 P. tetraodonis 
P. tetraodonis DSM9166 (T) 
S1688 P. elyakovii
S3431 P. arctica  
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P. ruthenica LMG19699 (T) 
P. prydzensis LMG21428 (T) 
 S3245 P. ruthenica  
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 S2678 P. rubra  
P. rubra DSM6842 (T) 
 S4059 P. rubra  
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G
Fig. 3 Dendrogram from cluster analysis of detected peaks from HPLC-UV/VIS detection of compounds in the ethyl acetate extracted broth and
biomass. Data were processed in NTSYSpc 2.20q, with SAHN clustering by UPGMA and simple distance measurement
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Nearly half of the isolated strains did not retain any
antibacterial effect after frozen storage and sub-culturing
despite being isolated on the original plates due to
antibacterial activity. The observed loss of antibacterial
activity may be due to a requirement for factors specific to
local seawater, as initial tests for antibacterial activity were
carried out using 50% local seawater (Gram et al. 2010).
Furthermore, loss of antibacterial activity may be due to
repression or inhibition of gene clusters encoding products
that are required for secondary metabolite synthesis (e.g.,
by catabolite repression). A reduction in antibiotic production
when the producer organism is grown in excess of a carbon
source is a known phenomenon (Sanchez et al. 2010), and
suppression of secondary metabolite production by excess
concentrations of other substrate components is demonstrated
in Streptomyces (Doull and Vining 1990). This could suggest
that culturing the strains under nutrient limited conditions
may reestablish production of antibacterial compounds. Also,
during the original sampling and screening procedure, the
agar plates may have harbored co-cultured microorganisms
which potentially induce antibacterial activity as has been
demonstrated by Mearns-Spragg et al. (1998). Hence, it may
be possible to re-induce the antibacterial activity if the right
conditions can be created.
Several bioactive Pseudoalteromonas have been isolated
from higher organisms, and it has been hypothesized that
antibacterial compounds may play a role in bacterial
competition or as protective agents beneficial for the host
organism (Holmström and Kjelleberg 1999). We provide
statistical evidence that surface-associated presumed antibac-
terial pseudoalteromonads are significantly more likely to
show stable production of antibacterial compounds than
Table 2 Ethyl acetate extractable secondary metabolites produced by pigmented Pseudoalteromonas strains
Compound MI (Da)c UV-max data RT (min) Code
Indolmycina 257 11.21 A
2-Pentyl-4-quinolinolb 215 12.31 B
Novel mono-brominated indole 280 13.78 C
Violaceina 343 14.29 D
Unidentified 244 212 nm (100%), 250 nm (48%) 15.21 E
2-n-Heptyl-(1H)-quinolin-4-oneb 243 15.47 F
Unidentified NI 228 nm (45%), 308 nm (100%) 15.70 G
Unidentified 386 <200 nm 15.78 H
Unidentified 316 286 nm (100%) 15.80 I
Unidentified NI <200 nm 15.81 J
Unidentified NI 228 nm (45%), 308 nm (100%) 15.98 K
Unidentified 676 <200 nm 15.99 L
Prodigiosina 323 16.00 M
Unidentified NI <200 nm 16.26 N
Unidentified NI 228 nm (45%), 308 nm (100%) 16.30 O
Bromoalterochromide Ab 843 16.49 P
Novel bromoalterochromide, 2 bromine 921 16.60 Q
Novel bromoalterochromide, 1 bromine 857 17.10 R
Unidentified 333 310 nm (100%) 17.20 S
2-n-Nonyl-(1H)-quinolin-4-oneb 271 17.96 T
Nonyl-quinolinone analogb 271 18.28 U
Unidentified 315 362 nm (100%) 18.90 V
Unidentified 244 218 nm (100%), 280 nm (82%) 19.42 W
Unidentified NI 218 nm (100%), 288 nm (82%) 19.78 X
Unidentified NI 250 nm (100), 280 nm (86) 19.92 Y
Pentabromopseudilinb 549 22.65 Z
NI no ionization or MI could not be assigned using ESI+ and ESI−
a Validated reference standard used for verification
b Accurate mass and UV data fit the data from Antibase2009
cMono-isotopic mass
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Pseudoalteromonas species isolated as planktonic cells. This
suggests that production of antibacterial compounds may
play an important role in the ability of Pseudoalteromonas
strains to colonize and persist on surfaces submerged in the
marine environment, as previously suggested for P. tunicata
strain D2 (Rao et al. 2005).
The analysis of 16S rRNA gene sequences from our global
collection of Pseudoalteromonas confirms that phylogenetic
analysis results in a number of clusters encompassing
predominantly pigmented species or non-pigmented species
(Ivanova et al. 2004). Strain S3431 was the single pigmented
strain in the so-called non-pigmented clusters. Novel
diversity might be represented in cluster III which consisted
of strains with 98% or less 16S rRNA gene sequence
similarity to Pseudoalteromonas type strains and formed a
separate cluster in the phylogenetic analysis. However, these
strains showed no antibacterial activity and no small
molecule metabolites were detected. Such novel diversity
could still represent untapped biotechnological potential,
producing, e.g., enzymes or peptides with biological activity,
as known for other non-pigmented Pseudoalteromonas
(Hoyoux et al. 2001; Violot et al. 2005).
Chemical profiling of the strains detected an array of
secondary metabolites. In addition to complementing our
analysis of 16S rRNA gene sequences, it also demonstrated
that some compounds (e.g., violacein, prodigiosin) were
characteristic of a species and other compounds were
produced by several species, and we also detected intra-
species clusters of different secondary metabolite profiles. In a
broad sense, the clustering based on 16S rRNAgene similarity
agreed with the groups resulting from the chemophylogenetic
analysis. However, some compounds were produced by
organisms of different species that then clustered together
using the secondary metabolites as basis. The chemical
analysis separated the four isolated P. luteoviolacea strains
into two distinct sub-groups, showing intra-species chemical
diversity. The P. luteoviolacea strains produced violacein and
pentabromopseudilin which are active against gram-positive
and gram-negative bacteria and the anti-staphylococcal agent
indolmycin (Hornemann et al. 1971; Hurdle et al. 2004).
Violacein and pentabromopseudilin have previously been
detected in P. luteoviolacea (Gauthier 1976a; Laatsch and
Pudleiner 1989), but to our knowledge, this is the first report
of Pseudoalteromonas strains producing indolmycin
(Månsson et al. 2010).
Within some species, all strains were consistently antibac-
terial. However, in others, such activity did not appear to be a
consistent trait of the species. For instance, strains of the 16S
cluster VI (P. phenolica) were heterogeneous in their ability
to inhibit Vibrio in our assays, while all but one strain in the
homogeneous cluster VII had identical metabolite profiles
and all were inhibitory. Even more obvious was the
heterogeneous chemical profiles within the P. rubra strains.
All except one strain shared a chemical marker prodigiosin
and/or RT 15.99 min but had major variations in 14 other
compounds. This may in part be due to loss of ability to
produce a compound. For instance, strain S2471 over time
lost ability to produce the brominated indole (RT 13.78 min).
Also, we note that the type strain DSM 6842 (ATCC 29570)
did not in our culture produce prodigiosin which has been
observed previously (Gauthier 1976b; Gauthier and Flatau
1976). The consistent bromoalterochromide production in
the two species P. piscicida and P. flavipulchra/maricaloris
(cluster VII) was expected (Speitling et al. 2007) and
supported the high DNA sequence similarity between the
two. This emphasizes the need to isolate and screen multiple
strains from each species when bioprospecting within the
genus Pseudoalteromonas, as even the homogeneous cluster
VII contains one strain with a metabolite profile that does not
share a single compound with the other strains in this cluster.
Several of the 26 detected peaks were known substances,
with a majority known as antibacterials. These included
violacein (Lichstein and Vandesand 1945), two bromop-
seudilins (Lovell 1966), two indolmycins (Werner 1980),
four quinolines (Wratten et al. 1977), and prodigiosin
(Kalesperis et al. 1975). Due to its very low aqueous
solubility, violacein probably protects against predation
rather than acts as a true antibiotic, and it has been shown to
induce cell death in grazing organisms (Matz et al. 2008).
Such compounds would be very beneficial for protection of
a biofilm, which is likely how surface-associated
Pseudoalteromonas would grow. The 14 compounds that
could not be identified were mainly not identified due to
poor ionization in ESI+ and ESI− and/or several plausible
candidates in Antibase2009. However, for chemotaxonomic
studies, identity of the compounds is not necessary as long
as they can be unambiguously identified between samples
(Frisvad et al. 2008).
Within cluster VIII (P. ruthenica) and cluster II (aurantia/
citrea), we found examples where strains with highly similar
Fig. 4 HPLC-UV/VIS profiles of the ethyl acetate extracted broth and
biomass of four P. luteoviolacea with the tailing violacein peak at 14–
15 min and in two traces pentabromopseudilin at 22-23 min in
contrast to indolmycin at 11 min in the two other traces
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16S rRNA gene sequences (>99%) and with identical
chemotaxonomy originated from geographically distinct
locations. This latter observation is in agreement with studies
on Salinispora biogeography and secondary metabolite
production in which the authors show how strains of the
marine bacterium S. arenicola isolated from worldwide
locations are highly related and produce identical patterns
of secondary metabolites (Jensen and Mafnas 2006; Jensen
et al. 2007). In contrast, the P. luteoviolacea and P. rubra
strains showed both local and global variations in their
secondary metabolite profile, which one might speculate is
due to adaptation to local specific niches.
In conclusion, we believe sampling from specific niches,
e.g., biofilms on surfaces, to be of importance in discovery of
novel secondary metabolites from the genus Pseudoaltero-
monas. While differences in metabolite patterns among
species encourage isolation and screening of novel diversity,
bioprospecting known Pseudoalteromonas species should
not be ruled out. Investigation of multiple strains of one
Pseudoalteromonas species can yield novel compounds due
to intra-species variations within secondary metabolite
profiles.
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Abstract 1 
The bacterial species Pseudoalteromonas luteoviolacea produces antibiotic compounds and 2 
Pseudoalteromonads are, in general, known for their bioactivity. This has made them an interesting topic of 3 
research in the area of drug discovery.  A major time sink in natural products discovery is the effort spent 4 
rediscovering known compounds, and methods to avoid this are in high demand. We recently found that 5 
four strains of P. luteoviolaceae indistinguishable by 16S rRNA gene sequence produced two different 6 
antibiotic profiles. The purpose of the present study was to determine if this sub-division was true for a 7 
larger group of P. luteoviolaceae isolates and to determine if it could be related to their phylogeny. These 8 
analyses would shed light on inter-species evolution and serve to determine if simple phylogenetic tools 9 
could assist in further discovery of bioactives in species already known to produce bioactive secondary 10 
metabolites. The 13 P. luteoviolacea strains divided into three chemoprofiles based on antibiotic 11 
production (violacein, violacein + pentabromopseudilin, violacein + indolmycin). Detailed phylogenetic 12 
analysis of GyrB and RecA translated amino acid sequences divided the strains into phylotypes related to 13 
antibacterial activity and production of the antibiotic compounds. Hence, we believe phylogeny within a 14 
bioactive species has the potential to be a useful tool in biodiscovery efforts. Additionally, the correlation 15 
between evolutionary groups and antibiotic production provides evidence that the antibiotic biosynthetic 16 
pathways are maintained under selective pressure and hence likely confer important benefits for the 17 
producer organism. 18 
 19 
237 words.  20 
3 
 
Introduction 1 
 2 
Many antibiotics used in treatment of infectious disease are of natural product origin, and despite high  3 
hopes for new drug discovery strategies, alternative approaches to drug discovery such as combinatorial 4 
chemistry has failed to adequately supply the drug pipeline (48). Therefore, we must revert to discovery of 5 
novel natural products capable of inhibiting or killing pathogenic bacteria (6). Screening of microorganisms 6 
(47) from extreme or underexplored environments(1) could be a promising approach as novel genetic 7 
diversity ensuring adaptation to extreme conditions may encode production of novel compounds.  The 8 
marine environment is still considered an underexplored source of novel antimicrobial compounds and 9 
especially marine microorganisms are viewed as a potential source of novel antibiotic compounds 10 
(15,23,40). Indeed, marine bacteria belonging to the Cyanobacteria (60), Actinobacteria (49), 11 
Pseudoalteromonas (2,62), and the Roseobacter clade (4,28) produce compounds with interesting 12 
pharmacological properties.  13 
 14 
Members of the genus Pseudoalteromonas are ubiquitous in the marine environment (65) and form two 15 
phylogenetic groups supported by analysis of 16S rRNA gene sequences (46,62). One group predominantly 16 
consists of non-pigmented pelagic bacteria with low or no antibacterial activity while the majority of 17 
species in the other group is pigmented and antagonistic bacteria typically isolated from marine biotic 18 
surfaces. The widespread occurrence of these bacteria is an indication of successful survival and 19 
competition strategies in which a trait such as production of antagonistic compounds could play an 20 
important ecological role (26). Consequently, the Pseudoalteromonas represent a promising target for 21 
biodiscovery efforts. 22 
 23 
One of the main challenges in natural products discovery is the effort squandered rediscovering known 24 
compounds (9), hence so called ‘dereplication’ strategies to reduce the degree of rediscovery prior to 25 
4 
 
purification and structure elucidation steps are of outmost importance  (29,50,55). One such strategy is 1 
early stage dereplication informed by microbial taxonomy (36,37,58). However, this is complicated by the 2 
inherent challenges of taxonomical classification (16) and more so, by the observation that closely related 3 
strains of the same species may produce different antibiotics (62,63) while strains of different genera may 4 
produce the same antibiotics as observed for e.g. the bioactive pigment violacein(18,39,64). Such cross-5 
species production of compounds is likely due to lateral gene transfer of gene clusters responsible for 6 
biosynthesis of these metabolites (14,51). Nonetheless, screening of a taxonomically dereplicated 7 
collection of Actinobacteria led to discovery of a high number of novel compounds as compared to the 8 
strain throughput (20). Hence, it may possible to apply knowledge of bacterial systematics and taxonomy as 9 
a guide for efficient bioprospecting within other groups of bacteria. We previously reported (41,62) that 10 
five Pseudoalteromonas luteoviolacea strains produced two  combinations of the three antibacterial 11 
compounds violacein (39), indolmycin (42), and pentabromopseudilin (PBP) (5) and accordingly may serve 12 
as a model to explore this hypothesis. 13 
 14 
The aim of the present study was investigate phylogeny as a tool for dereplication in biodiscovery efforts 15 
and provide an evolutionary perspective on bacterial antagonism within the species Pseudoalteromonas 16 
luteoviolacea. This was achieved through detailed analysis of GyrB and RecA sequences coupled with 17 
chemical detection of three known antibacterial compounds; violacein, indolmycin, and 18 
pentabromopseudilin. We found that the chemoprofile was related to phylogenetic affiliation which 19 
validates phylogeny as an approach for dereplication of bacterial strains in a natural products perspective 20 
and offers evidence that the underlying biosynthetic pathways are maintained through the course of 21 
evolution. 22 
 23 
Materials and methods 24 
 25 
5 
 
Bacterial strains and culture conditions. Thirteen P. luteoviolacea strains were used in this study (table 1). 1 
They originated from distinct geographical areas and were primarily isolated from surface water or algae. 2 
The strains were cultured in a marine minimal medium (MMM) (52) with 4.0 g/l mannose and 3.0 g/l 3 
casamino acids. All strains were incubated at 25 ºC and 200 rpm agitation.  4 
 5 
Assays for inhibition of bacterial growth. Vibrio anguillarum 90-11-287 (57) and Staphyloccoccus aureus 6 
8325 were cultured in tryptic soy broth (Difco, USA). Well diffusion agar assays were carried out as 7 
previously described (28). The assay substrate contained 30 g/l Sea Salts (Sigma, USA) and 10 g/l agar. To 8 
support growth of V. anguillarum 4 g/l glucose and 3 g/l casamino acids was added. An additional 5 g/l 9 
peptone was added to S. aureus agar. The inter-species inhibition was tested by embedding each of the 13 10 
strains in agar and testing inhibition by sterile filtered culture of the same strains. The agar-substrate was 11 
modified for the inhibition assays targeting Pseudoalteromonas luteoviolacea: Glucose was substituted with 12 
4 g/l mannose, and due to temperature sensitivity of the P. luteovioacea, standard bacteriological agar was 13 
replaced with low gelling point agarose (Sigma, USA). The growth substrate for the assays was cooled to 37 14 
ºC in a water bath before overnight bacterial culture was added, and the assays were subsequently 15 
performed as for V. anguillarum and S. aureus. 16 
 17 
Analytical detection of antibacterial compounds. Samples for LC-MS analyses were prepared from cultures 18 
in MMM extracted with ethyl acetate (EtOAc). Extracts were dried under nitrogen and redissolved in 19 
methanol (MeOH). LC-MS samples were analysed using an Agilent 1100 HPLC system with a diode array 20 
detector (Waldbronn, Germany) coupled to an LCT TOF mass spectrometer (Micromass, Manchester, UK) 21 
using a Z-spray electrospray (ESI) source. A Phenomenex Luna II C18 column (50 mm ×2 mm, 3 μm) was used 22 
for separation, applying a linear acetonitrile (MeCN)-water (20 mM formic acid) 0.3 ml min-1 gradient (15-23 
100%) over 20 min at 40°C. For all LC-MS analyses, violacein and indolmycin were detected in positive 24 
ionisation mode (ESI+), while pentabromopseudilin was detected in negative mode (ESI-). 25 
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 1 
PCR amplification and sequencing. DNA was purified from overnight P. luteoviolacea cultures using the 2 
NucleoSpin Tissue kit (Machery-Nagel, Germany) or QIAGEN Genomic-Tip G/100 (QIAGEN, USA) following 3 
the manufacturer’s protocol. 16S rRNA genes from strains H33, H33S, NCIMB 1942, NCIMB 1944 and 4 
NCIMB 2035 were amplified by PCR, and gyrB and recA genes were amplified from all strains. One reaction 5 
consisted of 2.5 µl 10X hot start PCR buffer (Fermentas, Canada), 2.5 µl 2mM dNTP mix, 4 µl 25 mM MgCl2, 6 
0.8 µl 12.5 µM forward primer, 0.8 µl 12.5 µM reverse primer, 12.28 µl MilliQ H2O, 0.2 µl Maxima Hot Start 7 
Taq DNA polymerase (Fermentas, Canada) and 1 µl DNA template at 50 ng/µl for a total volume of 25 µl. 8 
The reactions were performed on an Applied Biosystems Veriti 96 well cycler. 16S rRNA genes were 9 
amplified according to [Porsby]. The primers and reaction conditions used for gyrB amplification were as 10 
described in (66). Primers and conditions for amplification of recA fragments were according to (53). 11 
Sequencing was done by Eurofins MWG Operon, Germany.  12 
 13 
Phylogenetic analysis. The 16S rRNA gene sequences were obtained from GenBank or by sequencing and 14 
aligned in MEGA5 using MUSCLE (59). The evolutionary history was inferred using the maximum likelihood 15 
method based on the Hasegawa-Kishino-Yano model (25), determined by MEGA5 as the best fitting model. 16 
The phylogenetic tree was constructed using MEGA5 default settings. For analysis of recA and gyrB 17 
sequences, an alignment was created for each gene in MEGA5 using MUSCLE. The alignments were curated 18 
manually and trimmed to be of equal length and in-frame for translation to amino acid sequence. The two 19 
alignments were concatenated and phylogenetic analyses were performed in MEGA5. Evolutionary 20 
relationships based on the encoded amino acid sequence were inferred using the maximum likelihood 21 
method with Dayhoff matrix-based distance calculations (56). A phylogenetic tree was generated and 22 
tested with 1000 bootstrap replications.  23 
 24 
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Minimum inhibitory concentrations (MIC) of violacein and indolmycin. MICs were determined for 1 
violacein (Sigma, USA) and indolmycin (Bioaustralis, Australia) as these compounds were commercially 2 
available. MIC assays were carried out in 96-well microtiter plates according to the guidelines by the clinical 3 
and laboratory standards institute (7), with minor modifications. P. luteoviolacea strains, V. anguillarum 90-4 
11-287, and S. aureus 8325 were tested for sensitivity to indolmycin by determining the MIC. P. 5 
luteoviolacea was cultured in MMM with 4 g/l mannose and 3 g/l casamino acids, V. anguillarum in MMM 6 
with 4 g/l glucose and 3 g/l casamino acids, and S. aureus in MHB. Overnight bacterial cultures were diluted 7 
to 105 CFU/ml and 90 µl added per well. 10 µl of antibiotic solution was added to each well. Indolmycin was 8 
tested in serial two-fold dilution at final concentrations of 0.5 µg/ml to 128 µg/ml. Controls were included 9 
for no antibiotic and for ethanol solvent. The well containing the lowest concentration of antibiotic that 10 
had no visual bacterial growth after 48 hours corresponded to the MIC. 11 
 12 
Genbank nucleotide accession numbers. 16S rRNA nucleotide sequences JQ250820-JQ250824, gyrB 13 
nucleotide sequences JQ280430 – JQ280442 and recA nucleotide sequences JQ280417-JQ280429. 14 
 15 
Results 16 
 17 
P. luteoviolacea production of antibacterial compounds and antibacterial activity. A collection of P. 18 
luteoviolacea strains were tested for the ability to inhibit bacterial growth using either live cells or sterile 19 
filtered culture supernatant.  The strains were also tested for their ability to produce three known 20 
antibacterial compounds previously identified within the species (table 2). All 13 strains produced the 21 
purple antibacterialpigment violacein. Four strains did not produce other known antibiotics, three strains 22 
produced indolmycin and five strains produced PBP (table 2). No strain produced both indolmycin and PBP.  23 
Despite the violacein production by all strains, just 11 of the 13 strains inhibited V. anguillarum and S. 24 
aureus in the live cell assay. In the test of sterile filtered culture supernatants, only the three indolmycin 25 
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producing strains inhibited both V. anguillarum and S. aureus. Supernatants from nine strains inhibited S. 1 
aureus, and these strains produced indolmycin or PBP. The supernatant from the remaining four strains 2 
were not inhibitory against any of the target organisms and these were the four strains that produced 3 
neither indolmycin nor PBP. Sterile filtered culture supernatants of the P. luteoviolacea strains were also 4 
tested for intra-species inhibition (table S1). Five sterile filtered supernatants inhibited the full spectrum of 5 
P. luteoviolacea strains, including the producer strain itself: Two of the indolmycin producing strains 6 
(S4047-1 and S4054) and three of the PBP producers (S2607, S4060-1 and 2ta16). Four supernatants 7 
inhibited three to five P. luteoviolacea strains. Among these, interestingly the supernatants of strains H33 8 
and H33S, both unable to inhibit V. anguillarum or S. aureus, did inhibit three (H33) and five (H33S) strains 9 
respectively. Overall, however, , the intra-species inhibition patterns did not correlate with the antibiotic 10 
production profile of the strains.  11 
 12 
Phylogenetic analyses and assignment of phylotypes. A 16S rRNA gene sequence and a GyrB-RecA based 13 
phylogenetic tree were created. The 16S rRNA sequences were similar at a level of >99% and the 14 
phylogenetic reconstruction showed no correlation to production of antibiotics (figure 1). In contrast, three 15 
phylotypes were identified in the GyrB-RecA phylogeny (figure 2; I, II, and III) and corroborated the division 16 
of P. luteoviolacea strains into groups with specific antibiotic production and bacterial inhibition. Phylotype 17 
I was synonymous with the six PBP producing strains. Within phylotype II, the indolmycin producer S4054 18 
placed itself as a representative of an ancestral state to the two other indolmycin producers and, on a 19 
separate branch, the strains H33 and H33S. Phylotype III was synonymous with the two strains NCIMB 1944 20 
and NCIMB 2035 which were not antagonistic. 21 
 22 
MIC of known antagonistic compounds. To investigate the potential role of indolmycin and violacein as 23 
antibacterial compounds, the MICs against V. anguillarum, S. aureus, and the 13 P. luteovioloacea strains 24 
were determined. Under these experimental conditions violacein did not inhibit any of the tested strains at 25 
9 
 
the concentrations included in the experiment; hence the MIC of violacein for all tested strains was > 128 1 
µg/ml. The MIC of indolmycin to V. anguillarum was 2 µg/ml.  S. aureus was inhibited by indolmycin at all 2 
tested concentrations, resulting in a MIC of ≤ 0.5 µg/ml.  None of the P. luteoviolaceae, irrespective of 3 
antibiotic profile, were inhibited by indolmycin and MIC was > 128 µg/ml 4 
 5 
Discussion  6 
Pseudoalteromonas luteoviolacea is a well-known producer of several bioactive secondary metabolites 7 
which are believed to play important ecological roles for the producer organism, such as protection against 8 
predation or bacterial antagonism. However, little is known of the phylogenetic distribution of antibiotic 9 
compounds within this species. We recently (Mansson et al. 2010, Vynne et al 2011) found that within a 10 
collection of just five strains two distinct antibiotic profiles were detected, prompting us to speculate if this 11 
reflected phylogenetic diversity or was a mere phenotypic variation. In the present study, we expand our 12 
investigation to a collection of 13 strains demonstrating three different antibiotic profiles within this 13 
species. We have attempted to further broaden our collection; however, were not able to obtain more 14 
strains as P. luteoviolacea under certain conditions is autoinhibitory (18) and several laboratories no longer 15 
had stock cultures. Our data demonstrate that biodiscovery processes can benefit from exploring several 16 
strains of the same species.  17 
 18 
All strains produced violacein, a hallmark compound of the species; however, the data presented here and 19 
currently in preparation (10) indicates that the antibacterial activity of violacein is limited. Alternatively, 20 
violacein likely acts as a cell-associated anti-predation compound (44) which is more in line with its low 21 
solubility in water and its clear cell-association. Violacein is not present in a simple sterile filtered 22 
supernatant and these were only antibacterial if harvested from strains producing either indolmycin or PBP. 23 
The indolmycin or PBP containing supernatants were equally inhibitory towards S. aureus, whereas only 24 
indolmycin containing supernatants inhibited the Gram-negative V. anguillarum. This is in agreement with 25 
10 
 
previous studies describing pentabromospeudilin as a compound targeting Gram-positive bacteria (5), 1 
whereas indolmycin, previously only isolated from Streptomyces species (35,61), inhibits both Gram-2 
positive and Gram-negative bacteria (35) and is very potent against staphylococci (31).  The genetic basis of 3 
the biosynthetic pathways of PBP and indolmycin is not known, but the available mechanistic insight 4 
(24,30,54)  suggests that it is two distinct biosynthetic pathways with no common precursor. However, as 5 
indolmycin and violacein both are tryptophan derived it is not unlikely that their biosynthetic pathways are 6 
interlinked at an early stage. Interestingly, the strains H33 and H33S did not produce indolmycin or PBP, yet 7 
were active in the live cell assay and in intra-species inhibition. This could potentially be explained by some 8 
degree of antibacterial activity of violacein or violacein analogues present in the growing colony, or it could 9 
be related to macromolecular antibacterial substances as described in strains CPMOR-1 and CPMOR-2. 10 
CPMOR-1 and CPMOR-2 produce a macromolecular L-amino acid oxidase with antibiotic activity (19), but in 11 
contrast to H33 and H33S, CPMOR-1 and CPMOR-2 did not cause intra-species inhibition. Therefore it is 12 
also possible that other as yet undiscovered antibiotics are produced by H33 and H33S. 13 
 14 
Our analysis of 16S rRNA gene sequences (figure 1) resolved two clades with no apparent relation to 15 
antibiotic production. However, the resolving power of the 16S rRNA gene is limited when performing 16 
phylogenetic analyses below the species level and for many species, studies have shown the usefulness of 17 
phylogenetic analyses of housekeeping genes such as recA and gyrB. Hence, analysis of antibacterial 18 
secondary metabolite production and phylogenetic reconstruction based on the housekeeping genes recA 19 
and gyrB divided the 13 strains into three phylotypes with specific production of antibiotics (figure 2). Such 20 
a correlation among taxonomic units and secondary metabolite synthesis is well known from the world of 21 
fungal natural products (17) and has also been reported for a marine actinobacteria (34). Analysis of GyrB 22 
and RecA sequences provides a clearer resolution of taxonomy than 16S rRNA gene sequences when 23 
comparing strains at or below the species level(8,27,67), which may explain why phylotype specific 24 
11 
 
secondary metabolite production was only partially observed in our previous analysis of 16S rRNA gene 1 
based phylogeny and chemotypes in 101 Pseudoalteromonas strains (62). 2 
 3 
The phylogenetic analysis placed the indolmycin producer S4054 near the divergence point of the non-4 
indolmycin producers H33 and H33S. This indicates that indolmycin production is an ancestral trait, and we 5 
speculate that H33 and H33S may have lost or silenced the indolmycin biosynthetic pathway to rely on a 6 
different antagonistic compound in microbial competition since inhibition was observed in the live cell 7 
assay, or that the divergence point was shortly before acquisition of the indolmycin producing trait. This 8 
raises the question of which taxonomical level to consider when searching for novel chemical diversity, as 9 
selection of biological material based on 16S rRNA gene sequences may exclude chemical diversity (33).   It 10 
is tempting to speculate that phylotype III employs a different strategy when colonizing and competing in 11 
the marine environment as these strains showed no inhibition in live cell assays or tests of sterile 12 
supernatants. However, antagonism may simply be silenced under the tested growth conditions, as it is 13 
known that environmental factors such as host components (3) or microbial interactions (11,45) may 14 
facilitate the production of antagonistic compounds. Further insight could be gained via whole genome 15 
sequencing in order to search for potential clusters of genes involved in e.g. polyketide synthesis or non-16 
ribosomal peptide synthesis (22).  17 
 18 
Often, genes involved in biosynthetic pathways occur grouped within the bacterial genome and are 19 
subjects of acquisition or reduction events (13,32,38). Production of antagonistic compounds that play a 20 
key ecological role for the producer organism is expected to be under strong selective pressure, as was 21 
observed for phylotype I and could be argued for in the indolmycin sub-population in phylotype II. This is 22 
consistent with the model of gene fixation in the complexity hypothesis (32) in which genes with a positive 23 
selection pressure are maintained at a high occurrence within a taxonomical unit as observed for three 24 
closely related Salinispora species (34). Species specific chemotypes are known in the marine environment 25 
12 
 
from e.g. the actinobacterial genus Salinispora (34) and were suggested to reflect adaptation to specific 1 
environmental niches. Altogether, this suggests that the compounds indolmycin and PBP play important 2 
roles in the ecology of the producer organism, as their production can be traced through a phylogenetic 3 
reconstruction of closely related strains and thus are maintained on an evolutionary scale. Although the 4 
present study has no data to support previous reports of the antibacterial activity of violacein, we believe 5 
that the compound does play a key role in P. luteoviolacea ecology as for instance protection against 6 
predatory microorganisms (43,44).  7 
 8 
Based on the limit number of strains in this study, no apparent correlation among antibiotic production and 9 
geographical location was observed within the P. luteoviolacea strains, although the majority of the 10 
antagonistic strains were isolated from surfaces and, specifically, all indolmycin-producing strains were 11 
isolated from macroalgae or seaweed. The apparent lack of correlation among antibiotic production and 12 
geographic origin is in contrast to observations within the marine actinobacterium Salinispora arenicola, 13 
where biogeographic patterns including local endemism were observed among polyketide synthases likely 14 
involved in synthesis of bioactive secondary metabolites (12). Two of the P. luteoviolaceae strains (4054 15 
and 4060) had different antibiotic profile and were originally isolated from the same sample (21). No 16 
systematic intra-species inhibition pattern was observed and all P. luteoviolacea strains, irrespective of 17 
antibiotic production profile, were resistant to indolmycin. We speculate that the species gains an 18 
ecological advantage by colonizing with strains producing different antibiotics, hence broadening the 19 
competitive ability against other species. 20 
 21 
In summary, we found that the marine bacterium Pseudoalteromonas luteoviolacea produces the 22 
bioactives violacein, indolmycin, and PBP. Violacein as a pure compound did not inhibit any of the tested 23 
bacteria, whereas indolmycin inhibited V. anguillarum and S. aureus but not the P. luteoviolacea strains.  24 
We found that the antibiotic profile was correlated to – and hence could have been predicted by – the 25 
13 
 
phylogenetic analyses. This offered a glimpse of the evolutionary stability of the underlying biosynthetic 1 
pathways and provides a method for dereplicating bacterial strains as part of a natural product screening 2 
effort. 3 
 4 
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Figure 1: Phylogenetic analysis of 16S rRNA gene sequences in MEGA5 (59) using Pseudoalteromonas 
atlantica (accession no. X82134) as outgroup (not shown in tree). The 16S rRNA gene sequences were 
aligned using MUSCLE, and the evolutionary history inferred using the maximum likelihood method based 
on the Hasegawa-Kishino-Yano model (25). A phylogenetic tree was constructed using the default MEGA5 
settings. Scale bar: substitutions per site. Closed boxes: pentabromopseudilin producer, open circles: 
indolmycin producer. All strains produce violacein. 
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Figure 2: Phylogenetic analysis of concatenated RecA and GyrB amino acid sequences of 13 strains based 
on the maximum likelihood method. The evolutionary history was inferred by using the maximum 
likelihood method based on the Dayhoff matrix model(56). The tree with the highest log likelihood (-
1597,5915) is shown. The tree is drawn to scale, with branch lengths measured in the number of 
substitutions per site. All positions containing gaps and missing data were eliminated. There were a total of 
1000 positions in the final dataset. Evolutionary analyses were conducted in MEGA5 (59) using a discrete 
Gamma distribution to model evolutionary rate differences among sites (5 categories (+G, parameter = 
0,1000)). Clades identified as phylotypes are indicated by roman numerals I-III. Scale bar: substitutions per 
site. Closed boxes: pentabromopseudilin producer, open circles: indolmycin producer. All strains produce 
violacein. 
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Table 1: P. luteoviolacea strains used in this study. The phylogenetic 
position of all strains within the Pseudoalteromonas luteoviolacea clade 
was verified by analysis of partial 16S rRNA gene sequences (>1200 bp, 
data not shown).  
Strain name Origin Source 
DSM 6061 (T) Mediterranian, Nice Surface water 
S2607 Pacific, Eastern Australia Rock surface 
S4060-1 Pacific, Costa Rica Seaweed 
2ta16 Florida Keys, USA M. annularis coral 
CPMOR-2 Mediterranian, Murcia Surface water 
NCIMB1944 Mediterranian, Nice Surface water 
S4047-1 Pacific, Costa Rica Seaweed 
S4054 Pacific, Costa Rica Seaweed 
CPMOR-1 Mediterranian, Murcia Macroalgae 
H33 Sydney, Australia Unknown 
H33S Sydney, Australia Unknown 
NCIMB1942 Mediterranian, Nice Surface water 
NCIMB2035 Mediterranian, Nice Surface water 
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Table 2: Inhibitory activity of P. luteoviolacea strains in the live cell and supernatant well diffusion 
agar assays and production of three known antibacterial compounds in marine minimal medium 
cultures.  The production of antibacterial compounds was determined by LC-MS analysis. V. anguil. 
= Vibrio anguillarum. x: Inhibition or compound production, respectively. -: No inhibition or 
compound production. 
 
 
Live cell assay 
inhibition 
Inhibition by sterile 
supernatant Antibacterial compounds produced 
Ph
yl
ot
yp
e 
Strain V. anguil. S. aureus V. anguil. S. aureus Violacein 
Pentabromo-
pseudilin Indolmycin 
DSM6061 T x x - x x x - I 
S2607 x x - x x x - I 
S4060-1 x x - x x x - I 
2ta16 x x - x x x - I 
CPMOR-2 x x - x x x - I 
NCIMB 1944 x x - x x x - I 
S4047-1 x x x x x - x II 
S4054 WT x x x x x - x II 
CPMOR-1 x x x x x - x II 
H33 x x - - x - - II 
H33s x x - - x - - II 
NCIMB 1942 - - - - x - - III 
NCIMB 2035 - - - - x - - III 
 301 
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Table S1: Intra-species inhibition by P. luteoviolacea sterile supernatant in well diffusion agar assays. Substrate blanks were included and did not 1 
inhibit any organism. +: inhibition, (+): weak inhibition, -: no inhibition. 2 
Producer 
strain  
Inhibition (+) of target strain 
DSM6061 (T) S2607 S4047-1 S4054 S4060-1 2ta16 CPMOR-1 CPMOR-2 NCIMB 1942 NCIMB 1944 NCIMB 2035 H33 H33S 
DSM6061 T - + - - + - - - - - + - - 
S2607 + + + + + + + + + + + + + 
S4060-1 + + + + + + + + + + + + + 
2ta16 + + + + + + + + + + + + + 
CPMOR-2 - - - - - - - - - - - - - 
NCIMB 1944 (+) - (+) (+) - - - - - - - - - 
S4047-1 + + + + + + + + + + + + + 
S4054 + + + + + + + + + + + + + 
CPMOR-1 - - - - - - - - - - - - - 
H33 - - - - + - - - - - + + - 
H33S  - +  - -  + +  -  -  - -  + +  - 
NCIMB 1942 - - - - - - - - - - - - - 
NCIMB 2035 - - - - - - - - - - - - - 
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Abstract 1 
A novel aerobe marine bacterium was isolated from swab samples of an unidentified polychaete 2 
near Canal Concepción, Chile. The strain was gram negative with a polar flagellum, and it grew 3 
from 5 to 30 ºC. Growth required a NaCl concentration of 1 to 6% (w/v) and pH 5.5-8.9, and a wide 4 
range of carbohydrates were utilized as growth substrates. The main components of the total 5 
cellular fatty acids were summed feature 3 (C16:1 ω7c/C16:1 ω6c, 35.82%), C16:0 (20.43%) and C17:1 6 
ω8c (10.85%). The DNA G+C content of the strain was 39.6 mol%. The most similar strain was 7 
P.arctica LMG 23753T (99.7%), and 16S rRNA gene sequence identities ranged from 92.6% to 8 
99.7% when compared to Pseudoalteromonas type strains. DNA-DNA reassociation values showed 9 
less than 70% genomic DNA relatedness to Pseudoalteromonas type strains. Based on the 10 
available phylogenetic and phenotypic data, this isolate represents a novel species of the genus 11 
Pseudoalteromonas. The name Pseudoalteromonas galatheae is proposed and the type strain is 12 
S3431T = LMGXXXXX = DSM XXXX (to be added when/if accepted). 13 
 14 
  15 
The genus Pseudoalteromonas contains several species that produce different bioactive 1 
compounds, and it has been found that for most species pigmentation co-occurs with production 2 
of bioactive metabolites (Bowman, 2007;Egan et al., 2002;Vynne et al., 2011). Among the known 3 
bioactives produced by pigmented members of the genus are antifouling, anti-bacterial and 4 
cytotoxic compounds, however, also non-pigmented species may be of biotechnological interest 5 
due to the production of novel enzyme activities (Bowman, 2007).  6 
During a research cruise (Galathea 3), bacteria were collected from marine environments and 7 
screened for antibacterial activity (Gram et al., 2010). Of the isolated strains, more than one 8 
hundred were identified by 16S rRNA gene sequence similarity as Pseudoalteromonas (Gram et al., 9 
2010;Vynne et al., 2011). On February 3rd 2007, a swab sample was obtained from an unidentified 10 
polychaete near Canal Concepción, Chile (-50.4498 ºN, -74.8912 ºE). From subcultures of this 11 
sample, strain S3431 was isolated due to production of an intense black pigment. Later analysis 12 
would show a high level of 16S rRNA sequence similarity to strains of the so called non-pigmented 13 
group of the genus Pseudoalteromonas (Gauthier et al., 1995), in clear contrast to the intense 14 
black pigment produced by this strain. The most related type strain was P. arctica LMG 23753T 15 
(99.7% identical) as determined by a BLAST comparison of 16S rRNA gene sequence of S3431 and 16 
Pseudoalteromonas type strains. Several other type strains also had >99% identity and were 17 
included in this study. Further taxonomic and physiological analysis of this new strain determined 18 
that it represents a novel species within the Pseudoalteromonas genus. 19 
Strain S3431 was routinely cultured for morphological and physiological characterisation in marine 20 
broth 2216 (Difco, USA) and on marine agar 2216 (Difco, USA) at 25ºC. A marine minimal medium 21 
(MMM) containing no carbon source was used as substrate for BioLog assays (Östling et al., 1991). 22 
Temperature requirements for growth were tested in MB 2216 from 5ºC to 30ºC in 5º intervals, 23 
and at 37ºC. NaCl requirements were tested on ½YT agar medium containing 2 g/l yeast extract, 24 
1.25 g/l tryptone, 10 g/l agar and NaCl in concentrations of 0% – 9% (w/v). The pH range 25 
supporting growth was determined in MB, pH 4.2 – 10.3.  26 
 27 
Cell shape and motility was investigated in wet mounts using an Olympus BX51 phase contrast 28 
microscope, while the presence of flagella was determined by transmission electron microscopy 29 
(TEM). For TEM, colony mass from colonies grown on MA was resuspended in phosphate buffered 1 
saline, pH 7.4. Seven µl of this suspension were placed on a 300-mesh Ni-grid coated with carbon 2 
film glow discharged for 30 seconds. The grid was washed using 2 drops of double distilled H2O 3 
and stained with 3 drops of PTA pH 6.9 for 15 seconds, after which the grid was dried by filter 4 
paper. TEM was performed at 60 keV on a JEOL1010 transmission electron microscope fitted with 5 
a digital camera. 6 
Gram-testing was done using the 3% KOH method and aminopeptidase strips (BactiDent). Catalase 7 
activity was tested using the 3% H2O2 method, and oxidase activity was tested using BD BBL 8 
DrySlide. The ability of the strain to ferment glucose was tested using Hugh & Leifsons media 9 
modified for marine microorganisms by adding 2.0% Instant Ocean salts (Aquarium Systems, Inc., 10 
Sarrebourg, France) (Hugh & Leifson, 1953). BioLog GN2 microtiterplates were used to test for 11 
carbon assimilation: S3431 was grown on MA overnight and colony mass was resuspended to 12 
OD600 = 1.0 in MMM with no carbon source, supplemented with 5 mM thioglycolate. 150 µl of this 13 
suspension was added to each well of the GN2 microplate. The plate was manually read after 10 14 
days of incubation at 25ºC. 15 
Hemolytic activity was tested on Blood Agar Base (Oxoid) with 5% defibrinated calf blood. 16 
Production of enzymes was tested by spotting colony mass of S3431 on medium consisting of 17 
28.75 ml/l buffer (85% phosphoric acid 0.08 M, boric acid 0.08 M, glacial acetic acid 0.08 M), 30 g/l 18 
Instant Ocean salts and 10 g/l agar and destilled water to 1000 ml. The pH of the medium was 19 
adjusted to 6.0 and enzyme substrate was added to a concentration of 0.1% (w/v). Azurine-20 
crosslinked (AZCL)-amylose, AZCL-curdlan, AZCL-galactan, AZCL-rhamnogalacturon I, AZCL-xylose 21 
and AZCL-dextran were tested. Azo-avicel was used as substrate to test production of endo-22 
cellulases. Enzyme actitivity was detected by the presence of a colored zone in the agar 23 
surrounding the colony. AZCL-substrates and azo-avicel were purchased from Megazyme, Ireland. 24 
Production of caseinase activity was tested on agar plates containing 100 g/l skim milk powder 25 
(Difco), 30 g/l Sea Salts (Sigma) and 15 g/l agar. Chitinase production was assayed on agar plates 26 
containing 0.5 g/l peptone, 0.1 g/l yeast extract, 0.01 g/l FePo4, 30 g/l Sea Salts (Sigma) and 0.2% 27 
colloidal chitin (Weyland et al., 1970).  28 
The Pseudoalteromonas sp. S3431 16S-rRNA gene sequence was analysed using BLAST to 1 
determine closely related species. A phylogenetic tree was created based on Pseudoalteromonas 2 
type strain 16S-rRNA gene sequences. These were aligned using MUSCLE and a maximum 3 
likelihood tree was created using the Kimura 2-parameter model and 1000 bootstrap replications.  4 
Determination of GC-mol% of genomic DNA, cellular fatty acid profiling and DNA-DNA 5 
reassociation analyses were carried out by the DSMZ.  6 
 7 
Bacterial cells of the novel isolate were Gram-negative, motile rods with one polar flagella as 8 
described for members of the genus Pseudoalteromonas (figure 1) (Mikhailov et al., 2002). The 9 
cells were approximately 2.2 – 3.0 µm long and 0.7 – 0.8 µm wide. The isolate grew at 5 to 30ºC, 10 
but not at 35ºC. No sporulation was observed. Growth was observed at pH 5.5 but not pH 4.3, and 11 
at pH 8.9 but pH 9.7. The strain was capable of growth on ½YT agar containing 1 to 6% NaCl, but 12 
not in 0.5 or 7% NaCl. The strain was oxidase and catalase positive, and capable of oxidative but 13 
not fermentative glucose metabolism. Membrane vesicles appeared on several cells as evidenced 14 
by TEM, which was previously observed in other Pseudoalteromonas species (Nevot et al., 2006).  15 
Carbon source assimilation in the BioLog GN2 microplate system showed that, in addition to the 16 
carbon sources listed in table 1, S3431 was able to utilize α-cyclodextrin, dextrin, glycogen, tween 17 
40, tween 80, D-Cellobiose, gentiobiose, lactulose, D-raffinose, acetic acid, D-galacturonic acid, α-18 
ketoglutaric acid, propionic acid, succinic acid, L-alaninamide, L-alanine, L-alanyl-glycine, L-19 
asparagine, L-glutamic acid, glycyl-L-glutamic acid, L-proline, L-serine, L-threonine, inosine, uridine, 20 
α-D-glucose-6-phosphate and D-glucose-6-phosphate as sole carbon sources. 21 
The novel strain produced amylase but not curdlanase, galactanase, rhamnogalacturonase, 22 
xylanase or dextranase. No endo-cellulases were produced. Chitinase production was not 23 
detected, however agarolytic activity was observed on both chitin plates and agar medium 24 
containing 0.5 g/l peptone, 0.1 g/l yeast extract, 0.01 g/l FePO4·H2O and 30 g/l Sea Salts (Sigma). 25 
Caseinase activity was observed as clearing zones on skim milk agar. 26 
The 16S-rRNA gene sequence was compared to 16S-rRNA sequences from Pseudoalteromonas 27 
type strains using the BLAST tool. The most similar strain was P.arctica LMG 23753T (99.7%), and 28 
identities ranged from 92.6% to 99.7%. In a minimum evolution phylogenetic tree, the strain 1 
placed itself firmly within the so called non-pigmented group (supplementary figure 1), in contrast 2 
to the intense black pigment produced by this strain. 3 
The DNA-DNA reassociation values of S3431 to type strains with 99% 16S rRNA identity are shown 4 
in table 2, and were below the 70% recommended limit for delineating new species (Wayne et al., 5 
1987). G+C content in genomic DNA was 39.6 mol%, which is in range with other 6 
Pseudoalteromonas species (Gauthier et al., 1995). The main cellular fatty acids were summed 7 
feature 3 (C16:1 ω7c/C16:1 ω6c, 35.82%), C16:0 (20.43%) and C17:1 ω8c (10.85%) as shown in table 3 8 
which confirms the position of strain S3431 within the genus Pseudoalteromonas (Ivanova et al., 9 
2000). 10 
 11 
Based on the available phenotypic and phylogenetic information, strain S3431 should be 12 
recognized as a new species within the genus Pseudoalteromonas and the name 13 
Pseudoalteromonas galatheae sp. nov. is proposed. 14 
 15 
Description of Pseudoalteromonas galatheae sp. nov. 16 
Pseudoalteromonas galatheae (ga.la.the'ae. N.L. n. galathea, referring to the research expedition on 17 
which the type strain was first isolated).  18 
Cells are motile straight rods with polar flagella, 2.2 – 3.0 µm long and 0.7 – 0.8 µm wide. The cells 19 
are Gram-negative, non-spore forming, strictly aerobe and mainly occur as single cells. When 20 
grown on MA 2216 at 25 ºC, the strain forms raised circular black to dark brown colonies, which 21 
appear smooth and shiny. A brown pigment diffusing into the agar is produced. Growth occurs at 4 22 
– 30 ºC, with no growth at 37 ºC. Growth is observed within a pH range of 5.5-8.9. Substrate NaCl 23 
content from 1-6% supports growth. The strain utlizes D-glucose, D-mannose, D-galactose, 24 
maltose, sucrose, melibiose, lactose, succinate, D-gluconate, D-mannitol, sorbitol, citrate, xylose, 25 
trehalose, acetate, L-arginine, α-cyclodextrin, dextrin, glycogen, tween 40, tween 80, D-cellobiose, 26 
gentiobiose, lactulose, D-raffinose, acetic acid, D-galacturonic acid, α-ketoglutaric acid, propionic 27 
acid, succinic acid, L-alaninamide, L-alanine, L-alanyl-glycine, L-asparagine, L-glutamic acid, glycyl-1 
L-glutamic acid, L-proline, L-serine, L-threonine, inosine, uridine, α-D-glucose-6-phosphate and D-2 
glucose-6-phosphate as sole carbon sources. It does not grow on D-fructose, sorbitol, N-3 
acetylglucosamine or pyruvate. The strain produces amylase and hydrolyzes agar and casein, but is 4 
not hemolytic. The primary cellular fatty acids are summed feature 3 (C16:1 ω7c/C16:1 ω6c, 35.82%), 5 
C16:0 (20.43%) and C17:1 ω8c (10.85%).  6 
The type strain is S3431T (= DSM XXXXX = LMG XXXXXX, to be added when accepted), isolated from 7 
a marine polychaete in Canal Concepción, Chile. The DNA G+C mol content of the type strain is 8 
39.6%. 9 
 10 
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Figure 1: TEM of cells of Pseudoalteromonas galatheae S3431 showing the polar flagellum. 1 
Additionally, vesicle-like structures appear near the cell membrane.  2 
 
Table 1: Characteristics of Pseudoalteromonas type strains. 1: P. galatheae S3431, 2: P. arcticaT, 3: P. 
translucidaT, 4: P. haloplanktisT, 5: P. agarivoransT, 6: P. alienaT, 7: P. atlanticaT, 8: P. 
carrageenovoraT, 9: P. distinctaT, 10: P. elyakoviiT, 11: P. espejianaT, 12: P. issachenkoniiT, 13: P. 
nigrifaciensT, 14: P. paragorgicolaT, 15: P. tetraodonisT, 16: P. undinaT.   
Characteristic 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 
DNA G-C content (mol%) 39.6 39 46.3 43.3 43.8 
41-
43 
41.2 39.5 43.8 38.5 43 43 
39-
41 
41.1 41.5 42.2 
Growth at: 
                
4 ºC + + + - - + - (+) - v - + + + + + 
30 ºC + - + v + + + + + + + + + + + ND 
40ºC - - - - - - - - - - - - - - - - 
1% NaCl + + + + + v + + + + + + + + + + 
3-6% NaCl + + + + + + + + + + + + + + + + 
8% NaCl - + - + + - - + + + + + + - + + 
9% NaCl - + - + + - - + + + + + + - + + 
10% NaCl - - - + - - - + + + + + + - + + 
Enzymatic activity: 
                
Catalase positive + ND + + + + + + + + + + + + + + 
Oxidase positive + ND + + + + + + + + + + + + + + 
Amylase + - + v + + + - - + + - v + - v 
Caseinase + + + + + v + + - ND ND + - + ND ND 
Agarase + - - - + - + - - - - - - - - - 
Chitinase - ND - v ND - - - - - - + - - - + 
Utilization of: 
                
D-Glucose + + - + + v + + + + + + + ND + + 
L-Arabinose - ND ND - - ND - - - - - ND ND ND ND v 
D-Mannose + - ND + - - + - + + v - v ND - - 
D-Galactose + + + v - - + v - + + + + + + - 
D-Fructose - - ND + - - + + + + v + + ND - - 
Maltose + + - + + + + + - + + + + + + + 
Sucrose + + ND v - ND + + - + + + v ND + + 
Melibiose + + - - - - + + + v + + + - - - 
Lactose + - - - - - + + + v + + + - - - 
D-Gluconate + + ND - - - - - - - - - + ND - - 
Glycerol + - ND - - - + + + - v - + ND - - 
Succinate + - ND v - - + + - + - + + ND v + 
D-Mannitol + + + v + ND + + - + + + - + - - 
Sorbitol - ND ND - ND - - - - - - - v - - - 
Citrate + - - + - - v + + v + + + - + - 
N-Acetylglucosamine - - ND - - + - - - - - - ND ND ND + 
Xylose + - - - ND - - - - + + - v ND - - 
Trehalose + - ND - ND - + - - - + - + ND - v 
Acetate + - ND + - - + + + v + + + ND + + 
Pyruvate - + ND + - - + + + + + + + ND + + 
L-Arginine + ND - - ND ND - - ND - + ND v - - v 
 
Table 2: Per cent DNA-DNA similarity in 2X SSC at 66ºC {Vynne, 2012 455 /id}. All related 
type strains have less than 70% DNA-DNA similarity to S3431, which is the accepted 
threshold for species delineation {Wayne, 1987 152 /id}.  
WIP: Work in progress. 
Pseudoalteromonas species Per cent DNA:DNA similarity to strain 
S3431 
P. agarivorans DSM 14585T 28.2 
P. aliena LMG 22059T 44.5 
P. atlantica NCOMB 301T  26.9  
P. carrageenovora DSM 6820T 14.8  
P. distincta CIP 105340T 44.5  
P. elyakovii LMG 14908T 44.2  
P. espejiana DSM 9414T 48.0  
P. issachenkonii LMG19697T 33.6  
P. nigrifaciens LMG 2227T 15.4  
P. paragorgicola LMG 19696T 58.4  
P. tetraodonis DSM 9166T 11.3  
P.undina LMG 2880T 13.8  
P. antarctica CECT4664T WIP 
 
Table 3: Cellular fatty acid composition of Pseudoalteromonas galatheae S3431T. Fatty acids 
constituting less than 0.5% of the total amount were not included. -, Not detected in 
significant amounts. 
Fatty acid S3431T 
C12:0 1.25 
C14:0 0.51 
C15:0 - 
C16:0 20.43 
C17:0 5.76 
C18:0 1.14 
C15:1 ω8c 1.60 
C17:1 ω8c 10.85 
C17:1 ω6c 0.55 
C18:1 ω7c 7.77 
C16:0 iso 1.18 
C17:0 iso 0.60 
C17:0 anteiso 0.56 
C10:0 3OH 1.07 
C11:0 3OH 1.11 
C12:0 3OH 5.15 
Summed feature 1 (C15:0 iso H/C13:0 3OH) 0.62 
Summed feature 3 (C16:1 ω7c/C16:1 ω6c) 35.82 
Other 4.03 
 
  
 
Supplementary figure 1: Phylogenetic tree based on 16S rRNA gene sequences of 
Pseudoalteromonas type strains. The novel species P. galatheae S3431 sp. nov. placed itself in the 
non-pigmented clade, near P. translucida DSM 14402T, P. antarctica CECT 4664T, P. nigrifaciens 
NCIMB 8614T, and P. haloplanktis DSM6060T. The 16S rRNA gene sequences were aligned in MEGA 5 
and the phylogenetic reconstruction was based on the maximum likelihood method with the Kimura 
2-parameter model, with a Gamma distribution model allowing invariant sites to model the 
evolutionary rate differences. Scale bar: 0,005 substitutions per nucleotide site. 
  
 P. elyakovii KMM 162T (AF082562) 
 P. paragorgicola DSM 14403T (AY040229) 
 P. distincta KMM 638T (AF082564) 
 P. arctica LMG 23753T (DQ787199) 
 P. agarivorans DSM 14585T (AJ417594) 
 P. espejiana DSM 9414T (X82143) 
 P. atlantica DSM 6839T (X82134) 
 P. translucida DSM 14402T (AY040230) 
 P. galatheae S3431T  sp. nov. 
 P. antarctica CECT 4664T (X98336) 
 P. nigrifaciens NCIMB 8614T (X82146) 
 P. haloplanktis DSM 6060T (X67024) 
 P. marina DSM 17587T (AY563031) 
 P. undina DSM 6065T (X82140) 
 P. tetraodonis DSM 9166T (X82139) 
 P. carrageenovora DSM 6820T (X82136) 
 P. issachenkonii DSM 15925T (AF316144) 
 P. aliena DSM 16473T (AY387858) 
 P. prydzensis DSM 14232T (U85855) 
 P. mariniglutinosa DSM 15203T (AJ507251) 
 P. donghaensis HJ51T (FJ754319) 
 P. lipolytica LMEB 39T (FJ404721) 
 P. denitrificans DSM 6059T (X82138) 
 P. tunicata DSM 14096T (Z25522) 
 P. ulvae DSM 15557T (AF172987) 
 P. aurantia DSM 6057T (X82135) 
 P. citrea DSM 8771T (X82138) 
 P. phenolica JSM 21460T (AF332880) 
 P. ruthenica LMG 19699T (AF316891) 
 P. spongiae JCM 12884T (AY769918) 
 P. luteoviolacea DSM 6061T (X82144) 
 P. rubra DSM 6842T (X82147) 
 P. maricaloris LMG 19692T (AF144036) 
 P. flavipulchra DSM 14401T (AF297958) 
 P. piscicida ATCC 15057T (X82215) 
 P. peptidolytica DSM 14001T (AF007286) 
53 
48 
20 
10 
34 
13 
26 
49 
33 
63 
17 
31 
18 
65 
17 
1 
90 
4 
3 
40 
1 
57 
68 
43 
0,005 
PAPER 4 
 
 
 
 
Vynne N, Månsson M, Nielsen KF, Milton D, Gram L (2012) 
 
Production of a putatively novel acylated homoserine lactone-like quorum sensing activating 
molecule by Pseudoalteromonas luteoviolacea S4054 
 
Manuscript in preparation. 
Production of a putatively novel acylated homoserine lactone-like quorum sensing 1 
activating molecule by Pseudoalteromonas luteoviolacea S4054 2 
 3 
Vynne, N. G.1 *, Månsson, M.2, Nielsen, K.F.2, Milton, D.3 and Gram, L.1 4 
1: National Food Institute, Technical University of Denmark, Søltofts Plads bld. 221, DK-2800 Kgs. Lyngby, 5 
Denmark 6 
2: Department of Systems Biology, Technical University of Denmark, Søltofts Plads bld. 221, DK-2800 Kgs. 7 
Lyngby, Denmark 8 
3: Department of Molecular Biology, Umeå University,  S-901 87 Umeå, Sweden. 9 
 10 
*: corresponding author.  11 
e-mail: ngvy@food.dtu.dk 12 
Keywords: Quorum sensing, Pseudoalteromonas luteoviolacea, antibiotics, lux,  13 
 14 
Running title: AHL-like molecules in Pseudoalteromonas luteoviolacea15 
Abstract 16 
The bioactive strain Pseudoalteromonas luteoviolacea S4054 produces antibiotics and compounds capable 17 
of eliciting a signal response in the quorum sensing monitor strains Agrobacterium tumefaciens pZLR4, 18 
Chromobacterium violaceum CV026, and Escherichia coli JM109 pSB401.  Since quorum sensing in some 19 
cases control the production of antibiotics, we hypothesized that quorum sensing might be involved in 20 
control of antibiotic production by P. luteoviolacea S4054. Through shotgun cloning the pluI gene was 21 
identified as the gene coding for production of the signaling compounds. pluI showed homology to luxI AHL 22 
synthethases from Vibrionaceae and other Proteobacteria, but formed a monophyletic branch in 23 
phylogenetic analysis of luxI homologues indicating that pluI encodes a novel AHL synthethase. Genome 24 
sequencing revealed that pluI is located in an operon structure with downstream genes that may constitute 25 
a biosynthetic pathway potentially involved in biosynthesis of the potent antibiotic indolmycin. 26 
Immediately downsteam of the operon, the luxR homologue pluR was located on the opposite DNA strand. 27 
Chemical analysis of the signaling molecules revealed AHL-like traits, however it was not possible to identify 28 
the compounds using standard methods for AHL identification indicating that the signaling molecules might 29 
represent novel AHL-like compounds. 30 
  31 
Introduction 32 
Cell-density dependant signaling occurs widely among bacteria and is commonly termed quorum sensing 33 
(QS). QS allows a population of cells the benefits of coordinated gene expression, sensing the presence of 34 
other signal molecule producing microorganisms or possibly probing the local environmental conditions. A 35 
common QS system in the γ-Proteobacteria is the LuxI-LuxR system. This QS system was first described in 36 
Vibrio fischeri (8), where it regulates the expression of bioluminescence genes in a cell-density dependent 37 
manner. The signaling molecules of this system are N-acylated homoserine lactones (AHLs) and are 38 
produced by LuxI AHL synthethases (9). AHLs are produced continuously at low cell-densities AHLs, but as 39 
cell-density in the local environment increases, the concentration of AHLs reaches a threshold level and 40 
activates the QS regulated system through binding to the transcriptional regulator LuxR. This activates gene 41 
expression of the QS regulated phenotype, in the case of V. fischeri bioluminescence. In some bacteria, 42 
expression of the luxI gene is also increased leading to a strong autoinducing effect (25).  Some non-AHL 43 
molecules such as diketopiperazines are capable of modulating the Lux-system to activate or repress the 44 
signaling response (11,15). Hence the QS regulated phenotypes may be influenced by AHLs or by other 45 
compounds.   46 
For some bacteria, QS no doubt holds an important role in microbial community interactions through 47 
regulation of phenotypes such as biofilm formation, motility and production of antimicrobial compounds 48 
(10). In the marine environment, multiple bacterial species will be present on most surfaces and 49 
competition for space and nutrients is believed to play a major role in shaping the microbial community 50 
(14). The production of antibacterial compounds is one way for a bacterium to modulate the surrounding 51 
community and QS regulation of biosynthetic pathways for production of antibacterial compounds is well 52 
known (6,32). Recently production of the potent antibacterial compound tropodithietic acid was 53 
demonstrated to be QS controlled in Phaeobacter gallaeciensis (1), a member of the ecologically significant 54 
Roseobacter clade (2). Previous studies have indicated that AHLs are produced by Pseudoalteromonas 55 
species associated with different microbial communities (17,18), however, few studies have addressed the 56 
actual regulatory role of the compounds. Violacein, which is a key metabolite of the P. luteoviolacea species 57 
and may protect against predation (22), is produced under QS regulation in both distant and closely related 58 
organisms such as Chromobacterium violaceum and Pseudoalteromonas sp. 520P1 (23,37). A LuxI-LuxR 59 
system in P. luteoviolacea could potentially regulate production of violacein, but also of other bioactive 60 
compounds such as pentabromopseudilin and indolmycin which we previously identified in a collection of 61 
P. luteoviolacea strains (20,35,35).  62 
The purpose of the present study was to determine if QS regulatory systems could be involved in antibiotic 63 
production by P. luteoviolacea. We demonstrate that compounds inducing AHL-monitor bacteria are 64 
present in some but not all violacein producing P. luteoviolacea strains. In one AHL-monitor-inducing strain, 65 
P. luteoviolacea S4054, we identify a luxI gene homologue and we investigate the genomic context of this 66 
gene to identify a gene homologue to known luxR genes. We identify a putative novel biosynthetic pathway 67 
in an operon structure with the luxI gene, which is likely quorum sensing regulated. Thorough chemical 68 
analyses did, however, not lead to identification of any known AHL molecule and we conclude that the AHL-69 
like compound(s) likely represent a novel AHL structure. 70 
 71 
Materials and methods 72 
Strains, plasmids and media. Thirteen Pseudoalteromonas luteoviolacea strains previously described (34) 73 
were included in this study. P. luteoviolacea strains were routinely cultured at 25 ºC in a marine minimal 74 
medium (27) with 4 g/l mannose and 3 g/l casamino acids, unless otherwise mentioned. Chromobacterium 75 
violaceum CV026 was cultured in Luria broth (per litre: Bacto Tryptone, 10 g; Bacto yeast extract, 5 g; and 76 
sodium chloride, 5 g) at 25 ºC with 20 µg/ml kanamycin (23).  Agrobacterium tumefaciens pZLR4 was 77 
cultured in ABT medium (per litre: (NH4)2SO4 0.4 g, Na2HPO4 0.6 g, KH2PO4 0.3 g, NaCl 0.3 g, 1 mM MgCl2, 78 
0.1 mM CaCl2, 0.01 mM FeCl3, 2.5 mg thiamin supplemented with 0.5% glucose and 0.5% cas-amino acids) 79 
(4)  supplemented with 20 µg/ml gentamicin. The bacterial strains and plasmids used for cloning 80 
procedures in this study are listed in table 1. E. coli strains were grown at 37 ºC in Luria broth 81 
supplemented with carbenicillin 100 µg/ml or tetracyclin 10 µg/ml. All broth cultures were incubated with 82 
agitation, and supplemented with 1.2% agar as required. 83 
Bioassays for detection of potential QS activating molecules. Well diffusion agar assays were used to 84 
screen for the presence of QS activating molecules in sterile filtered culture supernatants and ethyl acetate 85 
extracts. Ethyl acetate extracts were prepared as described for LC-MS analysis. To prepare the assays, 50 ml 86 
overnight culture of C. violaceum CV026 was added to 100 ml molten LB-agar at 46 ºC, supplemented with 87 
20 µg/ml kanamycin (23), or 50 ml overnight culture of A. tumefaciens pZLR4 were added to 100 ml ABT-88 
agar at 46 ºC supplemented with 20 µg/ml gentamicin and 75 µg/ml X-gal (3). The solution was poured into 89 
petri dishes to form a 5 mm thick layer. Wells were cut after the agar had solidified and 50 µl sample was 90 
loaded per well. The assays were incubated at 25 ºC and read after 24 and 48 h. Simple T-streaks against C. 91 
violaceum CV026 were used to screen E. coli clones for production of QS activating compounds (23).  92 
The monitor strain E. coli JM109 pSB401 (40) was used as a heterologous host to express and detect 93 
potential QS activating molecules. The E. coli JM109 clones containing both the pSB401 plasmid and a 94 
pBluescript construct were plated on LB-agar with 50 µg/ml carbenicillin, 10 µg/ml tetracyclin, 20 µg/ml 95 
IPTG and 50 µg/ml X-gal, incubated overnight at 37 ºC and screened for bioluminescence using a LAS-4000 96 
(Fujifilm Life Sciences, USA).  97 
Thin layer chromatography (TLC). Ethyl acetate extracts or synthetic AHL standards were spotted onto a 98 
C18 TLC plate (TLC aluminum sheets 20×20 cm
2, RP-18 F254 S, 1.05559. Merck 64271 Darmstadt, Germany) 99 
and the plates were developed in 10 ml 60:40 (v/v) methanol/water until the front reached the top (28). 100 
The TLC plate was dried and agar top-layers were prepared as for the well diffusion assay. The top layer of 101 
bacterium-containing agar was poured onto the TLC plate immediately following preparation, and 102 
incubated at 25 ºC for 24h. 103 
PCR conditions, DNA techniques, DNA sequencing and bioinformatics. PCR was performed as previously 104 
described (5,24). Unless otherwise stated, all conditions for the various DNA techniques were as described 105 
by (30). Reaction conditions for DNA-restriction enzymes were as suggested by the manufacturers. DNA 106 
sequencing of the unknown DNA regions obtained from shotgun cloning was performed by primer walking 107 
in two directions from known regions of DNA sequence using the primers listed in table 2.  Sequence data 108 
were processed and assembled in CLC-bio DNA workbench, and MEGA 5 was used for sequence alignment 109 
and phylogenetic reconstruction. 110 
Shotgun cloning to identify genes involved in QS. Genomic DNA was purified from P. luteoviolacea S4054 111 
using the QIAGEN Genomic-Tip/100 kit. The genomic DNA was digested with EcoRI or BamHI and ligated 112 
into the corresponding pBluescript digest. The shotgun library obtained in pBluescript was transformed into 113 
chemically competent E. coli JM109 pSB401, incubated overnight at 37 ºC and screened for luminescence. 114 
Luminescent clones were tested for induction of violacein production in C. violaceum CV026 by T-streaks, 115 
and the pBluescript vector from positive clones was cloned by transformation into chemically competent E. 116 
coli DH5-α λpir, plated on LB-agar with 50 µg/ml carbenicillin and incubated overnight at 37 ºC. The 117 
resulting clones were verified for activity in the C. violaceum CV026 bioassay and the pBluescript DNA insert 118 
was sequenced using a primer walking method. 119 
LC-MS and LC-MS/MS analyses. P. luteoviolacea S4054, E. coli NV5, and E. coli NV1 were grown in MMM 120 
for 3 days at 25°C and the cultures were extracted with equal volumes of ethyl acetate, centrifuged, and 121 
the ethyl acetate phase was evaporated under N2 to dryness. Samples were redissolved in 500 μl MeOH 122 
and analysed by LC-MS. LC-MS analyses were performed on an Agilent 1100 System equipped with a 123 
UV/VIS photo diode array detector (scanning 200–600 nm). Separation was done on a 100 mm×2 mm i.d., 3 124 
μm Gemini C6-phenyl column (Phenomenex, Torrance, CA, USA), running at 40°C using gradient (15-100% 125 
over 20 minutes) of water (H2O) and acetonitrile (MeCN); both buffered with 50 μl/l trifluoroacetic acid) at 126 
a flow of 300 μl/min. LC-MS/MS analyses were performed on a maXis quadrupole time of flight mass 127 
spectrometer (Bruker Daltonics, Bremen, Germany) equipped with an electrospray (ESI) ion source. The MS 128 
was connected to an Ultimate 3000 UHPLC system (Dionex, Sunnyvale, CA) equipped with a diode-array 129 
detector. Separation was performed at 40 °C on a 150 mm × 2.1 mm ID, 2.6 μm Kinetex C18 column 130 
(Phenomenex) using a linear water/MeCN (both buffered with 20 mM formic acid) gradient starting from 131 
15% MeCN and increased to 100% in 13 min at a flow of 0.4 mL min−1. Experiments were performed in ESI+ 132 
with a data acquisition range of m/z 100–1200 with collision energy of 40 V. The MS was calibrated using 133 
sodium formate automatically infused prior to each analytical run. 134 
Purification and structure elucidation of the QS activating molecule. Preparative TLC was performed on 135 
C18 plates (20 x 20 cm, Analtech). On each plate, approximately 20 mg of crude extract was loaded in 500 136 
uL 50/50 (v/v) MeOH/H2O with a solvent streaker. Plates were developed in 60% MeOH in water. To 137 
visualize the active compounds, the plates were overlaid with agar containing C. violaceum CV026 or A. 138 
tumefaciens pZLR4 as described above but limited to a 3 cm wide band at the left and right edges.  139 
Three different solid phase extraction columns were attempted on a small scale (2 mg crude extract): 140 
Strata-X (30 mg/1 mL, Phenomenex), Strata-NH2 (100 mg/1 mL, Phenomenex), and diol (100 mg/1 mL, 141 
Phenomenex). From all three columns, five fractions were collected and tested in the QS assays. From 142 
Strata-X: 100% H2O, 25% MeOH in H20, 40% MeOH, 60% MeOH, and 100% MeOH. From Strata-NH2: 95% 143 
MeCN in H2O, 60% MeCN, 40% MeCN, 25% MeCN, and 100% H2O. From diol: 100% heptane, 100% 144 
dichlormethane, 100% EtOAc, 50% EtOAc in MeOH, and 100% MeOH. Fractions were evaporated under N2 145 
and redissolved in 100% MeOH immediately before biotesting.  146 
An 8 L culture of P. luteoviolacea S4054 was grown in Marine Broth 2216 (Difco, USA). On day 3, a mixture 147 
(50/50) of sterile XAD-7 (Sigma-Aldrich, St. Louis, MO) and Diaion HP20SS resin (Sigma-Aldrich) was added 148 
to the broth (12 g of resin L−1). After 24 h the resin was filtered off and washed with water (2 x 2 L), 149 
followed by extraction with methanol/water (50/50 v/v; 800 mL) (24h) and methanol (2 x 800 mL) (24 h). 150 
All organic extracts were pooled and dried completely to give a crude extract (2.0712 g). Violacein and 151 
indolmycin were quantitatively removed from the extract by cation-exchange as previously described (20). 152 
The remaining extract was subjected to anion-exchange. The crude extract (640 mg) was re-dissolved in 153 
methanol/water (50/50 v/v; 5 ml) and mixed with 3 g Strata-SAX (Phenomenex, Torrance, CA) and dried 154 
before packing into a 100 g SNAP column (Biotage, Uppsala, Sweden).  Using an Isolera flash purification 155 
system (Biotage), the column was equilibrated (5 mL/min) upside-down with water + ammonium hydroxide 156 
(2%). The column was then turned and washed with methanol with ammonium hydroxide (2%) (fraction 1). 157 
The column was then stripped with methanol with formic acid (1%) and washed until no colour remained 158 
(fraction 2). Fraction 1, enriched with QS activity, was redissolved in EtOAc and absorbed onto xx g Isolute 159 
diol (Biotage) and added to a 100 g SNAP column with pure diol (10 g). A total of 12 fractions were collected 160 
ranging from heptane, dichloromethane, EtOAc to pure MeOH (5 mL/min).  The fractions with QS activity 161 
(100 % dichloromethane to 20% dicholormethane) were pooled and further separated on a Luna II C18 162 
column (250 × 10 mm, 5 μm) (Phenomenex) using a 10-90% MeCN/H2O gradient (buffered with 20 mM FA, 163 
flow rate 5 mL/min) over 20 minutes on a Gilson 322 liquid chromatograph with a 215 liquid 164 
handler/injector (BioLab, Risskov, Denmark). This yielded four fractions with QS activity. NMR spectra were 165 
recorded on a Varian Unity Inova 500 MHz spectrometer equipped with a 5 mm probe using standard pulse 166 
sequences. The signals of the solvent were used as internal references (δH 4.80 for D2O).  167 
Stability test of AHL-like compounds. The lactone ring of classic AHLs opens under alkaline conditions, 168 
leading to a loss of QS inducing activity. To test the AHL-like nature of the compounds obtained from 169 
chemical fractionation, the compounds and a mix of synthetic AHLs were suspended in solutions of pH 2, 170 
pH 7, and pH 11 for two hours, after which samples were tested in well diffusion agar assays against the 171 
monitor strain A. tumefaciens pZLR4.  172 
Genome mining for luxI – luxR gene pairs and quorum sensing controlled gene clusters. A permanent 173 
draft genome of P. luteoviolacea was obtained by sequencing and assembly as described elsewhere (33). 174 
The genome sequence was submitted to the IMG ER pipeline for annotation and visualization (21). The 175 
nucleotide sequence obtained from cloning experiments was identified and the neighboring gene clusters 176 
investigated. luxR homologue genes were identified by a search for genes with the Pfam 03472 autoinducer 177 
binding domain or genes in COG2771 . The resulting genes were submitted to BLASTX and LuxR to identify 178 
LuxR homologues. The gene cluster downstream of the luxI homologue gene was investigated for its 179 
putative biological function through analysis of the annotations and BLAST. 180 
 181 
Results and discussion 182 
Characterization and production of AHL-like molecules by Pseudoalteromonas luteoviolacea strains. 183 
Thirteen Pseudoalteromonas luteoviolacea strains were cultured overnight in MMM and sterile filtered 184 
supernatants were tested in well assays using C. violaceum CV026 or A. tumefaciens pZLR4 monitor strains. 185 
Three strains (S4047-1, S4054, and CPMOR-1) activated both monitor strains indicating the presence of 186 
AHL-like compounds in the growth supernatants. Ten strains did not activate either monitor strain, but 187 
were previously shown to produce violacein. Hence, violacein production in P. luteoviolacea is not 188 
universally regulated by molecules that elicit a response in traditional QS monitor strains. We previously 189 
showed that the three strains are closely related produce indolmycin, an antibiotic compound not 190 
produced by the remaining 10 P. luteoviolacea strains (34), hence it was tempting to speculate that 191 
indolmycin production could be QS regulated. Organic extracts of overnight cultures of the QS-activating 192 
strains were prepared and loaded on a TLC plate, subsequently overlaid with A. tumefaciens pZLR4 (figure 193 
1). Figure 1 shows the presence of at least three putative AHL-like compounds in the culture supernatant of 194 
strain S4054, which was chosen for further studies of the potential QS system.  195 
Cloning and characterization of a luxI homologue from P. luteoviolacea S4054. To elucidate the genetics 196 
of the putative QS system in P. luteoviolacea S4054 a shotgun cloning approach was applied, in which a 197 
shotgun library was screened for its ability to induce luminescence in E. coli JM109 pSB401 when expressed 198 
in the same host. Twenty three luminescent clones were isolated and tested against the C. violaceum 199 
CV026 monitor strain. Clones NV-5 and NV-17 elicited the strongest response based on the intensity of 200 
violacein production in CV026 and in TLC bioassays a pattern similar to the wild type was observed. Hence, 201 
the DNA fragment cloned from S4054 encodes a gene which is expressed in E. coli DH5-α λpir and enables 202 
synthesis of AHL-like compounds. A restriction pattern analysis was carried out on the insert DNA 203 
fragments from positive clones which indicated that NV-5 and NV-17 clones contained the same DNA 204 
fragment, with an additional fragment in NV-17 (data not shown). Since NV-5 produced the strongest 205 
response in CV026 and contained the shortest DNA insert, this construct was chosen for sequencing based 206 
on a primer walking strategy. In the resulting nucleotide sequence the gene pluI with homology to various 207 
luxI genes was identified using BLAST. The 20 best BLASTX hits were used to produce the phylogenetic tree 208 
in figure 2, which placed PluI on a monophyletic branch adjacent to LuxI proteins from primarily 209 
Vibrionaceae, which are known to synthetize AHL molecules (9). Hence, molecular and bioinformatics 210 
analyses provided evidence that pluI encodes a novel LuxI homologue AHL-synthethase involved in the 211 
production of AHL-like molecules by P. luteoviolacea S4054. 212 
Analysis of the genomic context of pluI. To facilitate analysis of the genomic context of the pluI gene whole 213 
genome sequencing was done (33). The genome confirmed the pluI sequence obtained by cloning and 214 
subsequent primer walking. Upstream of pluI a palindromic sequence resembling a Lux-box was identified. 215 
In canonic LuxIR systems the Lux-box is targeted by the LuxR protein for DNA binding suggesting that the 216 
downstream genes are QS regulated. pluI was situated in an operon structure (figure 3) and immediately 217 
following the operon, a luxR homologue pluR was identified on the opposite DNA strand. The genes pluI 218 
and pluR likely form a QS system for regulation of gene expression. The putative operon structure very 219 
likely contained genes regulated by this PluIR system in a genomic organization parallel to the V. fischeri 220 
luxI-CDABEG genes (8). Annotation of the genes contained in the operon structure showed functions such 221 
as aminotransferases and a methyltransferase which are included in the biosynthetic pathway of the 222 
antibiotic indolmycin (16), however as the genes involved in biosynthesis of indolmycin are not known, 223 
further studies are required to determine the actual product of the putative pluIR regulated operon. The 224 
presence of a tryptophanyl tRNA synthethase in the operon also suggests a link to indolmycin, which is 225 
tryptophan derived and selectively targets tryptophanyl tRNA to exert its antibacterial activity (38). 226 
Chemical analysis of AHL-like compounds from P. luteoviolacea S4054. The supernatant was analyzed for 227 
the presence of AHL-like molecules in the TLC assay with Agrobacterium and Chromobacterium. None of 228 
the signals were present in the blank medium. The strong response in the A. tumefaciens pZLR4 monitor 229 
strain coupled with a weaker response in C. violaceum CV026 suggests that the QS activating molecules 230 
share characteristics with 3-oxo substituted AHLs (3). When subjected to alkaline conditions, the synthetic 231 
AHL standards and the QS activating compounds isolated from strain S4054 lost the ability to elicit a 232 
response in the QS monitor strain A. tumefaciens pZLR4, as would be expected from AHLs (42).  233 
Ethyl acetate extracts and supernatants of cultures of s4054 were investigated for the presence of AHLs 234 
using validated LC-HRMS methods (36). No peaks matched the retention time or accurate mass of 235 
commonly found AHL compounds or any analogues reported in literature (19). LC-MS/MS experiments (26) 236 
with in-source fragmentation (40 V) were performed in order to confirm the presence of potential novel 237 
AHL analogues. Blank medium spiked with AHL standards was used as positive control to ensure that there 238 
was no ion suppression. However, the characteristic fragment of 102 Da corresponding to the lactone 239 
moiety of the AHLs could not be observed in any of the P. luteoviolacea extracts. With the potential of a 240 
completely novel QS compound, the metabolite profiles of s4054 and the E. coli clone NV5 were compared 241 
as common peaks are likely candidates for the QS compound(s). The E. coli clone NV1 containing the 242 
pBluescript vector without the luxI insert was used as negative control. However, no shared compounds 243 
were detected between S4054 and clone NV5, suggesting that the AHL molecules were present in very low 244 
amounts or did not perform well in the chromatography. S4054 and NV5 were subjected to preparative 245 
reverse phase C18 TLC in order to investigate more pure fractions of the QS compound, yet it was not 246 
possible to obtain sufficient resolution. Likewise, it was not possible to obtain resolution of the QS activity 247 
when subjecting the crude extracts to different solid phase extraction columns (C18, diol, amino) with a 248 
finer particle size.  As the QS compound might be present in concentrations below the detection limits of 249 
our instruments, an 8 L culture was prepared and subjected to cation- and anion-exchange to remove 250 
charged compounds. As expected for AHL-like compounds, the activity was recovered from the neutral 251 
fraction. Subsequent purification was done on diol and C18 to obtain orthogonal separation of the 252 
compounds. This led to four fractions with QS activity. However, it was not possible to deduce an accurate 253 
mass from LC-MS analyses. The active fractions were analysed by NMR, which revealed the presence of an 254 
NH-proton and a large aliphatic moiety consistent with an AHL; however, the amounts obtained were 255 
insufficient for detailed structural analysis. Overall, NMR and chromatographic behavior suggest that we 256 
are dealing with an AHL-like molecule, potentially with a modification in the homoserine lactone or with 257 
multiple oxo/hydroxyl-groups causing tailing which makes it difficult to detect on columns traditionally 258 
used for AHL purification (36).  259 
 260 
  261 
Conclusion. P. luteoviolacea S4054 produced molecules that elicited QS responses in the monitor strains 262 
C.violaceum CV026, A. tumefaciens pZLR4, and E. coli JM109 pSB401.This, in addition to genomic evidence 263 
and indications from chemical analyses, provided strong evidence for the AHL-like nature of these 264 
molecules, however we were unable to elucidate the complete structure of the active compounds. The pluI 265 
gene forms a monophyletic cluster in a phylogenetic analysis of luxI homologues which indicates that it 266 
might represent a novel family of LuxI synthethase homologues. The pluI gene was located in an operon 267 
structure with a potential biosynthetic pathway downstream of pluI. This pathway was not related to the 268 
violacein pathway, which appears to not be quorum sensing regulated in P. luteoviolacea, but some gene 269 
functions corresponded to known biosynthetic steps in the biosynthesis of the potent antibiotic indolmycin. 270 
Quorum sensing regulation of antibiotic production is potentially an important modulating factor in 271 
microbial communities, and further work is warranted to elucidate the mechanisms of the P. luteoviolacea 272 
S4054 QS system and its in situ function. 273 
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 Figure 1: TLC of extract from P. luteoviolacea S4054. A: 10 µl ethyl acetate extract from P. luteoviolacea 
overnight culture in MMM. At least three spots are visible in lane A, indicative of three or more AHL-like 
compounds in the sample.  The amounts of synthetic AHLs loaded as standards were: OHHL 10 pM, HHL 3 
nM, and OHL 3.8 pM.  
  280 
 Figure 2: Phylogenetic tree of the top 20 BLASTX hits for the pluI gene. The tree is based on a multiple 
sequence alignment of translated nucleotide sequences calculated in MEGA5 (31), which was also used to 
infer the phylogeny using the maximum likelihood method based on the Whelan and Goldman model (39). 
The rigidity of the tree was tested using 100 bootstrap replications as indicated for nodes supported 70% or 
higher. PluI forms a monophyletic branch adjacent to LuxI proteins from mostly Vibrionaceae and far 
removed from the P. atlantica protein. This supports the hypothesis that PluI represents a novel AHL 
synthethase. Scale bar:  substitutions per site. 
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 autoinducer synthesis protein LuxI Vibrio fischeri MJ11 (YP002158590.1) 
 LuxI Cloning vector pLR3 (ADP02959.1) 
 luxI Aliivibrio fischeri (CAA68562.1) 
 LuxI Aliivibrio fischeri (AAP22376.1) 
Autoinducer synthesis protein luxI Vibrio (P35328.1)   
 3-oxo-C6-HSL autoinducer synthesis protein LuxI Vibrio fischeri ES114 (YP 206882.1) 
 autoinducer synthesis protein LuxI Aliivibrio logei (AEK79977.1) 
 autoinducer synthesis protein LuxI Aliivibrio salmonicida LFI1238 (YP 002265246.1) 
 LuxI Aliivibrio salmonicida (AAM46725.1) 
 hypothetical protein Shewanella hanedai (BAF40893.1) 
 LuxI autoinducer synthesis protein Reinekea sp. MED297 (ZP 01113403.1) 
 autoinducer synthesis protein luxI Vibrio furnissii CIP 102972 (ZP 05878948.1) 
  acyl-homoserine-lactone synthase Vibrio ordalii ATCC 33509 (ZP 09363603.1) 
  acyl-homoserine-lactone synthase Vibrio anguillarum 775 (YP 004577681.1) 
 PluI P. luteoviolacea S4054 
 autoinducer synthesis protein Pseudoalteromonas atlantica T6c (YP 659946.1) 
  unnamed protein product Saccharophagus degradans 2-40 (YP 528965.1) 
 Acyl-homoserine-lactone synthase Hyphomicrobium denitrificans 1NES1 (EHB75527.1) 
 N-acyl-L-homoserine lactone synthetase Burkholderia dolosa AUO158 (ZP 04947583.1) 
 UnaI protein Burkholderia unamae (CBI71277.1) 
 unnamed protein product Burkholderia phymatum STM815 (YP 001860597.1) 
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 Figure 3: Genomic organization of QS related elements in P. luteoviolacea S4054 and a putatively QS 
regulated operon. Predicted functions: Dark blue: pluI, red: aminotransferase, yellow: dehydrogenase, 
green: methyltransferase, grey: hypothetical protein, purple: coenzyme F390 synthethase, pink: 
methylase, brown: lyase, olive: tryptophanyl t-RNA synthethase, light blue: pluR. Upstream of pluI a 
palindromic sequence reminiscent of a lux-box was identified (not shown). 
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Table 1: Bacterial strains and plasmids used in this study.   
Strain or plasmids Genotype or relevant markers Source 
Pseudoalteromonas luteoviolacea   
DSM 6061 (T) Type strain, wild type DSMZ 
S2607 Wild type (13) 
S4047-1 Wild type (13) 
S4054 Wild type (13) 
S4060-1  Wild type (13) 
CPMOR-1 Wild type (12) 
CPMOR-2 Wild type (12) 
2ta16 Wild type (29) 
H33 Wild type T. Harder, unpublished 
H33S Wild type T. Harder, unpublished 
NCIMB 1942 Wild type NCIMB 
NCIMB 1944 Wild type NCIMB 
NCIMB 2035 Wild type NCIMB 
   
Chromobacterium violaceum 
CV026   
Agrobacterium tumefaciens 
pZLR4   
   
Escherichia coli   
DH5α-λ pir F−Φ80dlacZΔM15 Δ(lacZYA-argF 
U169 deoR supE44 hsdR17 recA1 
endA1 gyrA96 thi-1 relA1 (7) 
JM109  recA1 endA1 gyrA96 thi hsdR17 
supE44 relA1Δ(lac-
proAB) mcrA [F′traD36 proAB 
lacIqlacZΔM (41) 
   
Plasmids   
pBluescript  Apr; ColE1 origin Stratagene 
pSB401 Tcr; p15A origin (40) 
 284 
  285 
Table 2: Primers used for sequencing. 
Primer Sequence 5'-3' 
T3 AAT TAA CCC TCA CTA AAG GG 
T7 GTA ATA CGA CTC ACT ATA GGG C 
NV5-1 TCG GGT GAG AAT ATT 
NV5-2 ACG TAA TCA ATG CCT 
NV5-3 AAA ACA TGG CCA ACC 
NV5-4 TTG AAG AGT TTG CGT 
NV5-5 TAT CGC GGC AAA TCG 
NV5-6 TGT TAC TTA ATG AAG 
NV5-7 CTT CTT GCC AAT AGC 
NV5-8 AGC TCT ATC CCT GAT 
NV5-9 GTA TTG GCG CGT TCA 
NV5-10 CTA CGT TAC GTT TAC 
NV5-11 GCT TCA TTG TAA TAC 
NV5-12 TGC AGT AGA TAA GCA 
NV5-13 CGA GTT TAA AGC CGT 
NV5-14 GTG AGC TGT TCG CAG 
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Abstract: The ability to produce antibacterial compounds is wide spread among members of the 13 
genus Pseudoalteromonas. Here we present the 6.08-Mb draft genome sequence of P. luteoviolacea 14 
S4054, which produces the antibiotics violacein and indolmycin, and investigate the potential for 15 
further discoveries of bioactive compounds. 16 
  17 
Marine bacteria are widely investigated as a potential source of novel molecules with 18 
pharmacologically relevant activites. Several species of the genus Pseudoalteromonas produce 19 
antibacterial, antifouling or cytotoxic compounds (9) (1), however the ecological role of these 20 
compounds is not yet fully understood. Often, the bioactive Pseudoalteromonas have been isolated 21 
from the surfaces of marine eukaryotes and their bioactivity may be part of a symbiotic relationship 22 
(2). P. luteoviolacea S4054 was isolated from a seaweed sample in the Pacific Ocean and it produces 23 
the antibacterial compounds violacein and indolmycin (9) (7). Violacein is produced by different 24 
bacterial species, while to our knowledge indolmycin has not previously been isolated from a marine 25 
bacterium. The biosynthetic pathways responsible for production of these compounds are candidates 26 
for horizontal gene transfer events in S4054, however, only the violacein pathway is described on a 27 
genetic level, enabling identification through homology searches.  28 
 29 
Genomic DNA was obtained by successive phenol-chloroform purification steps. Mated paired-end 30 
library preparation, Illumina Hi Seq 2000 sequencing runs and initial data processing were done by 31 
BGI (Beijing, China). After quality filtering and trimming, the short reads were assembled and gaps 32 
filled using SOAPdenovo (6). This resulted in 126 contigs at a depth of 30.8-fold genome coverage 33 
and a total length of 6,076,381 bp. The draft genome was uploaded to the IMG/ER pipeline for gene 34 
annotation. A total of 5,268 genes were annotated, 5,121 of which were protein encoding. One 35 
hundred and twenty six genes fell into COG categories in secondary metabolism, with 30 genes in 36 
COG1020 (non-ribosomal peptide synthase modules and related proteins) and 20 genes in COG1028 37 
(dehydrogenases). Ten genes encoded proteins involved in PKS biosynthesis. BLASTP homology 38 
searches identified 5 genes encoding proteins VioA, B. C, D and E which form the violacein 39 
biosynthetic pathway (5). Upstream of the VioA-E genes, a gene encoding a multi-antimicrobial and 40 
toxic compound extrusion pump was located, similar to the organization found in the 1 
Pseudoalteromonas tunicata D2 genome (8). In addition to the violacein pathway, six biosynthetic 2 
pathways were identified containing clusters of potential polyketide synthase or nonribosomal peptide 3 
synthesis coding genes. Genes encoding surface attachment related functions such as curli, type IV 4 
pili and P pili were identified, suggesting a surface associated lifestyle. The genome contained a 5 
necrosis inducing protein NPP1 homologue indicating a potential for plant pathogenicity (3). In 6 
addition, the genome had potential for quorum sensing regulated processes based on the presence of 7 
one pair of luxI - luxR genes (4). 8 
 9 
The data presented here provides further insight on the genetic potential for production of bioactive 10 
secondary metabolites within the pseudoalteromonads, and we believe it may advance studies on the 11 
ecology of these organisms. 12 
 13 
Nucleotide accession number The draft genome sequence for P. luteoviolacea S4054 is deposited 14 
in GenBank under the accession number XXXXXXXXXXXXXXX. 15 
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